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Nomenclature
The nomenclature used to describe the genes and proteins of Saccharomyces cerevisiae 
is different to that used for other organisms, therefore a brief explanation is appropriate. 
Genes and their encoded protein are given the same name consisting of three letters and 
a number. The authors that describe identification of a new gene or protein designate 
these letters and numbers. Often genes are identified through screens for mutants, 
therefore the name will come from the screen (CDC31, cell division cycle mutant 
number 31; MPS2, monopolar spindle mutant number 2). Alternatively, the name may 
be a description of the protein (SPC29, spindle pole component with a molecular weight 
of 29 kDa). Gene names are given in upper case italics (SPC29) unless the gene has 
been mutated, then the gene name is given in lower case italics (spc29), if  the mutation 
results in a temperature sensitive phenotype the gene name is followed with (ts), for 
example spc29(ts). Mutants are often given additional numbers to distinguish between 
different mutations in the same gene, for example spc29-2. If a gene is completely 
deleted from the genome or contains a deletion within the coding sequence, this is 
described with zl, for example Aspc29::HIS3 describes a strain in which the SPC29 
gene has been deleted from the genome and replaced (::) with the HIS3 gene. When 
referring to the protein the name is not given in italics, the first letter is given in upper 
case, the following two letters are given in lower case and the number is followed with 
a p (for protein), for example Spc29p.
Yeast strains are usually given names that describe the identity of the individual that 
constructed the strain, followed by a number (SEYM, Sarah Elliott yeast strain number 
14). The same applies for plasmids, however most plasmid names contain the pre-fix 'p' 
to designate it as a plasmid name (pSEl, plasmid constructed by Sarah Elliott, plasmid 
number I).
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Abstract
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In the budding yeast Saccharomyces cerevisiae, microtubule organising functions are 
carried out by the spindle pole body (SPB). The SPB is a disk-like, multilayered 
structure that is embedded in the nuclear membrane throughout the cell cycle. The 
major substructures of the SPB are the outer, central and inner plaques and the half­
bridge. The central plaque is embedded in the nuclear membrane. The outer and inner 
plaques are positioned on the cytoplasmic and nuclear side of the central plaque where 
they organise the cytoplasmic and nuclear microtubules respectively. The half-bridge 
extends from the central plaque along the nuclear envelope and is involved in SPB 
duplication and organises cytoplasmic microtubules during G1 of the cell cycle and 
during mating.
Described within is the identification and characterisation of a novel SPB component, 
Spc29p. Spc29p was found as a component of a salt stable SPB subcomplex composed 
of central and inner plaque SPB components. This complex contained Spc29p, the 
central plaque component Spc42p, the y-tubulin-complex-binding protein Spell Op and 
calmodulin. Spc29p acts as a linker between Spc42p and the globular C-terminus of 
Spcl lOp at the central plaque. Evidence is provided that the calmodulin-binding site of 
S pe ll Op influences the binding of Spc29p to S p e ll Op. In addition, co-overexpression 
of Spc29p, Spc42p and Spcl 1 Op resulted in a three fold increase in the diameter of the 
SPB, indicating that expression levels of SPB components may be involved in the size 
control of the SPB.
Construction and analysis of spc29 temperature sensitive mutants uncovered another 
important function of Spc29p. Using immunofluorescence, FACS analysis and electron 
microscopy the spc29(ts) mutants were found to have an SPB duplication defect. A role 
for Spc29p in SPB duplication was supported by the genetic and biochemical 
interactions between Spc29p and other SPB components involved in SPB duplication, 
namely the half-bridge components Cdc31p and Karlp. Evidence is also provided for 
an interaction between Spc29p at the periphery of the central plaque, with the 
Bbplp/Mps2p complex, which is involved in embedding the SPB in the nuclear 
envelope.
Spc29p was also found to be phosphorylated in a cell cycle dependent manner.
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Introduction
Yeast as a model system
The budding yeast Saccharomyces cerevisiae is a unicellular, eukaryotic organism that 
is used as a model system to study cellular structures and processes for example, the 
cytoskeleton, the endoplasmic reticulum and the Golgi apparatus, cell cycle control, 
mitosis, transcription, protein synthesis and vesicle trafficking to name but a few. The 
reason the budding yeast has become so popular as a model system is due to the ease in 
which it can be manipulated genetically and biochemically. The sixteen chromosomes 
of the haploid budding yeast have been fully sequenced and the genome sequence is 
easy to access. Yeast can be genetically manipulated, for example chromosomal genes 
can be specifically deleted, mutated or epitope-tagged with ease enabling the study of 
gene and protein function. There is also a host o f vectors designed for yeast that can be 
used to construct plasmids for the study of genetic interactions in the two hybrid 
system, suppression analysis and in determining synthetic lethality between mutants. In 
addition, experimental techniques for studying the budding yeast are well established 
and described in the literature. The study of budding yeast can be easily justified by the 
enormous number of homologues found in higher eukaryotes including humans, in fact 
the similarities can be so high that some human genes can substitute for their yeast 
homologues without any loss of function.
The budding yeast life cycle
Budding yeast can proliferate in either a haploid or diploid state. A diploid cell can 
divide either by mitosis or, in times of nutrient starvation, can go through meiosis and 
sporulation to form four haploid spores (Kupiec et al., 1997). Haploid cells can divide 
by mitosis or can undergo conjugation (mating) to form diploid cells (Marsh and Rose, 
1997) (Figure 1). Haploid budding yeast cells exist in two mating types, MATa or 
M AT a, MATa cells mate with M A Ta  cells, cells with the same mating type cannot mate 
with each other. However, due to the HO endonuclease, haploid yeast cells can
Sarah L. Elliott, 2001
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Figure 1 The budding yeast life cycle
Diploid cells sporulate when there is a lack of nutrients in the growth 
medium, producing haploid spores. These spores can proliferate as haploid 
cells or can mate to form diploid cells.
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switch from one mating type to the other. Therefore, "wild type" laboratory strains are 
HO' to prevent the mating type switch. Haploid cells are easier to manipulate 
genetically as they have only one copy of each gene and different mating types are kept 
separate to avoid formation of diploids. MATa cells are used more frequently than 
M A Ta  cells as cultures o f MATa cells can be synchronised in G1 using the synthetic 
mating pheromone, a-factor. Also, "wild type" laboratory strains are in fact mutant 
strains that have certain growth requirements (for example YPH499, Table 2), these are 
usually addition of specific amino acids or the nucleotide base uracil to the growth 
medium. The major advantage of this is that marker genes can be used to follow genetic 
manipulations.
The cell cycle
The cell cycle of all eukaryotic cells consists of two stages, interphase and mitosis 
(Alberts et al., 1994). Interphase is the time when a cell is not dividing, it is composed 
of the two "gap" phases, G1 and G2, that occur before and after S phase, in which DNA 
replication occurs. M phase occurs after G2 and makes up the rest of the cell cycle. M 
phase is when the cell segregates its contents, including the duplicated chromosomes 
into two daughter cells. The cell cycle is therefore composed of four phases, G l, S, G2 
and M phase. This is of course, a simplified view of the cell cycle, but suffices for 
general purposes. S. cerevisiae cells divide by budding, which means that a bud forms 
in late G l and grows while the mother cell remains the same size. As the bud grows, 
cytoplasmic components are transported into the bud, then during mitosis the nucleus 
elongates so that it is positioned along the mother bud axis with the centre of the 
nucleus in the bud neck. Therefore, after chromosome separation and cytokinesis, the 
nucleus is split between mother and daughter cells. This means that by looking at the 
morphology of a cell it can be, to some extent, determined which stage of the cell cycle 
that cell is in (Figure 2).
When a cell is in the early Gl growth phase there are a number o f paths it can follow, 
determined mainly by the external environment (Lew et al., 1997). If there is a lack of 
nutrients in the growth medium, haploid G l cells will enter a quiescent, stress resistance 
state in which protein synthesis is greatly reduced. Diploid cells in early G l will 
undergo meiosis and sporulation in the absence o f nutrients. When nutrients are 
abundant, haploid cells in early G l are capable o f mating. Mating pheromones secreted
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Figure 2 The budding yeast cell cycle
The morphology of a budding yeast cell changes as the cell progresses 
through the cell cycle.
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from cells of opposite mating types will arrest mating partners in G l, preventing entry 
into S phase until after mating has occurred. However, in late G l there is a point that 
once passed commits the cell to completing the cell cycle, at this point cells are no 
longer capable of mating until G l of the next cell cycle. This point in late G l is termed 
START.
Cell cycle regulation
The cell cycle can be described as a series of events that occur in a defined order to 
achieve the accurate division of a cells contents into two daughter cells (Alberts et al., 
1994; Lew et al., 1997). Each distinct event cannot occur until the previous event has 
been completed, for example mitosis will not commence until DNA replication is 
complete. The progression of the cell cycle in eukaryotic cells is controlled by cyclins. 
Cyclins exert their control by initiating the transcription or degradation of proteins 
involved in the different stages of the cell cycle. Cyclins were first identified in rapidly 
dividing early embryonic sea urchin cells and were named according to the cyclic 
increase and decrease in their protein levels during cycles o f cell division (Evans et al., 
1983). Since then cyclins have been identified as components o f all eukaryotic cells. 
The function o f cyclins is to activate and provide substrate specificity to cyclin 
dependent kinases (CDKs). The cyclin/CDK complexes act by phosphorylating target 
proteins, for example transcription factors, which are activated by the phosphorylation 
event. Phosphorylation by the cyclin/CDK complexes also targets some proteins for 
degradation. Degradation is an irreversible way of "switching off ' modified proteins 
and therefore helps to give directionality to the cell cycle.
A protein targeted for degradation by a cyclin/CDK complex is first ubiquitinated by 
one of the ubiquitin ligase enzymes (or 'E3' enzymes), either the APC (anaphase 
promoting complex) or the SCF (Skplp-cullin-F-box protein complex) (Morgan, 1999; 
Peters, 1998; Zachariae and Nasmyth, 1999). This ubiquitination then allows the protein 
to be recognised and hence degraded by the proteosome. The activity of the APC and 
SCF is increased by the binding of activator proteins. In the case of the SCF the 
activators are members of the F-box protein family, for example Cdc4p and G rrlp 
(Skowyra et al., 1997). The activity of the APC is dependent on the association of one 
of two additional subunits, these activating proteins are Cdc20p and Cdhlp/H ctlp 
(Visintin et al., 1997). Association of the different activator proteins with the SCF and
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the APC changes during the cell cycle, hence changing their substrate specificity and 
adding another level of control to the cell cycle (Morgan, 1999; Peters, 1998; Zachariae 
and Nasmyth, 1999).
In budding yeast the major CDK involved in cell cycle control is Cdc28p. Cdc28p is 
present in the cell as an inactive monomer throughout the cell cycle. Activation of 
Cdc28p is dependent on its association with one of a number of different cyclin 
subunits. The cyclins in budding yeast are divided into two groups, the G l cyclins 
(Clnlp, Cln2p and Cln3p) and the B-type cyclins (Clblp-6p) (Lew et al., 1997; 
Nasmyth, 1993; Nasmyth, 1996a; Nasmyth, 1996b). The G l cyclins are essential for 
START. Clnlp and Cln2p in association with Cdc28p, increase the levels o f the B-type 
cyclins by turning off their degradation and by turning on degradation of the cyclin B 
inhibitor, Siclp. Ubiquitination of phospho-Siclp by the sCFcdc4p complex, followed by 
degradation by the proteosome is essential for the transition from G l to S phase (Dirick 
et al., 1995; Peters, 1998; Schneider et al., 1996; Schwob et al., 1994; Tyers, 1996; 
Verma et al., 1997a; Verma et al., 1997b). C lnlp and Cln2p also turn off the ability of 
cells to react to mating pheromone (Oehlen and Cross, 1994) by phosphorylating Farlp 
(the protein required for Gl arrest in response to mating pheromone) thereby targeting it 
for ubiquitination by the sCFCdc4p complex followed by proteolysis by the proteosome 
(Henchoz et al., 1997). Another function of Clnl/2p is to trigger the polarisation of the 
cytoskeleton required for bud formation (Lew and Reed, 1993). Cln3p activates the 
transcription of proteins required for continuation of the cell cycle, including CLB5 and 
CLB6 (Dirick et al., 1995). The G l cyclins eventually switch themselves off by 
autophosphorylation followed by ubiquitination by the SCFGrr]p complex and 
degradation by the proteosome (Koepp et al., 1999; Skowyra et aL, 1997; Skowyra et 
al., 1999). The B-type cyclins in association with Cdc28p carry out a number of 
different roles in S phase, G2 and mitosis. Due to some functional redundancy between 
the Clbs, distinct roles for the individual Clbs has been difficult to determine. Some of 
the roles established so far are; Clb5p and Clb6p trigger DNA replication (Schwob et 
al., 1994; Schwob and Nasmyth, 1993), Clb3p and Clb4p initiate formation of the 
mitotic spindle (Fitch et al., 1992; Richardson et al., 1992) and Clblp and Clb2p trigger 
bud growth in G2, anaphase and nuclear division (Fitch et al., 1992; Lew and Reed, 
1993; Richardson et a l,  1992; Surana et a l ,  1991). More recently it has been suggested 
that Clb5p is involved in positioning of pre-anaphase spindles (Segal et a l, 1998). In 
late mitosis, after chromosome segregation, the B-type cyclins are destroyed, allowing
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the cell to exit mitosis (Ghiara et al., 1991; King et al., 1996a; King et al., 1996b; Lew 
and Reed, 1993).
Cyclins and Cdc28p are important regulators of the cell cycle, however opinions on 
their exact functions and importance is changing all the time as more discoveries are 
made about the complex control of the cell cycle. For example, during mitosis the 
metaphase to anaphase transition seemed to coincide with a drop in B-type cyclin 
levels, which then leads to inactivation of Cdc28p which triggers mitotic exit (Holloway 
et al., 1993; Surana et al., 1993). This drop in B-type cyclin levels is due to 
ubiquitination by the APCCdc20p followed by degradation by the proteosome (King et al., 
1995; Sudakin et al., 1995; Yeong et al., 2000; Zachariae et al., 1996). The APC is 
required for the onset of anaphase (Imiger et al., 1995) and exit from mitosis (Morgan, 
1999; Shirayama et al., 1999). However, it is not the destruction of B-type cyclins that 
is required for onset of anaphase as expression of high levels of non-degradable cyclin 
fails to block anaphase (Surana et al., 1993), but arrests cells in late mitosis. The protein 
that must be destroyed, in an APCCdc20p-dependent manner, before anaphase can occur is 
Pdslp. The presence of indestructible Pdslp prevents anaphase onset, therefore Pdslp is 
termed an anaphase inhibitor (Cohen-Fix and Koshland, 1997a; Cohen-Fix and 
Koshland, 1997b; Cohen-Fix et al., 1996; Yamamoto et al., 1996a; Yamamoto et al., 
1996b). More specifically, the role of Pdslp is as a separin inhibitor. The separin in 
budding yeast is Esplp, which forms a stable complex with Pdslp. When Pdslp is 
destroyed, Esplp is then free to cleave Scclp, a component o f the cohesin complex that 
holds sister chromatids together (Ciosk et al., 1998; Uhlmann et al., 1999; Uhlmann et 
al., 2000). Therefore, ubiquitination o f Pdslp by the APCCdc20p followed by its 
degradation allows separation of sister chromatids to occur. Pdslp has also been shown 
to inhibit cyclin degradation and therefore must be destroyed before cyclin degradation, 
followed by mitotic exit, can occur (Cohen-Fix, 2000; Cohen-Fix and Koshland, 1999; 
Morgan, 1999; Shirayama et al., 1999; Tinker-Kulberg and Morgan, 1999).
Mitotic exit occurs when the mitotic cyclins are destroyed (Glotzer et al., 1991; 
Holloway et al., 1993; Imiger et al., 1995; Surana et al., 1993). More specifically the 
destruction of Clb2p by the APCCdhlp seems to be the critical event (Visintin et al., 
1997). This destruction occurs as a result o f activation of the mitotic exit network 
(MEN). The MEN includes the phosphatase Cdcl4p, the GTPase Temlp, L telp (the 
Tem lp GDP/GTP exchange factor) and the kinases Cdc5p (polo-like kinase), Cdcl5p, 
Dbf2p and Dbf20p (Charles et al., 1998; Glover et al., 1998; Jaspersen et al., 1998; 
Shirayama et al., 1998; Toyn and Johnston, 1994; Visintin et al., 1998). The mechanism
Sarah L. Elliott, 2001 19
of action of the MEN is to trigger mitotic cyclin destruction. This is achieved by tipping 
the balance between phosphorylation and dephosphorylation of the APC activator 
Cdhlp (also known as Hctlp). Exit from mitosis is triggered first by the destruction of 
Pdslp (Shirayama et al., 1999) and then by the activation of the GTPase, Temlp. This 
occurs when the nucleus migrates into the bud bringing Tem lp at the spindle pole into 
contact with L telp in the bud (Bardin et al., 2000; Pereira et al., 2000). Activated 
Tem lp, then facilitates the release of the phosphatase, Cdcl4p, from the nucleolus 
(Shirayama et al., 1994; Shou et al., 1999). Pdslp inhibits release o f Cdcl4p from the 
nucleolus (Shirayama et al., 1999), therefore must be destroyed before Cdcl4p can be 
released. Cdcl4p released from the nucleolus dephosphorylates Cdhlp allowing it to 
bind to the APC and direct the ubiquitination and consequent destruction o f Clb2p 
(Jaspersen et al., 1999; Visintin et al., 1998). However, Cdhlp is phosphorylated by 
Clb/Cdc28p therefore, if a cell is to exit mitosis, a mechanism must exist to tip the 
balance in favour o f dephosphorylation of Cdhlp by Cdcl4p. This is achieved by the 
biphasic destruction of Clb/Cdc28p and the activation, by Cdcl4p, o f the Clb inhibitor 
Siclp (Morgan, 1999). APCCdc20p, as well as mediating the destruction of Pdslp, is also 
responsible for the destruction of the cyclin Clb5p at the metaphase to anaphase 
transition which provides the drop in Cdc28p activity required for the success of 
Cdcl4p in promoting mitotic exit (Shirayama et al., 1999).
Cell cycle checkpoints
Another level of cell cycle regulation is checkpoint control (Burke, 2000; Elledge, 
1996; Gardner and Burke, 2000; Hoyt, 2000; Lew, 2000; Lew et al., 1997; Longhese et 
al., 1998; Murakami and Nurse, 2000; Nurse, 1997; Weinert, 1998). Cell cycle events 
are monitored to ensure that each stage is accurately completed before the next 
commences and that any defects are corrected. The most important checkpoint is 
START, it is the point of no return in the cell cycle and a cell must reach a minimum 
size before it can pass START (Johnston, 1977; Nurse, 1975). Other checkpoints after 
START can only delay or arrest the cell cycle. For example, DNA replication must be 
complete before mitosis begins and the chromosomes are separated (DNA replication 
checkpoint) and the chromosomes must be segregated before cytokinesis occurs 
(spindle checkpoint). There is also a checkpoint to detect DNA damage and delay the 
cell cycle until the damage has been repaired (DNA damage checkpoint). These
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checkpoints are important to ensure the integrity o f chromosomes and the accurate 
segregation of sister chromatids to mother and daughter cells.
The DNA replication checkpoint is activated by the presence of replication forks (Piatti 
et al., 1995; Toyn et al., 1995). Components of the protein replication fork complex 
activate the checkpoint via the kinases M eclp and Rad53p (Allen et al., 1994; Weinert, 
1998; Weinert et al., 1994) resulting in a cell cycle arrest until DNA replication is 
complete. The DNA damage checkpoint is activated by double strand DNA breaks 
(Foiani et al., 1998; Mills et al., 1999; Sandell and Zakian, 1993; Siede et al., 1994; 
Weinert et al., 1994) and can arrest the cell cycle at a number of different stages, again 
via M eclp and Rad53p (Allen et al., 1994; de la Torre-Ruiz and Lowndes, 2000; 
Weinert, 1998). Components of the DNA damage checkpoint also activate the 
transcription of DNA damage repair genes (Aboussekhra et al., 1996; Allen et al., 1994; 
Foiani et al., 2000; Kiser and Weinert, 1996; Navas et al., 1996). The mechanism of 
action of these checkpoints is yet to be confirmed, however, it makes sense for a target 
o f these checkpoints to be stabilisation of Pdslp. Stabilisation of Pdslp would results in 
arrest of the cell cycle in metaphase as sister chromatids would remain attached and 
cyclin levels would remain high.
Accurate segregation of chromosomes in mitosis requires the bipolar attachment of 
replicated chomosomes, via their kinetochores, to the mitotic spindle. If  mitosis occurs 
in the absence of these connections the result would be aneuploidy and death. The 
nucleus must also migrate into the bud to ensure that the chromosomes are equally 
segregated between mother and daughter cells. The spindle checkpoint monitors 
attachment of kinetochores to spindle microtubules and movement of the nucleus into 
the bud via two separate pathways (Amon, 1999; Burke, 2000; Hoyt, 2000; Lew, 2000). 
The pathway monitoring attachment of spindle microtubules to the kinetochores 
involves proteins encoded by MAD1, MAD2, MAD3, BUB1, BUB3 and MPS1 (Brady 
and Hardwick, 2000; Chen et al., 1999; Hardwick et al., 1999; Hardwick and Murray, 
1995; Hardwick et al., 1996). The MAD and BUB genes are non-essential, but the MPS1 
gene is essential and appears to have dual functions in spindle pole assembly and 
spindle checkpoint signalling (Weiss and Winey, 1996). When an unattached 
kinetochore is detected by a complex of Mad and Bub proteins localised at the 
kinetochore, the APC activator Cdc20p is inhibited by Mad2p. Hence, Cdc20p cannot 
direct the destruction o f Pdslp and cells arrest at the metaphase to anaphase transition. 
Therefore, sister chromatids remain attached until all kinetochores are connected to the 
spindle. The second spindle checkpoint pathway involves the other Bub protein, Bub2p,
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and B falp (Fesquet et al., 1999; Fraschini et al., 1999; Pereira et al., 2000). Bub2p and 
B falp together form the GAP that activates the GTPase activity of Tem lp when the 
checkpoint is activated. Tem lp is localised at the spindle pole body that is destined to 
travel into the bud via its interaction with Bub2p,/Bfalp. Therefore, Tem lp is held in its 
inactive GDP-bound form until the nucleus is properly positioned and Tem lp is brought 
into contact with its exchange factor (GEF) Ltelp, which is localised in the bud (Bardin 
et al., 2000; Pereira et al., 2000; Shirayama et al., 1994). In other words mitotic exit is 
prevented until the nucleus is properly oriented between mother and bud.
The budding yeast cytoskeleton
The cytoskeleton is an internal array of protein filaments that is a part of all eukaryotic 
cells (Alberts et al., 1994). The cytoskeleton organises the cytoplasm, generates force 
within the cell, determines the shape of the cell and maintains the structural integrity of 
the cell. There are three types of cytoskeletal filaments, microfilaments, intermediate 
filaments and microtubules. Microfilaments (5-7 nm in diameter) are long flexible 
polymers of actin, intermediate filaments (~10 nm in diameter) are based on polymers 
o f any of a number of related fibrous coiled-coil proteins and microtubules are based on 
more rigid polymers of tubulin (hollow tubes 25 nm in diameter). Cells of the budding 
yeast do not appear to contain intermediate filaments per se, however the 
microfilaments and microtubules of Saccharomyces cerevisiae closely resemble those 
of higher eukaryotes. The functions of these cytoskeletal components have been 
extensively studied in budding yeast (Adams, 1984; Adams and Pringle, 1984; Amberg, 
1998; Ayscough and Drubin, 1996; Barnes et al., 1990; Botstein, 1986; Botstein et al., 
1997; Cid et al., 1995; Kilmartin and Huffaker et al., 1987; Steams, 1990; Steams et 
al., 1990; Welch et al., 1994).
Microfilaments in budding yeast are formed by the polymerisation of actin, the product 
of the single actin gene, ACT1 (Gallwitz and Seidel, 1980; Gallwitz and Sures, 1980). 
Actin forms patches as well as filaments, the distribution o f both alters through the cell 
cycle. Actin functions in maintenance o f cell polarity, changes in cell shape (for 
example, during mating) and resistance to osmotic forces. Microtubules are formed by 
the polymerisation of a - and p-tubulin, in budding yeast these proteins are encoded by 
the TUB1, TUB3 (a-tubulin, (Schatz et al., 1986a; Schatz et al., 1986b)) and TUB2 (P- 
tubulin, (Neff et al., 1983)) genes.
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Microtubules and microtubule organising centres
Microtubules are dynamic structures that fulfil numerous different roles throughout the 
cell cycle (Alberts et al., 1994). During interphase microtubules are distributed 
throughout the cytoplasm where they are involved in vesicle trafficking and organelle 
positioning. At the onset of mitosis, the chromosomes condense and the microtubule 
network is reorganised to form the mitotic spindle, which separates the duplicated 
chromosomes into mother and daughter cells (Figure 3. Note, a mammalian cell is used 
to demonstrate the organisation of the microtubule network throughout the cell cycle as 
microtubules and DNA are easier to distinguish by immunofluorescence in mammalian 
cells than in yeast). Microtubules consist of a - and p-tubulin heterodimers (Weisenberg 
et al., 1968). These tubulin heterodimers come together in vitro to form protofilaments, 
which in turn form the cylinders known as microtubules (Figure 4). The orientation of 
the a  and p subunits give microtubules biochemically distinct ends termed the plus and 
minus ends. Therefore, microtubules can be considered as "polar" structures. In vitro 
microtubules will self-assemble when the concentration of the tubulin subunits reaches 
the critical concentration (Weisenberg, 1972). Once a microtubule has formed, tubulin 
can associate and dissociate with the microtubule ends. Assembly o f tubulin into 
microtubules is more rapid at the plus end than the minus end (Allen and Borisy, 1974; 
Bergen and Borisy, 1980). Rapid disassembly also occurs at the plus end, these 
disassembly events are called catastrophes. The resulting alternation between rapid 
growth or rescue, followed by catastrophes is termed dynamic instability (Desai and 
Mitchison, 1997; Mandelkow et al., 1991; Mitchison and Kirschner, 1984). The 
dynamic nature of microtubules is due to GTP hydrolysis (Desai and Mitchison, 1997; 
Erickson and O'Brien, 1992; Mitchison, 1993; Weisenberg et al., 1976). GTP-bound 
tubulin assembles at the plus end of growing microtubules where the GTP bound to p- 
tubulin is rapidly hydrolysed to form GDP. GDP-bound tubulin is less stable and 
therefore more likely to dissociate from the microtubule ends. Exchange of GDP for 
GTP only occurs after depolymerisation. Growth occurs when addition of GTP-tubulin 
is faster than GTP hydrolysis, forming a cap of GTP-tubulin at the growing end, 
therefore stabilising the microtubule (Desai and Mitchison, 1997; Inoue and Salmon, 
1995). In vivo the concentration of free tubulin is lower than the critical concentration 
for spontaneous microtubule assembly, therefore initiation of microtubule formation 
occurs at specific nucleation sites within the cell. These sites are termed microtubule 
organising centres (MTOCs) (Pickett-Heaps, 1969). MTOCs dictate the number, 
orientation and polarity of the microtubules that make up the microtubule network of a
in
te
rp
ha
se
 
I 
ea
rly
 
pr
op
ha
se
 
I 
lat
e 
pr
op
ha
se
 
I 
pr
om
et
ap
ha
se
Sarah L. Elliott, 2001 23
Fi
gu
re
 
3 
Th
e 
m
ic
ro
tu
bu
le
 
ne
tw
or
k 
(A
lb
er
ts 
et 
al.
, 
19
94
)
V
is
ua
lis
at
io
n 
of 
m
ic
ro
tu
bu
le
s 
(g
re
en
) 
an
d 
DN
A 
(b
lu
e)
 i
n 
a 
m
am
m
al
ia
n 
ce
ll 
at 
di
ff
er
en
t 
sta
ge
s 
of 
the
 
ce
ll 
cy
cl
e
Sarah L. Elliott, 2001
tubulin 
protofi lamenttubulin microtubules
Figure 4 Assembly of M icrotubules
In vitro, when the concentration of free tubulin heterodimers reaches a 
critical concentration, tubulin protofi laments begin to form. These 
protofilaments then form tubes, the walls of which consist of 13 
protofi laments giving a diameter of 25 nm. Due to the arrangement of the a -  
and (3-tubulin subunits, microtubules have distinct ends, termed the plus and 
minus ends. Once these microtubules have formed, there is continuous 
exchange of tubulin heterodimers from both ends of the microtubule. This 
exchange is more rapid at the plus ends of the microtubules.
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cell. Dynamic instability is important in vivo as it enables the dynamic processes like 
mitosis to occur. However, many microtubule based processes require microtubules to 
be stabilised, this stabilisation is controlled by microtubule motors and microtubule 
binding proteins (MAPs) (Desai and Mitchison, 1997).
In mammalian cells the major MTOC is the centrosome (Figure 5). The centrosome 
consists of a pair of centrioles surrounded by a dense matrix called the pericentriolar 
material from which microtubules emanate. A centriole consists o f a cylindrical array of 
nine short microtubules triplets arranged symmetrically to form a short tube. The 
pericentriolar material contains microtubule nucleating factors, for example y-tubulin. y- 
Tubulin is the third member of the tubulin family (Oakley and Oakley, 1989). It has 
approximately 30% identity to the a - and p-tubulins. y-tubulin is a universal component 
of MTOCs (Oakley et al., 1990; Steams et al., 1991; Steams and Kirschner, 1994) 
which is present at MTOCs in a complex with other proteins (Pereira and Schiebel, 
1997). This complex, the y-tubulin-complex, varies in size between different organisms 
and is essential for microtubule nucleation in vivo (Schiebel, 2000; Tassin and Bomens, 
1999).
An additional function of microtubules is in motility, in this case microtubule 
organising functions are carried out by the basal body. Basal bodies direct the formation 
of flagella and cilia in many different cell types from single cellular organisms to 
human cells. For example, the flagella of sperm cells and the cilia lining the respiratory 
and digestive tracts as well as sensory cilia found in the ears and eyes are all formed 
around basal bodies (Alberts et al., 1994).
In the budding yeast Saccharomyces cerevisiae microtubule organising functions are 
carried out by the spindle pole body (SPB) (Knop et al., 1999).
The Spindle Pole Body 
SPB Morphology
The spindle pole body is a multilayered structure that is embedded in the nuclear 
envelope throughout the cell cycle (Byers and Goetsch, 1975b). This is possible as yeast 
undergo closed mitosis, which means that the nuclear envelope stays intact during 
mitosis. The morphology of the SPB has been well documented by electron microscopy
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Figure 5 M icrotubule organising centres (MTOCs)
The centrosome is the major MTOC of mammalian cells, it is a cytoplasmic 
organelle that is generally found in the centre of the cell, near the nucleus. 
The centrosome consists of a pair of centrioles surrounded by a pericentriolar 
matrix from which microtubules emanate. Basal bodies are found at the base 
of cilia and flagella and are responsible for generation of movement. The 
spindle pole body (SPB) of S. cerevisiae is the functional equivalent to the 
mammalian centrosome. The SPB is a multi layered structure that is 
embedded in the nuclear membrane, from where it nucleates spatially distinct 
nuclear and cytoplasmic microtubules.
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studies (Adams and Kilmartin, 1999; Bullitt et al., 1997; Byers, 1981a; Byers, 1981b; 
Byers and Goetsch, 1975b; Byers et al., 1978; Moens and Rapport, 1971; O'Toole et al., 
1999; Peterson et al., 1972; Peterson and Ris, 1976; Robinow and Marak, 1966; Rout 
and Kilmartin, 1990). The SPB consists of a number o f substructures. The major 
substructures are the central plaque, the outer plaque, the inner plaque and the half­
bridge (Figure 5). The central plaque is embedded in the nuclear envelope, the outer 
plaque is located on the cytoplasmic side o f the SPB and organises cytoplasmic 
microtubules while the inner plaque is on the nuclear side where it organises nuclear 
microtubules. The half-bridge extends from one side of the SPB over the cytoplasmic 
and nuclear surface of the nuclear membrane. The half-bridge is more dynamic than the 
other SPB substructures and is involved in SPB duplication. Microtubules are 
associated with the inner plaque at all stages of the cell cycle, however the association 
of the cytoplasmic microtubules with the SPB substructures changes. During G1 and 
mating the half-bridge appears to be the major site of cytoplasmic organisation. 
Throughout the rest of the cell cycle cytoplasmic microtubules are organised by the 
outer plaque (Knop et al., 1999; Knop and Schiebel, 1998; Pereira et al., 1999).
The minor substructures, as seen by electron microscopy, are the intermediate layers 
IL1 and IL2, which are present between the outer and central plaques. The inner plaque 
can also be split into two minor layers, IP1 and IP2. IP1 appears as a beaded layer and 
IP2 is formed by the capped minus ends of the nuclear microtubules. This gives a final 
count o f six layers making up the SPB (Bullitt et al., 1997).
SPB duplication
Although the SPB is structurally different to the centrosome it is functionally equivalent 
as both nucleate and organise microtubules and both duplicate once per cell cycle 
(Figure 6). SPB duplication occurs in G1 of the cell cycle. In early G1 the half-bridge 
elongates and the precursor of the new SPB, the satellite, forms at the end of the half­
bridge furthest from the mother SPB. After START, with the appearance of 
Cdc28p/Clns, SPB duplication occurs rapidly, therefore intermediates in SPB 
duplication have only recently been observed (Adams and Kilmartin, 1999) (Figure 7). 
The satellite extends to form the duplication plaque, which gains the outer plaque and is 
then inserted into the nuclear envelope. On addition o f the inner plaque SPB duplication 
is complete, however the side by side SPBs are still attached to each other by the
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Figure 6 The SPB and the cell cycle
Gl cells are unbudded and contain a single SPB with its associated half­
bridge. Before START of the cell cycle SPB duplication begins with the 
formation of the satellite. SPB duplication is completed before the end of 
Gl when the bud begins to appear. During S phase the duplicated SPBs 
separate and migrate to opposite sides of the nucleus. During mitosis the 
SPBs organise the mitotic spindle and one SPB moves into the bud. 
Therefore when cell division occurs each daughter cell will contain a single 
SPB with its associated half-bridge.
CM, cytoplasmic microtubules; HB, half-bridge; I, inner plaque; NE, 
nuclear envelope; NM, nuclear microtubules; Nu, nucleus; O, outer plaque; 
S, satellite; SM, spindle microtubules; SPB, spindle pole body.
Sarah L. Elliott, 2001 29
SPB
M f-
bridge
Spc72p 
Nudlp ‘ 
Cnm67p  ^ , 
S p c4 2 p i^
Spc29p" 
C m dlp /
Spc11 Op
outer plaque
intermediate layer I (IL1)
IL2 and the cytoplasmic 
side of the central plaque
half-bridge outer layer
"• -^.nuclear 
^^Tnembrane
nucleus
"V^central plaque 
inner plaque
— spindle microtubules
Cnm67p, Nudlp Cnm67p, Nudlp
satellite Spc42p, Spc29p Spc42p, Spc29p(?)
I\  duplication plaqueafter
anaphase
Figure 7 SPB duplication
Intermediate structures seen during SPB duplication. After START the 
satellite extends to form the duplication plaque, which contains 
components of the central and outer plaques. As the duplication plaque 
is inserted into the nuclear membrane, nuclear SPB proteins form the 
inner plaque. Reproduced from The Journal of Cell Biology, 1996, 
145, p821. by copyright permission of The Rockefeller University 
Press.
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bridge. As DNA duplication occurs, the bridge is cleaved by an unknown process 
allowing the two SPBs, each associated with a half-bridge, to separate and move to 
opposite sides o f the cell. This is thought to be a microtubule based movement 
involving nuclear and cytoplasmic microtubules and microtubule motors. Once the 
SPBs are correctly positioned, one in the mother cell, one in the bud and joined by the 
mitotic spindle, the chromosomes are separated. In haploid cells each of the sixteen 
yeast chromosomes are attached to the poles via a single microtubule from each SPB. 
There are also a few microtubules that interconnect the two SPBs, therefore the mitotic 
spindle of haploid cells consists of approximately forty microtubules (Byers and 
Goetsch, 1975b; Peterson and Ris, 1976; Winey et al., 1995). Once the duplicated 
chromosomes are separated cytokinesis occurs. After cytokinesis each cell will contain 
a single SPB and a full set o f chromosomes.
SPB duplication is conservative as the new SPB forms adjacent to the old SPB and 
there does not appear to be a "template" for SPB duplication. However, it has recently 
been suggested that pre-formed SPBs can incorporate new components due to turn over 
of core SPB components throughout the cell cycle (Davis and Yoder, abstract, Colorado 
meeting, 2000), indicating that the SPB may be more dynamic that earlier imagined.
SPB composition
The y-tubulin-complex
y-tubulin was first identified as a suppresser of a (3-tubulin mutation in Aspergillus 
nidulans (Oakley and Oakley, 1989). Since then y-tubulins have been identified in many 
different organisms including human, Schizosaccharomyces pombe, Drosophila 
melanogaster, Xenopus laevis, Saccharomyces cerevisiae and plant cells (Horio et al., 
1991; Liu et al., 1994; Lopez et al., 1995; Steams et al., 1991; Sobel and Snyder, 1995; 
Zheng et al., 1991). The role of y-tubulin in micro tubule nucleation has been 
demonstrated by disrupting y-tubulin function in a number of organisms. For example, 
when antibodies to y-tubulin were injected into mammalian cells, microtubule 
nucleation by the centrosome was prevented throughout the cell cycle (Joshi et al.,
1992). In the S. Cerevisiae tub4(ts) mutant strain (TUB4 encodes the yeast y-tubulin), 
when incubated at the non-permissive temperature, SPB duplication occurred normally, 
but the newly formed SPB was unable to nucleate microtubules (Marschall et al., 1996).
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In addition, y-tubulin-containing ring complexes isolated from Xenopus egg extracts 
nucleated microtubules in vitro (Zheng et al., 1995). It is now established that y-tubulin 
is localised at the MTOCs in many different organisms and its role in microtubule 
nucleation has been clearly demonstrated. The y-tubulin open ring complex (yTuRC) 
has been observed in a number of organisms (Moritz et al., 1995; Murphy et al., 1998; 
Vogel et al., 1997) since first visualised by electron microscopy (Zheng et al., 1995). In 
Xenopus, y-tubulin is present in a 25 S ring complex containing at least 6 other proteins 
including a - and |3-tubulins. Cryo-electron microscopy studies revealed that the 
Drosophila yTuRC consists of approximately 13 radially arranged structural repeats and 
has a diameter of ~25 nm. Upon treatment with salt the yTuRC is disrupted giving rise 
to the y-tubulin small complex (yTuSC) (Oegema et al., 1999).
The y-tubulins of A. nidulans and S. pombe show great similarity to the y-tubulins of 
higher organisms, in fact the human y-tubulin can substitute for the fission yeast y- 
tubulin (Horio and Oakley, 1994). For a long time y-tubulin could not be found in 
budding yeast casting doubt on the importance o f y-tubulin and its function in 
microtubule nucleation in vivo. Finally, the S. cerevisiae y-tubulin was identified by the 
yeast genome sequencing project. The reason that the budding yeast y-tubulin had not 
been identified by conventional methods was because it only exhibits approximately 
40% identity to the y-tubulins from other organisms (Sobel and Snyder, 1995), whereas 
y-tubulins from different species usually have around 65% homology. Despite this 
difference, the budding yeast y-tubulin exhibits the same characteristics as y-tubulins 
from other organisms. Since the discovery of Tub4p, the budding yeast spindle pole 
body has become one of the most studied and understood MTOCs.
By studying the SPB in budding yeast it is hoped that a greater insight will be gained 
into the function, composition and duplication processes of centrosomes and 
microtubule organising centres in general. Already human homologues of SPB 
components have been identified, as mentioned above, Tub4p is the yeast y-tubulin. 
Tub4p forms a complex with Spc97p and Spc98p which also have homologues in 
humans (hGCP2 and hGCP3, (Murphy et al., 1998; Tassin et al., 1998)), Xenopus 
(Xgripl09, (Martin et al., 1998)) and Drosophila (Dgrip84 and Dgrip91, (Oegema et 
al., 1999)). In each of these organisms the Spc97/98p homologues were found to co- 
localise with y-tubulin at the centrosomes and co-sediment with y-tubulin on sucrose 
gradients.
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SPC98 was first identified as a multicopy suppresser of a tub4(ts) mutant strain 
(Geissler et al., 1996) and was found to encode the 90 kDa spindle pole body protein 
described by Rout and Kilmartin (1990). Subsequent screens identified SPC97 as a 
multicopy suppresser of an spc98(ts) mutant strain (Knop et al., 1997). As expected the 
Saccharomyces cerevisiae y-tubulin-complex is present at the inner and outer plaques of 
the SPB where it is involved in microtubule nucleation (Rout and Kilmartin, 1990; 
Spang et al., 1996a). Further investigation found that the budding yeast y-tubulin was 
present in a 6S (-200 kDa) complex consisting of one molecule of Spc97p, one 
molecule of Spc98p and two or more molecules of Tub4p (Knop and Schiebel, 1997). 
No y-tubulin ring structure has been observed in budding yeast. However, it seems that 
the Tub4p-complex may be the equivalent of the Drosophila yTuSC, which contains 
one molecule of Dgrip84, one molecule of Dgrip91 (homologues o f Spc97p and Spc98p 
respectively) and two molecules of y-tubulin. The yTuSC is capable of nucleating 
microtubules in vitro, but is much less active than the yTuRC in promoting nucleation. 
At this time it is estimated that the yTuRC consists of approximately six yTuSCs units 
(Oegema et al., 1999). In budding yeast the Tub4p-complex is suspected to form the 
cap structures at the microtubule minus ends situated at the inner plaque o f the SPB as 
observed by electron microscopy (Byers et al., 1978). It is possible that these caps are 
based on a ring structure, formed by approximately six Tub4p-complexes, which then 
acts as a seed for nucleation of a microtubule. Recently the yTuRC of Drosophila has 
been shown to form the cap-like structure at the minus ends of microtubules and to 
nucleate microtubules at subcritical a-/p~tubulin concentration (Keating and Borisy, 
2000; Moritz et al., 2000).
As the Tub4p-complex is present at the inner and outer plaques o f the SPB there are 
likely to be control mechanisms in place to mediate the localisation of the Tub4p- 
complex. Preliminary investigation into the regulation and assembly o f the Tub4p- 
complex suggests the involvement of the nuclear localisation signal (NLS) of Spc98p 
and phosphorylation (Pereira et al., 1998). The Tub4p-complex appears to assemble in 
the cytoplasm before binding to the outer plaque or import into the nucleus where it 
binds to the inner plaque. Import of the Tub4p-complex is mediated by the essential 
NLS of Spc98p. Spc98p is also phosphorylated in a cell cycle dependent manner. 
Phosphorylation o f Spc98p possibly only occurs at the inner plaque leaving Spc98p at 
the outer plaque in the dephosphorylated form. The precise function of Spc98p 
phosphorylation is yet to be determined, however it has been suggested that the kinase 
M pslp is involved.
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A screen for suppressers of the tub4-l mutant identified GIM1-5. The Gim proteins 
form a non-essential complex (GimC) in wild type cells, however Agirn mutants have 
microtubule defects and elevated sensitivity to temperature and microtubule and actin 
depolymerising drugs. Further analysis of the Gim proteins revealed them to be 
members of a phylogenetically conserved family of proteins involved in the efficient 
folding of a-tubulin, y-tubulin and actin (Geissler et al., 1998). More specifically 
Siegers et al (1999) found that GimC is a co-chaperone that interacts with the 
chaperonin TRiC to ensure the proper and efficient folding o f actin and tubulin in vivo.
y-Tubulin-complex-binding proteins
The y-tubulin-complex is tethered to the SPB via y-tubulin-complex-binding proteins at 
the inner and outer plaques and the half-bridge (Knop and Schiebel, 1997; Knop and 
Schiebel, 1998; Pereira et al., 1999). At the outer plaque and the half-bridge the y- 
tubulin-complex-binding protein is Spc72p (Knop and Schiebel, 1998). Spc72p is a 
coiled-coil protein with an N-terminal globular domain that localises to the outer plaque 
of the SPB (Soues and Adams, 1998; Wigge et al., 1998). Spc72p was found to interact 
with Spc97p and Spc98p of the Tub4p-complex using the two hybrid system (Knop and 
Schiebel, 1998). spc72(ts) cells failed to organise cytoplasmic microtubules at the non- 
permissive temperature, therefore, these cells were unable to move the nucleus into the 
bud. However this did not cause a cell cycle block, so cytokinesis occurred resulting in 
a population of cells containing two or more nuclei (Chen et al., 1998). spc72(ts) 
mutants also exhibited defects in spindle elongation and karyogamy suggesting roles for 
Spc72p and cytoplasmic microtubules in these processes. Spc72p was then shown to 
bind the half-bridge component K arlp and this interaction mediates microtubule 
nucleation from the half-bridge in G l and during mating (Pereira et al., 1999) 
explaining the karyogamy defect observed in spc72(ts) and karl(ts) mutants (Conde and 
Fink, 1976; Pereira et al., 1999).
At the inner plaque the y-tubulin-complex-binding protein is S p e ll Op. S pe ll Op was 
first identified by Rout and Kilmartin (1990) when they used enriched SPBs to raise 
monoclonal antibodies. Of the antibodies raised 14 identified three different SPB 
components of 110 kDa, 90 kDa and 80 kDa. Antibodies against the 110 kDa protein 
were used to localise the protein by immunoelectron microscopy. It was found that the 
110 kDa protein was present on the nuclear side o f the SPB at all stages o f the cell
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cycle. Kilmartin et al (1993) later used the antibodies against the 110 kDa SPB protein 
to screen an expression library and cloned SPC110. SPC110 was found to be identical 
to the NUF1 (nuclear filament related) gene. NUF1 was found in a similar way using 
antibodies prepared against fractions of yeast nuclei and was predicted to encode a 
coiled-coil protein (Mirzayan et al., 1992). Further analysis by Kilmartin et al (1993) 
showed that the SPC110 transcript is cell cycle regulated and when the putative coiled- 
coil domain was expressed in E. coli it formed rods of the expected length. The anti- 
SpcllOp antibodies labelled the space between the central and inner plaques where 
filaments could be seen by electron microscopy. The coiled-coil domain was then 
shown to act as a spacer between the central and inner plaques, as deletions in the 
coiled-coil domain resulted in a proportional decrease in the distance between the 
central and inner plaques (Kilmartin et al., 1993). Since the identification of SpcllOp 
and its initial characterisation as a coiled-coil spacer protein, mutational analysis of 
spcllO  and cmdl (yeast calmodulin) mutants has given a greater insight into the 
function of Spc 11 Op.
Calmodulin is a calcium-binding protein involved in numerous cellular processes. 
Calmodulin is highly conserved for example the human calmodulin can substitute for 
the budding yeast calmodulin (Davis and Thomer, 1989). The essential functions of 
calmodulin in budding yeast are calcium independent as cm dl mutants that cannot bind 
calcium in vitro are functional in vivo (Geiser et al., 1991). One of the functions of 
calmodulin is in mitosis. This was shown by cmdl mutants that exhibited defects in 
chromosome segregation (cm dl-1, (Davis, 1992)), spindle formation and SPB 
duplication (cm dl-101, (Sun et al., 1992)). In some cm dl-101 cells nuclear 
microtubules could be seen detached from the inner plaque. Systematic mutagenesis of 
calmodulin revealed four diverse essential functions in yeast (Ohya and Botstein, 
1994a; Ohya and Botstein, 1994b). One of these groups of mutants (cmdlC) showed a 
severe defect in mitosis, arresting as large budded cells with monopolar spindles. 
Spcl lOp was then found to be one of the calmodulin target proteins. First SPC110 was 
identified as a suppresser of cmdl-1 (Geiser et al., 1993) and in a separate screen the C- 
terminus of SpcllOp interacted with calmodulin in the two hybrid system. Direct 
binding of calmodulin to C-SpcllOp was shown by overlay assays. To further support 
this data a fraction of calmodulin localised to the SPB as shown by 
immunofluorescence (Geiser et al., 1993; Stirling et al., 1994). More specifically 
calmodulin localised to the central plaque of the SPB as shown by immunoelectron 
microscopy (Spang et al., 1996b), this localisation was dependent on the C-terminus of
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SpcllOp. Therefore, if calmodulin localises to the central plaque and binds to the C- 
terminus of SpcllOp, this gives the orientation of SpcllOp within the SPB. This is 
supported by the labelling of the inner plaque by antibodies raised against the N- 
terminus of Spcl lOp (Spang et al., 1996b). The calmodulin binding site of Spcl lOp was 
determined using the two hybrid system (Geiser et al., 1993) and by introducing point 
mutations into the C-terminus of SpcllOp and studying the ability of these SpcllOp 
mutant proteins to bind calmodulin in vitro (Stirling et al., 1994). Point mutations in the 
calmodulin binding site of SpcllOp abolished calmodulin binding in vitro and 
prevented SpcllOp from functioning in vivo. These SpcllOp mutant proteins were 
present in lower levels in the cell, but elevation by gene dosage resulted in partial 
recovery of SpcllOp function. Overexpression of calmodulin also suppressed the 
defects in these spcl 10 mutants, supporting the notion that SpcllOp stability is a 
consequence of calmodulin binding and pointing to a role for calmodulin in SpcllOp 
function (Stirling et al., 1994). Interestingly, C-terminal truncation of Spcl lOp resulting 
in deletion of the calmodulin-binding site suppresses the cmdl-1 mutation.
Temperature sensitive alleles of SPC110 exhibit very similar phenotypes to the cmdl-1 
and cm dl-101 mutants (Kilmartin and Goh, 1996; Stirling et al., 1996; Sundberg et al., 
1996). spcllO(ts) mutants arrest as large budded cells with a G2 DNA content, there is 
failure of chromosome segregation and spindle breakage. Closer analysis by electron 
microscopy showed detachment o f nuclear microtubules from the SPB (Kilmartin and 
Goh, 1996). Overexpression of SPC110 caused the self-assembly of SpcllOp- 
calmodulin into ordered spheroidal polymers in the nucleus (Kilmartin and Goh, 1996). 
Similar aggregates were seen in spcl 10-220 cells at the non-permissive temperature 
(Sundberg et al., 1996). These aggregates were capable of microtubule nucleation and 
so were named intranuclear microtubule organisers (IMOs). The IMO is a transient 
structure, appearing in the nucleus at the time of SPB duplication and disappearing after 
SPB separation. SpcllOp and the 90 kDa protein (Spc98p) were localised to these 
IMOs, giving the first indication o f a direct interaction between SpcllOp and the 
Tub4p-complex. SpcllOp can be divided into three functional regions (Sundberg and 
Davis, 1997). Mutations in region I (N-terminal) were suppressed by overexpression of 
SPC98. Region II is the carboxy-region of the coiled-coil domain, mutations here lead 
to loss of SPB integrity during mitosis suggesting it is involved in attachment of 
Spcl lOp to the central plaque. Region III is the calmodulin binding site.
These results suggest roles for calmodulin and SpcllOp within the SPB. Calmodulin 
binding to Spcl lOp appears to relieve some inhibition, probably caused by the very C-
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terminus of Spcl 1 Op, allowing Spcl lOp to incorporate into the new SPB. To summarise 
the functions of SpcllOp, the C-terminus contains a calmodulin-binding site and is 
positioned at the central plaque, the coiled-coil region acts as a spacer between the 
central and inner plaques and the N-terminus is required to anchor nuclear microtubules 
to the SPB (Figure 8). Evidence to support this final point came from biochemical and 
genetic studies. The N-terminal domain of Spcl lOp interacted with the Tub4p-complex 
components Spc98p and Spc97p, but not Tub4p in the two hybrid system. An 
interaction between the N-terminus of Spcl lOp and the Tub4p-complex was also shown 
using the purified components (Knop and Schiebel, 1997).
SpcllOp is also a phosphoprotein that is phosphorylated in a cell cycle dependent 
manner (Friedman et al., 1996; Stirling and Stark, 1996). SpcllOp is phosphorylated 
during spindle formation and dephosphorylated as cells enter anaphase. Transport of 
Spcl lOp into the nucleus occurs via a nuclear localisation signal (NLS). Deletion of the 
NLS inhibits SPB duplication (Adams and Kilmartin, 1999).
It may be that y-tubulin-complex-binding proteins are conserved components of 
MTOCs as a centrosomal protein, p i 16, related to SpcllOp has been identified in 
vertebrates, p i 16 also co-purifies with y-tubulin (Tassin et al., 1997). Also, Flory et al 
recently identified a human coiled-coil, calmodulin-binding centrosomal protein, named 
kendrin, which is encoded by the same gene as pericentrin. Pericentrin is known to 
interact with the y-tubulin complex (Dictenberg et al., 1998), it is therefore very likely 
that kendrin/pericentrin is a human orthologue of Spcl lOp.
The central and outer plaques
As mentioned above the calmodulin-binding C-termini of Spcl lOp are positioned at the 
central plaque. For general purposes the central plaque as a term includes the IL2 layer. 
This is due to the appearance of SPBs in whole cells when observed by electron 
microscopy where the minor layers of the SPB are hard to distinguish from the major 
layers. The IL2 layer consists of a crystal of Spc42p (Bullitt et al., 1997). Spc42p was 
first identified in a similar way to Spcl 1 Op, by using enriched SPBs to raise monoclonal 
antibodies (Rout and Kilmartin, 1991). Further analysis showed that Spc42p and 
SpcllOp have a number of common features, both contain coiled-coil regions and both 
appear to be cell cycle regulated at the mRNA level with expression occurring at the
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time of SPB duplication. Spc42p is also a phosphoprotein (Donaldson and Kilmartin, 
1996), but the role of phoshorylation in the function of Spc42p is unclear. Spc42p is 
important for SPB integrity and plays a role in SPB duplication as seen by analysis of 
spc42(ts) mutants (Donaldson and Kilmartin, 1996). One of the phenotypes observed 
was detachment of SPBs from the nuclear envelope, suggesting a role for Spc42p in 
embedding the SPB in the nuclear envelope. Other phenotypes were failure of SPB 
duplication and accumulation of an electron dense mass on the cytoplasmic side o f the 
half-bridge. This mass may result from the disassembly of the satellite due to loss of 
Spc42p function explaining the defect in SPB duplication. Spc42p self-assembles into a 
hexagonal crystal as seen by cryo-electron microscopy o f isolated diploid SPBs and 
SPBs from cells overexpressing SPC42 (Bullitt et al., 1997). Overexpression of SPC42 
caused this central crystal to extend out laterally from the central plaque to form a 
dome-like structure around the SPB (Donaldson and Kilmartin, 1996). In these cells the 
dimensions of the inner and outer plaques remain as wild type. The coiled-coil region of 
Spc42p is probably important for formation of the Spc42p crystal at the central plaque 
as point mutations that disrupt the a-helical structure cause a temperature sensitive 
phenotype (Donaldson and Kilmartin, 1996).
The known components on the cytoplasmic side of the SPB in order from Spc42p are 
Cnm67p, Spc94p/Nudlp, Spc72p, Stu2p, the Tub4p-complex and the cytoplasmic 
microtubules. At the cytoplasmic side o f the SPB Spc42p interacts with the coiled-coil 
protein Cnm67p (Elliott et al., 1999). Deletion of CNM67 is not lethal, but results in 
SPBs lacking an outer plaque, therefore in Acnm67 cells cytoplasmic microtubules are 
organised entirely by the half-bridge (Brachat et al., 1998). Cytoplasmic microtubules 
nucleated by the half-bridge cannot fully compensate for the lack of the outer plaque, 
therefore, Acmn67 cells have misorientated spindles during mitosis leading to bi- and 
multi-nucleated cells. Cnm67p is not strictly required for mitosis, however, Cnm67p is 
essential for sporulation. Spore wall formation is initiated by an enlargement of the 
outer plaque which acts as a nucleation site for spore wall assembly (Byers, 1981a; 
Kupiec et al., 1997; Moens and Rapport, 1971). In Acmn67 cells there is no outer 
plaque, therefore sporulation cannot occur (Brachat et al., 1998). Cnm67p localises 
close to Spc94p/Nudlp at the outer plaque (Wigge et al., 1998), so it was not surprising 
to find that Cnm67p and Spc42p co-purified with protein A-tagged Spc94p. Two-hybrid 
studies gave the order of the three proteins within the SPB as given above (Elliott et al., 
1999). Spc94p has also been shown to interact with Spc72p using the two hybrid system 
and by immunoprecipitation (Gruneberg et al., 2000).
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Stu2p is a microtubule binding protein that localises to the SPB and to a lesser extent 
along spindle microtubules (Wang and Huffaker, 1997). STU2 was identified as a 
suppresser of a P-tubulin cold sensitive mutant. Stu2p was later used to identify Spc72p 
in a two hybrid screen (Chen et al., 1998). The theory for Stu2p function is that it forms 
a lateral attachment to microtubules which anchors and stabilises microtubules while 
allowing subunit exchange at the minus ends.
The half-bridge
The only known components of the half-bridge are Cdc31p and Karlp. Cdc31p is a 
member of the calcium-binding protein family known as centrins which also includes 
components of the human centrosome (CEN1, 2 and 3 (Errabolu et al., 1994; 
Middendorp et al., 1997)). Cdc31p forms a complex at the half-bridge with Karlp, 
which is a membrane protein. Both CDC31 and KAR1 were first identified in genetic 
screens. CDC31 was identified in a screen for cell cycle mutants (Hartwell et al., 1970), 
whereas KAR1 was identified in a screen for mutants defective in nuclear fusion 
(karyogamy) during mating (Conde and Fink, 1976). Cdc31p and Karlp are known to 
be involved in SPB duplication as demonstrated by analysing temperature sensitive 
mutants. The phenotype of cdc31(ts) and karl(ts) cells are very similar (Byers, 1981a; 
Byers, 1981b; Rose and Fink, 1987; Winey et al., 1991a). Both arrest with a single, 
abnormally large SPB that has failed to duplicate. This phenotype probably results from 
accumulation of SPB components around the pre-existing SPB due to the absence of a 
satellite. In support of this, Cdc31p action was found to be at the time of satellite 
formation (Winey et al., 1991a). CDC31 was first cloned by complementation of the 
cdc31 mutants from the original screen for cell cycle mutants (Baum et al., 1986). 
Sequence analysis showed that Cdc31p shows significant homology with calmodulin 
and other calcium-binding proteins. Cdc31p was identified as a member of a growing 
family called the centrins and as with other centrins, Cdc31p undergoes a calcium- 
dependent conformational change (Geier et al., 1996; Wiech et al., 1996). Cdc31p was 
localised to the SPB half-bridge by immunoelectron microscopy (Spang et al., 1993).
Study of karl mutants has shown that Karlp is involved in mitosis and karyogamy. 
This was confirmed when mutational analysis o f KAR1 defined three functional regions 
(Vallen et al., 1992). The first region is required for karyogamy, region II is essential 
for mitosis and region III is essential for both functions and encodes a membrane
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spanning domain. These three regions are distinct, the rest o f the protein is non-essential 
suggesting that Karlp contains distinct protein binding domains flexibly connected to a 
membrane anchor. K arlp was then localised to the half-bridge (Spang et al., 1995). The 
localisation of Karlp and Cdc31p to the same substructure of the SPB along with the 
similar phenotypes of karl(ts) and cdc31(ts) mutants and genetic interactions between 
the two genes (Vallen et al., 1994) led to investigation of a possible direct interaction 
between K arlp and Cdc31p. [35S]-labelled Cdc31p was shown to interact with Karlp in 
vitro using an overlay assay. In addition, the Cdc31p-binding site of K arlp is part of the 
region identified as essential for mitosis (Biggins and Rose, 1994; Spang et al., 1995). 
The region essential for karyogamy coincides with the region of K arlp that binds to 
Spc72p. Both spc72(ts) and karl(ts) mutants have defects in karyogamy. This is now 
understood to be due to a defect in microtubule nucleation by the half-bridge. If 
microtubules are not nucleated by the half-bridge during mating then the two nuclei 
from the mating cells cannot be brought together, therefore nuclear fusion does not 
occur (Pereira et al., 1999). The localisation of Cdc3 lp was claimed to be dependent on 
Karlp as Cdc31p was no longer detectable at the SPB after depletion of K arlp (Biggins 
and Rose, 1994; Spang et al., 1995). However, a dominant mutation in CDC31 
(■CDC31-16) allows cells to tolerate a complete deletion of KAR1 (Vallen et al., 1994). 
This suggests that there are other proteins involved in the Cdc31p/Karlp complex. One 
candidate protein is Dsk2p (Biggins et al., 1996; Vallen et al., 1994). Dsk2p is a non- 
essential nuclear enriched protein that has an N-terminal ubiquitin-like domain. DSK2-1 
was found in a genetic screen for mutations that suppress the karlA17  mutation. In 
karlA17  cells Cdc31p is mislocalised, however in karlA17 DSK2-1 cells Cdc31p is 
relocalised to the SPB. Another member of the family of proteins containing a 
ubiquitin-like domain is Rad23p, which is involved in DNA repair (Watkins et al.,
1993) and interacts with the 26S proteosome (Schauber et al., 1998). Cells containing 
DSK2 or RAD23 deletions are viable, however the double deletion strain (Adsk2 
Arad23) is temperature sensitive due to a block in SPB duplication which can be 
suppressed by overexpression of CDC31 or by CDC31-16 (Biggins et al., 1996). The 
phenotype of this double deletion mutant is similar to the phenotype of cdc31(ts) and 
karl(ts) mutants, however Cdc31p is not mislocalised in these cells. In addition, 
overexpression of DSK2-1 (the allele that suppressed the karlA17  mutation) also caused 
a block in SPB duplication, providing further evidence o f a role for Dsk2p in this 
process. Overexpression of DSK2 caused accumulation of cells with short bipolar 
spindles, suggesting that Dsk2p may play a number of different roles in the cell cycle.
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There are homologues o f DSK2 in other organisms, for example dhp l+ in S. pombe (He 
et al., 1998) and XDRP1 (Xenopus Dsk2-related protein (Funakoshi et al., 1999)). In S. 
pombe, overexpression of dphl+also causes mitotic arrest with short bipolar spindles. In 
Xenopus, microinjected XDRP1 blocked cell division in cleaving Xenopus embryos and 
inhibited cyclin A degradation. XDRP1 interacted with cyclin A in the two hybrid 
system and in Xenopus egg extracts. Cyclin A seems to play a role in microtubule 
nucleation and mitotic spindle formation (Maldonado-Codina and Glover, 1992; Verde 
et al., 1992) and the role of XDRP1 seems to be to protect cyclin A from degradation 
until these essential functions have been carried out.
Regulation of SPB duplication
Although it is well established that Cdc31p and Karlp are involved in SPB duplication, 
the actual mechanisms involved have proved more difficult to elucidate. There are a 
host of other mutants that exhibit SPB duplication defects, for example a screen for 
mutants with monopolar spindles identified MSP1 and MPS2 which when mutated 
result in SPB duplication defects (Schutz and Winey, 1998; Winey et al., 1991b). 
M pslp is a protein kinase that may be involved in phosphorylation of SPB components 
(Pereira et al., 1998) and formation of the satellite (Winey et.al., 1991b). These 
functions may be part of a checkpoint that monitors SPB duplication (Fesquet et al., 
1999; Schutz et al., 1997; Schutz and Winey, 1998). Mps2p is a membrane protein that 
is involved in inserting the newly formed SPB into the nuclear membrane (Munoz- 
Centeno et al., 1999; Schramm et al., 2000; Winey et al., 1991b). It also appears that 
there is some functional overlap between nuclear pore components and the SPB, for 
example N dclp localises to both nuclear pores and the SPB (Chial et al., 1998). When 
mutations were introduced into NDC1, the cells exhibited SPB duplication defects 
(Chial et al., 1998; Thomas and Botstein, 1986; Winey et al., 1993). Interestingly, both 
N dclp and Mps2p are membrane proteins and when mutated, cells exhibit almost 
identical defects in SPB duplication. Both arrest with a newly formed SPB attached to 
the mother SPB by the bridge, that is unable to insert into the nuclear membrane and 
therefore lacks an inner plaque. What is not yet understood is why the deletion of 
POM 152 which encodes a nuclear pore component (Wozniak et al., 1994) rescues the 
SPB duplication defects of ndcl(ts) and mps2(ts) mutants (Chial et al., 1998; Schramm, 
unpublished data). However, Poml52p co-fractionates with SPBs (Wigge et al., 1998), 
but at the time this was explained as contamination.
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Separation of SPBs by cleaving the bridge is a process which is not yet understood, 
however homologues of the sCFCdc4p complex in mammalian cells appear to be involved 
in separation of centrioles in vitro and centrosome duplication in Xenopus embryos 
(Freed et al., 1999). Also, mutations in CDC4, CDC34 and CDC53 (components of the 
g£pCdc4P compiex) result in cells that arrest with SPBs that have duplicated, but not 
separated (Chun et al., 1996; King et al., 1996a; Mathias et al., 1996). There is also 
evidence for participation of the proteosome in SPB duplication, mutations in one of the 
cap structure proteins (Pcslp) results in cells arrested with a single, enlarged SPB 
(similar to the phenotype of cdc31(ts) and karl(ts) mutants). This suggests that the role 
of the proteosome is in an early step in SPB duplication and that this role is distinct to 
cyclin degradation (McDonald and Byers, 1997).
As mentioned at the start of this chapter the cell cycle contains checkpoints that monitor 
cell cycle events and arrest the cell cycle if defects are detected, but how is SPB 
duplication monitored? In order for a cell to form a bipolar mitotic spindle SPB 
duplication must occur, therefore the spindle checkpoint will arrest cells that have not 
properly duplicated or separated their SPBs.
Aim s
When this study commenced, the spindle pole body of Saccharomyces cerevisiae was 
not as well understood as it is at the present time. The only components identified were 
Spc42p, SpcllOp, Cmdlp, Cdc31p, K arlp and the components of the y-tubulin 
complex. Little was know about the components of the outer plaque, how the known 
components interacted with each other within the SPB or the processes involved in SPB 
duplication. The aim of the project here in was to identify and characterise additional 
components of the SPB in the hope of gaining an increased knowledge of the structure 
of the SPB and perhaps to elucidate further the mechanism of SPB duplication.
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Materials and Methods
Media and Plates
All chemicals were from Fisher chemicals unless otherwise indicated.
LB 10 g Bacto-tryptone (DIFCO)
5 g Bacto-yeast extract (DIFCO) 
lO gN aCl
Made up to 1 litre with distilled water then autoclaved 
For plates 15 g Bacto-agar (DIFCO) was added
Selection 100 mg/1 Ampicillin (SIGMA) diluted from 1000 x stock
in ddH20 , stored at -20°C
50 mg/1 Kanamycin monosulphate (SIGMA) diluted from 
400 x stock in ddH20 , stored at -20°C
Induction 1 mM IPTG (Melford Laboratories, Ltd.) diluted from
100 x stock in ddH20 , stored at -20°C
SOC Medium 2 g Bacto-tryptone (DIFCO)
0.55 g Bacto-yeast extract (DIFCO)
1 ml 1 M NaCl 
1 ml 1 M KC1 
97 ml dd H20
This solution was autoclaved, then allowed to cool.
To the cooled solution was added:
1 ml 2 M Mg2+ (1 M MgCl2, 1 M M gS04)
1 ml 2 M Glucose
The final solution was filter sterilised and stored in 10 ml 
aliquots at room temperature.
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PSi Broth 5 g Bacto-yeast extract (DIFCO)
20 g Bacto-tryptone (DIFCO)
5 g Magnesium sulphate
Adjusted to pH 7.6 with potassium hydroxide
Made up to 1 litre with distilled water then autoclaved
YPD 10 g Bacto-yeast extract (DIFCO)
20 g Bacto-peptone (DIFCO)
20 g Glucose
Made up to 1 litre with distilled water then autoclaved 
For plates 20 g Bacto-agar was added
YPD-KanMx plates YPD containing 20 g Bacto-agar
0.2 g/1 Kanamycin (Geneticin G-418 Sulphate from 
GIBCO). The YPD was autoclaved then cooled. 
Kanamycin was dissolved in 20 ml ddH20 , filter 
sterilised, then added to the cooled YPD, the plates were 
poured immediately after mixing.
YPAD YPD containing 100 mg/1 Adenine (SIGMA)
YPAD for immunofluorescence 10 g Bacto-yeast extract (DIFCO)
20 g Bacto-peptone (DIFCO)
500 mg Adenine (SIGMA)
900 ml distilled water 
The above was mixed and divided equally into four 250 
ml bottles then autoclaved. Before use 25 ml 20% 
Glucose (sterile filtered) was added.
SC Medium 6.7 g Bacto-yeast nitrogen base without amino acids
(DIFCO)
20 g Glucose 
2 g Drop out mix
Made up to 1 litre with distilled water then autoclaved
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SC Plates A 6.7 g Bacto-yeast nitrogen base without amino acids
(DIFCO)
20 g Glucose 
2 g Drop out mix
Made up to 500 ml with distilled water 
B 20 g Bacto-agar (DIFCO)
Made up to 500 ml with distilled water 
A and B were autoclaved separately and mixed before pouring plates.
SC medium and plates containing galactose/raffmose (SIGMA) instead of glucose were 
made as above, minus glucose. After autoclaving and cooling, filter sterilised 20% 
raffmose and/or 20% galactose was added to a final concentration of 2%.
Drop out mix: A mix of amino acids and other growth requirements used to make SC- 
medium and plates. All the contents of the drop out mix were from SIGMA.
Adenine 5 g Isoleucine 20 g
Alanine 20 g Lysine 20 g
Arginine 20 g Methionine 20 g
Asparagine 20 g para-Aminobenzoic acid 2 g
Aspartic acid 20 g Phenylalanine 20 g
Cysteine 20 g Proline 20 g
Glutamine 20 g Serine 20 g
Glutamic acid 20 g Threonine 20 g
Glycine 20 g Tyrosine 20 g
Inositol 20 g Valine 20 g
The following was added to 36.7 g of the above mix as required, to allow selection of 
cells containing specific marker genes.
Histidine 2 g
Leucine 4 g
Uracil 2 g
Tryptophan 2 g
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5-FOA plates A 6.7 g Bacto-yeast nitrogen base without amino acids
(DIFCO)
20 g Glucose
2 g Drop out mix minus Uracil 
50 mg Uracil
1 g 5-FOA (Melford Laboratories Ltd.)
Made up to 500 ml with distilled water 
Filter sterilised 
B 20 g Bacto-agar (DIFCO)
Made up to 500 ml with distilled water 
Autoclaved 
A and B were mixed before pouring plates
SPO plates 2.5 g Bacto-yeast extract (DIFCO)
15 g Potassium acetate 
0.5 g Glucose 
40 mg Adenine 
40 mg Uracil 
40 mg Tyrosine
20 mg of amino acids: Arg, His, Leu, Lys, Met and Trp.
100 mg Phenylalanine
350 mg Threonine
20 g Bacto-agar (DIFCO)
Made up to 1 litre with distilled water and autoclaved
X-Gal plates (3 plates) 20 ml 5 x SC-His-Leu
10 ml 20% Galactose (filter sterilised)
10 ml 20% Rafflnose (filter sterilised)
10 ml BU salts (46.5 g Na2H P042H20 , 33.9 g
NaH2P 0 4lH 20  in 1 litre of ddH20 )
50 ml 4% Bacto-agar in ddH20  (agar was autoclaved
and stored solid, agar was melted before use using 
a microwave)
200 pi X-Gal (Melford Laboratories, Ltd.) (40 mg/ml in 
DMF (SIGMA), stored at -20°C)
X-Gal plates were made fresh for each experiment.
Sarah L. Elliott, 2001 47
X-Gal top agar (per plate) 9.3 ml 0.5M KPi, pH 7
600 pi DMF (SIGMA)
100 pi 10% SDS (ICN)
50 mg ultrapure LMP agarose (GIBCO)
Solution was heated briefly (30 sec - 1 min) using a microwave, then left to cool.
To the warm solution was added 5 pi p-mercaptoethanol and 100 pi o f 40 mg/ml X-Gal 
(Melford Laboratories, Ltd.) in DMF (SIGMA).
Solutions
TBS 25 mM Tris (GIBCO)
137 mM NaCl
2.7 mM KC1
pH 7.55 (adjusted with HC1)
PBS 137 mM NaCl
2.7 mM KC1
10 mM Na2H P04
1.76 mM KH2P 0 4
pH 7.2 (adjusted with HC1)
50 x TAE stock 2 M Tris
50 mM EDTA (MERCK) 
pH 7.7 (adjusted with acetic acid)
Laemmli running buffer 25 mM Tris 
192 mM Glycine 
0.1% SDS (ICN)
Blotting buffer 25 mM Tris 
192 mM Glycine 
0.025% SDS (ICN) 
20% Methanol
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HU buffer
Coomassie blue stain
Destain solution 
Ponceau S stain
lOx PCR buffer 
(Perkin Elmer)
lOx Ligation buffer 
(EPICENTRE Technologies)
Tfbl
8 M Urea 
5% SDS (ICN)
200 mM Tris-HCl, pH 8.0 
0.1 mM EDTA (MERCK)
0.5% Bromophenol blue (MERCK)
100 mM DTT (BIOMOL)
0.25% Coomassie Brilliant blue R250 (Serva) 
7% Acetic acid 
50% Methanol
10% Acetic acid 
50% Methanol
0.2% Ponceau S (SIGMA)
3% TCA
100 mM Tris-HCl, pH 8.3 
500 mM KC1
50 mM Tris-HCl, pH7.8 
10 mM MgCl2 
1 mM DTT 
1 mM ATP
30 mM Potassium acetate 
100 mM Rubidium chloride 
10 mM Calcium chloride 
50 mM Manganese chloride 
15% Glycerol (ALDRICH)
Adjusted to pH 5.8 with dilute acetic acid
Sarah L. Elliott, 2001
Tfbll 10 mM MOPS
10 mM Rubidium chloride 
75 mM Calcium chloride 
15% Glycerol (ALDRICH)
Adjusted to pH 6.5 with sodium hydroxide
QIAGEN Plasmid Purification:
Buffer PI 50 mM Tris-HCl, pH 8.0
10 mM EDTA 
100 pg/ml RNase A
Buffer P2 200 mM NaOH 
1 % SDS
Buffer P3 3 M potassium acetate, pH 5.5
Buffer QBT 750 mM NaCl 
50 mM MOPS, pH 7.0 
15% isopropanol 
0.15% Triton X-100
Buffer QC 1 M NaCl
50 mM MOPS, pH 7.0 
15% Isopropanol
Buffer QF 1.25 M NaCl
50 mM Tris-HCl, pH 8.5
15% Isopropanol
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DNA sample buffer
LiSorb
LiPEG
S buffer
Lysis solution
NaPi buffer (0.1 M)
10 mM Tris-HCl, pH 8.0 
1 mM EDTA (MERCK)
0.8% Bromophenol blue (MERCK)
0.8% Xylene cyanole (SIGMA)
15% Ficoll 400 (Pharmacia Biotech)
100 mM Lithium acetate (SIGMA)
10 mM Tris-HCl, pH 8.0 
1 mM EDTA (MERCK)
1 M Sorbitol (SIGMA)
Filter sterilised
100 mM Lithium acetate (SIGMA)
1 M Tris-HCl, pH8.0 
1 mM EDTA (MERCK)
40% PEG 3350 (SIGMA)
Filter sterilised
10 mM K2H P04, pH 7.5 
10 mM EDTA (MERCK)
50 mM p-Mercaptoethanol (SIGMA)
50 pg/ml Zymolyase 50T (Seikagaku Corporation,Tokyo) 
Prepared fresh
25 mM Tris-HCl, pH 7.5 
25 mM EDTA (MERCK)
2.5% SDS (ICN)
6.8 ml NaH2P 0 4 (1 M)
93.2 ml Na2H P04 (1 M)
Made up to 1 litre with distilled water 
pH 8
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KPi buffer
SP buffer
Wickerman's solution
PBS-B
DAPI-mounting solution
IP buffer
IP buffer (low salt)
IP buffer (high salt)
TST buffer
32.95 ml K2H P 04 (500 mM) 
67.05 ml KH2P 0 4 (500 mM) 
pH 6.5
40 mM KPi
0.5 mM MgCl2
1.2 M Sorbitol (SIGMA)
YPAD
1.1 M Sorbitol (SIGMA)
Filter sterilised
PBS
1% BSA (SIGMA)
75% Citifuor (Agar Scientific) 
25% PBS
0.25 pg/ml DAPI (SIGMA)
- r
50 mM Tris-HCl, pH 7.4 
10 mM EDTA (MERCK)
1 mM EGTA (SIGMA)
5% Glycerol (ALDRICH)
IP buffer 
100 mM NaCl
IP buffer 
1 M NaCl
50 mM Tris-HCl pH 7.4
150 mM NaCl
0.05% Tween 20 (SIGMA)
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Protease Inhibitors
PMSF stock 
Benzamidine stock
Complete, Mini, EDTA-free, Protease Inhibitor Cocktail 
Tablets (Boehringer Mannheim). One tablet was added 
per 10 ml of buffer. Once the tablets were added, buffers 
were stored on ice and used within 6 hours.
200 mM PMSF (Fluka) in DMSO, stored at -20°C 
500 mM Benzamidine (SIGMA) in ddH20 , 
stored at -20°C
Phosphate-citrate buffer 170 mM KH2P 0 4
30 mM sodium citrate (weighed out) to yield pH 5.8
Phosphate-Mg buffer 40 mM KPi, pH6.5 
0.5 mM MgCl2
Pretreatment solution 0.2 M Tris-HCl, pH 9.0 
20 mM EDTA (MERCK)
0.1 M p-Mercaptoethanol (added immediately before use)
Lead citrate 1.33 g Lead nitrate (TAAB)
1.76 g Sodium citrate (TAAB)
30 ml C 0 2-free ddH20  was added and the solution was shaken 
vigorously for several minutes, then 5 times over 30 min. The milky 
solution was then cleared with the addition of 5 to 8 ml of 1 N sodium 
hydroxide, which also altered the pH to 12.0. The solution was then 
made up to 50 ml with C 0 2-free ddH20 .
CB buffer 100 mM N aH C03 
0.5 M NaCl
Adjusted to pH 8.3 with HC1
AP buffer 50 mM Tris-HCl, pH 8.0 
150 mM NaCl 
1 mM MgCl2 
0.1 mM ZnCl2
1 mM PMSF added from stock immediately before use
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Primers
Primers used for cloning SPC29
Primers designed for cloning SPC29 contained sequences approximately 400 bp 
upstream of the START codon and a BamHl restriction site (SPC29-A) or 
approximately 200 bp downstream of the STOP codon and a Xhol restriction site 
(SPC29-B). Chromosomal DNA was used as the template. The PCR product was then 
inserted into pRS315 and pRS425.
Name Sequence
SPC29-A 5'CGggatccGCAAAAACAATGATCCAGTGC3' (forward)
SPC29-B 5'TCCGctcgagAACGAAAGGAGGAGACGGATA3' (reverse)
Primers used to construct spc29(ts) alleles
These primers were designed to contain sequence homology with the pRS315 vector. 
Therefore, these primers could be used to amplify any gene in pRS315. Also, the PCR 
product would have end regions that could facilitate homologous recombination with 
the cut pRS315 when both were transformed into yeast cells. pRS315-iSPC29 was used 
as a template.
Name Sequence
Ml 5'GGATGTGCTGCAAGGCG3’
M2 5'TTGTGTGGAATTGTGAGCG3'
Primers used to sequence SPC29
Name Sequence
SPC29-1 5'TAGGAAAGTGAAGAGCCCG3'
SPC29-2 5CATCAAGAATAACAAGACTGG3'
SPC29-3 5TTTATCTCCTCTGTCTGAG3'
SPC29-4 5'AAATGGTGGAGGAGGTAGT3’
Primers used to construct SPC29 and SPC1102433'2832 two hybrid plasmids
Two hybrid plasmids were designed to contain short sequences of the gene from the 
START codon and containing a BamHl site (SPC29-2H1) or ending at the STOP codon 
and containing a Xhol site (SPC29-2H2, SPC110-2H8). The forward primer used to
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create SPC1 K f433 m2 was designed to contain the appropriate sequence, a START
codon and a BamHl site (SPC110-5B). Additional bases are required to ensure the
correct reading frame is maintained. The PCR products were inserted into the two 
hybrid plasmids. These PCR products could also be inserted into expression vectors.
Name Sequence
SPC29-2H1 5'CGggatccGT ATGGATT AT AGTAACTTTGG AAA3’ (forward)
SPC29-2H2 5'TCCGctcgagTCAATTGTGAAAAGACGAAGAC3' (reverse)
SPC110-5B 5GGTCggatccAGTATCACTCAGAAGTAAGAC3'(forward)
SPC110-2H8 5CTGGCctcgagCIACCAAGAT AT ACGCCCG3' (reverse)
Primers used for SPC29 disruption cassettes and tags
The S-primers were designed to amplify epitope tags and disruption cassettes from 
plasmids. The primers have 'tails' which do not bind to the template DNA, but are 
amplified as part of the PCR product. These 'tails' are homologous to regions of the 
gene of interest allowing homologous recombination either at the 3' end to give gene 
fusions (S2 and S3) or at the start and end of the gene to give a gene disruptions (SI and 
S2). The SI 'tail' contains the 45 bp before START and the START codon. S2 is the 
reverse primer used with both SI and S3 primers. It contains the STOP codon and the 
45 bp after the STOP codon. S3 contains the 45 bp before the STOP codon. The PCR 
products are transformed into the yeast strain o f interest to form gene fusions or 
knockouts in the genome.
Name_________________ Sequence________________________________________________________
5 1-SPC29 5'TGTAAAAGTTTAACCAA AGATCCAA AGTGGCTTGTAGGAAT 
AATGcgtacgctgcaggtcgac3' (forward)
52-SPC29 5'TTAGTTACGATTATGCTGGTATTATTTAGTTAAGTACTTAAT 
TCAatcgatgaattcgagctcg3' (reverse)
53-SPC29 5AGTACGGAGGATATACTAAAAATATTGTCTTCGTCTTTTCAC 
AATcgtacgctgcaggtcgac3’ (forward)
54-SPC29 5'GAGGGCGTGAATGTAAGCGTGACATAACTAATTACATGA 
ctcgagTCAatcgatgaattcgagctcg3' (reverse)
(S4 replaces S2 for Gall-SPC29 construct only)
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Vectors and plasmids
Table 1 Plasmid backbones
Name Description Source or Reference
pRS305 LEU2-based yeast integration vector
pRS306 G&43-based yeast integration vector
pRS315 CEN6, LEU2-based yeast-is. coli shuttle vector
pRS316 CEN6, URA3-based yeast-is. coli shuttle vector
pRS414 CEN6, TRP1-based yeast-E. coli shuttle vector
pRS423 2 pm, HIS3-based yeast-is. coli shuttle vector
pRS425 2 pm, ZJsf/2-based yeast-is. coli shuttle vector
pRS426 2 pm, (7iL43-based yeast-is. coli shuttle vector
p413Gall CEN6, i/iS i-based yeast-is. coli shuttle vector
containing the Ga/ipromoter
pACT2 Two hybrid vector: 2 pm, ZisG2-based vector
carrying the GAL4 activation domain
pEG202 Two hybrid vector: 2 pm, HIS3-based vector
carrying the lexA DNA-binding domain
pET28c E.coli expression vector containing HIS6 under
the control of the T7 promoter
pGEX-5X-l E.coli expression vector containing GST under
the control of the lacZ promoter
pMM5 Two hybrid vector: pRS423 containing
Gall-LexA-Myc
pMM6 Two hybrid vector: pRS425 containing
Gall-GAL4-HA
Sikorski and Hieter 
(1989)
Sikorski and Hieter 
(1989)
Sikorski and Hieter 
(1989)
Sikorski and Hieter 
(1989)
Christianson et al 
(1992)
Christianson et al 
(1992)
Christianson et al 
(1992)
Christianson et al 
(1992)
Mumberg et al 
(1994)
Durfee et al (1993) 
Gyuris et al (1993) 
Novagen 
Pharmacia 
M. Knop 
M. Knop
YDpW TRP1-based integration plasmid Berben et al (1991)
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Table 2 Plasmids used as templates for PCR to construct tags for 
chromosomal integration.
Name Description Source or Reference
p YM 1 pFA6a-3HA-kanMX6 
pYM4 pFA6a-3MY C-kanMX6 
pYM7 pF A6a-Pro A-kanMX6 
p YM 12 pF A6a-GFPS65T-kanMX6
Knop et al (1999) 
Knop et al (1999) 
Knop et al (1999) 
Wach et a / (1997)
Table 3 Plasmids used as templates for PCR to construct disruption 
cassettes
Name Source or Reference
pFA6akanMX4
pFA6aHis3MX6
Wach et al (1994) 
Wach et al ( 1994)
Table 4 Plasmids
Name Description Source or Reference
pSEl pRS315-£PC29 this study
pSE3 pRS425-SPC29 this study
pSE4 pEG202-SPC29 this study
pSE7 pACT2-SPC29 this study
pSE ll pRS316-SPC29 this study
pSE16 pRS425-*S,PC770 this study
pSE17 pRS425-SPC42 this study
pSE19 pRS305-Gal 1-SPC42 this study
pSE20 pRS306-Gal 1-SPC29 this study
pSE29 pEG202-£PC7102433'2832 this study
pSE32 pEG202-spcl 10-1202433'2832 this study
pSE33 pEG202-spcl 10-1242433'2832 this study
pSE39 pEG202-s/?c710-1162433'2832 this study
pSE40 pEG2Q2-spcl 10-1182433-2832 this study
pSE41 pET28c-SPC29 this study
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Table 4 Plasmids continued
Name Description
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Source or Reference
pSE63 pMM5 containing SPC29 this study
pSE64 pMM6 containing SPC29 this study
pSE65 pMM5 containing BBP1 this study
pSE66 pMM6 containing BBP1 this study
pSE67 pMM5 containing MPS21'307 this study
pSE68 pMM6 containing MPS21'307 this study
pSE72 pMM6 containing KAR1-ATM this study
pAL2 pET28c containing MPS2] 307 A. Camasses
pBG2A-9 pRS425 containing DSK2 B. Geier
pCM108 pRS315 containing SPC110 E. Schiebel
pCMDl pRS425 containing CMD1 E. Schiebel
pC Sll pGEX-5X-l containing BBP1 C. Schramm
pCS14 pRS425 containing BBP1 C. Schramm
pDSllO YDpW containing SPC110 Stirling et al (1994)
pDSl 16 YDpW containing spcl 10-116 Stirling et al (1994)
pDSl 18 YDpW containing spc 110-118 Stirling et al (1994)
pDS120 YDpW containing spcl 10-120 Stirling et al (1994)
pDS124 YDpW containing spcl 10-124 Stirling et al (1994)
pMK82 p413Gall containing SPC110 M. Knop
pMK150 pAC Tl-SPC llO 2433'2832 M. Knop
pMK151 pACT2-SPCl101'612 M. Knop
pMK174 pACT2-SPC42M15 M. Knop
pMK175 PEG202-SPC421-415 M. Knop
pMK176 pACT2-SPC42291-1092 M. Knop
pMK177 pEG202-SPC42291-1092 M. Knop
pMK296 pRS425-CDC31-16 M. Knop
pSG ll pEG202- SPCllO 1'612 S. Geissler
pSG13 pEG202-573C7 7 o2433'2832 S. Geissler
pSMl 19 pRS3\5-KARl E. Schiebel
pSM192 pRS414-A TG-ProA-SPCl 10 E. Schiebel
pSM234 pRS425-CDC37 E. Schiebel
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E. coli strains
Plasmids listed above were transformed and amplified in one or more of the following
strains:
DH5a deoR endAl gyrA96 hsdR l7(rk'mk') recAl relA l supE44 thi-l A(lacZYA-
argFVl 69) <pWdacZAM15 F  A/; Clontech, Palo Alto, USA
SURE el4'(M crA’) A{mcrCB-hsdSMR-mrr) 171 endAl supE44 thi-l gyrA96
relAl lac recB recJ sbcC umuCwTn5 (Kan1) uvrC [F  proAB 
lacTZA(M15 TnlO (Tefi)]; Stratagene, La Jolla, USA
BL21 E. coli B F" A, dcm ompT hsdS{x^m^') gal (DE3); Stratagene, La Jolla,
USA
Yeast strains
Table 5 Background strains
Name Genotype Source or Reference
CRY1 MATa ade2 canl-100 h is3-ll, 15 leu2-3, 112
trpl-1 ura3-l
ESM356-1 MATa ura3-52 his3A200 leu2Al trplA63
ESM357-9 M ataura3-52 leu2Al his3A200 trplA63
SGY37VII MATa ura3-52::URA3-lexA-op-LacZ trpl
his3 leu2
YPH499 MATa ura3-52 lys2-801 ade2-101 trplA63
his3A200 leu2Al
YPH501 MA Ta/aura3-52 lys2-801 ade2-101 trplA63
his3A200 leu2Al
M. Stark
E. Schiebel
E. Schiebel
Geissler et al 
(1996)
Sikorski and Hieter 
(1989)
Sikorski and Hieter 
(1989)
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Table 6 Constructed strains
Name Genotype
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Source or Reference
SEY7
SEY13
SEY14
SEY23
SEY27
SEY33
SEY35
SEY37
SEY39
SEY40
SEY41
SEY47
SEY56
SEY63
SEY64
SEY80
MATa ura3-52 leu2Al his3A200 trplA63 
SPC29-GFP-kanMX6
MATa ura3-52 lys2-801 ade2-101 trplA63 
his3A200 leu2Al SPC29-3HA-kanMX6
MATa ura3-52 lys2-801 ade2-101 trplA63 
his3A200 leu2Al SPC29-3Myc-kanMX6
MATa his3A200 trplA63leu2Al ura3-52::pSE20
MATa his3A200 trplA63leu2Al::pSE\9  
ura3-52::pSE20 pMK82
MATa ura3-52 lys2-801 ade2-101 trplA63 
his3A200 leu2Al spc98-l Aspc29::HIS3 pSEl 1
MATa ura3-52 lys2-801 ade2-101 trplA63 
his3A200 leu2Al spc97-14 Aspc29::HIS3 pSEl 1
MATa ura3-52 lys2-801 ade2-101 trplA63 
his3A200 leu2Al spcl 10-2 Aspc29::HIS3 pSEl 1
MATa ade2 canl-100 his3-ll, 15 leu2-3, 112 
trpl-1 ura3-l cmdl-1 Aspc29::HIS3 pS E ll
MATa ade2 canl-100 his3-ll, 15 leu2-3, 112 
trpl-1 ura3-l Aspc29::HIS3 pSEl 1
MATa ura3-52 lys2-801 ade2-101 trplA63 
his3A200 leu2Al Aspc29::HIS3 pSEl 1
MATa his3A200 leu2Al trplA63ura3-52::pSE20 
Gall -SPC29- GFP
MATa ura3-52 lys2-801 ade2-101 trplA63 
his3A200 leu2Al spc42-9 Aspc29::kanMX4 pSEl 1
MATa ura3-52 lys2-801 ade2-101 trplA63 
his3A200 mps2-l /ew2zt/::pRS305
MATa ura3-52 lys2-801 ade2-101 trplA63 
his3A200 mps2-l Zew2zl7::pSE19
MATa ura3-52 lys2-801 ade2-101 trplA63 
his3A200 leu2Al spc29-2 SPC72-GFP-kanMX6
this study
this study
this study
this study 
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
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Table 6 Constructed strains continued
Name Genotype
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Source or Reference
SEY82
SEY83
spc29-2
spc29-3
spc29-9
spc42-9
spc42-10
sp c l10-118
sp c l10-124
ESM172
ESM473
ESM504
YMK230
MATa ura3-52 lys2-801 ade2-101 trplA63  
his3A200 leu2Al spc29-2 SPC42-GFP-kanMX6
MATa ura3-52 lys2-801 ade2-101 trplA63
his3A200 leu2Al spc29-2 SPC110-GFP-kanMX6
MATa ura3-52 lys2-801 ade2-101 trplA63  
his3A200 leu2Al spc29-2
MATa ura3-52 lys2-801 ade2-101 trplA63 
his3A200 leu2Al spc29-3
MATa ura3-52 lys2-801 ade2-101 trplA63 
his3A200 leu2Al spc29-9
MATa ura3-52 lys2-801 ade2-101 trplA63 
his3A200 leu2Al spc42-9
MATa ura3-52 lys2-801 ade2-101 trplA63 
his3A200 leu2Al spc42-10
MATa ade2-l his3 /rp7-7::pDSl 18 leu2 ura3 
spcl 10::LEU2
MATa ade2-l his3 ^/?7-7;:pDS124 leu2 ura3 
spcl 10:: LEU2
MATa ura3-52 lys2-801 ade2-101 trplA63  
his3A200 leu2Al Aspcl 10::HIS3 pSM192
MATa ura3-52 lys2-801 ade2-101 trplA63  
his3A200 leu2Al Aspc29::HlS3 pSEl 1
M ataura3-52 leu2Al his3A200 trplA63 
SPC72-GFP
MATa ura3-52 lys2-801 ade2-101 trplA63 
his3A200 leu2Al Akarl::HIS3 pMK296
this study 
this study 
this study 
this study 
this study 
this study 
this study 
M. Stark 
M. Stark
Knop et al 
(1997)
this study 
E. Schiebel 
M. Knop
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Antibodies
Table 7 Primary antibodies
Antibody Species Dilution Source
anti-HA (12A5) mouse (monoclonal) 1:10 E. Schiebel
anti-Myc (9E10) mouse (monoclonal) 1:20 E. Schiebel
anti-tubulin (Wa3) mouse (monoclonal) 1:20 E. Schiebel
anti-90 kDa SPB protein mouse (monoclonal) 1:5 J. Kilmartin
anti-Bbplp rabbit (polyclonal) 1:200 C. Schramm
anti-Cdc31p goat (polyclonal) 1:400 E. Schiebel
anti-Cnm67p rabbit (polyclonal) 1:1000 E. Schiebel
anti-Karl p goat (polyclonal) 1:200 E. Schiebel
anti-Karl p rabbit (polyclonal) 1:400 E. Schiebel
anti-Mps2p rabbit (polyclonal) 1:200 C. Schramm
anti-Spc29p rabbit (polyclonal) 1:100 this study
anti-Spc42p rabbit (polyclonal) 1:10 000 E. Schiebel
anti-Spc72p rabbit (polyclonal) 1:250 E. Schiebel
anti-Spc98p rabbit (polyclonal) 1:1000 E. Schiebel
anti-Spcl lOp rabbit (polyclonal) 1:1000 E. Schiebel
anti-Tub2p rabbit (polyclonal) 1:3000 E. Schiebel
Table 8 Secondary antibodies
Antibody Species Coupled to Dilution Source
anti-goat rabbit HRP 1:5000 Dianova
anti-mouse sheep HRP 1:5000 Dianova
anti-rabbit goat HRP 1:5000 Dianova
anti-goat donkey Cy3 1:1000 Dianova
anti-rabbit goat Cy3 1:1000 Dianova
anti-mouse goat FITC 1:250 Dianova
anti-mouse rabbit FITC 1:250 Dianova
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Methods
For all centrifugation steps; Eppendorf mini centrifuges were used for small volumes. 
Larger volumes were centrifuged in Sorvall rotors in Sorvall RC-5B Refrigerated 
Superspeed Centrifuges or in falcon tubes in a Heraeus Varifuge 3.2RS.
DNA Manipulations 
PCR
Template (0.15 pg) 1 pi
Primer 1 (10 pM) 1 pi
Primer 2 (10 pM) 1 Hi
10 x PCR buffer 10 pi
dNTPs (each dNTP is present at 2 mM) 10 pi
Magnesium chloride (25 mM) 4 - 24 pi
ddH20 made up to 100 pi
2 U Taq polymerase and 0.4 U Vent polymerase was added per PCR tube (multiply 
safecups from Sarstedt), just before starting the reaction. PCR machines were from 
Biometra.
Programme: 3 min 94°C
 ► 1 min ~54°C (depended on calculated annealing temperature of primers)
x 25 elongation 72°C (time depended on length of expected product)
  1 min 94°C
1 min 55°C 
3 min 72°C
PCR products were analysed by agarose gel electrophoresis, then extracted from the gel 
using the Gel Extraction Kit from Qiagen. The PCR products were then transformed 
directly into yeast competent cells or digested with restriction enzymes then ligated into 
plasmid backbones and transformed into E. coli competent cells.
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Restriction digests
All digests were carried out using BioLabs or Gibco enzymes and their recommended 
reaction buffers and BSA, if recommended. 3 U of enzyme was used per pg of DNA. 
Control digests were carried out using 3 pi mini DNA, the restriction reaction was 
carried out in a final volume of 20 pi and incubated at 37°C for approximately 1 hour. 
Plasmid DNA (3 pg) and PCR fragment (10 pi of gel extracted fragment) digests were 
carried out in a final volume of 100 pi and incubated at 37°C overnight. Incubation 
temperatures were changed when appropriate. Digests were analysed by agarose gel 
electrophoresis.
DNA agarose gel electrophoresis
0.8% agarose (Gibco) in TAE (solublised by heating in a microwave) was used for most 
DNA analysis. DNA was mixed with 0.2 volumes DNA sample buffer and loaded into 
the wells o f the gel. Gels were run at 90 V for 30 to 60 minutes in TAE. Gel apparatus 
was from BioRad. DNA bands were visualised by UV (254 nm) after staining in an 
ethidium bromide bath (1 ng/ml). The 1 kb ladder from Gibco was used as a DNA 
marker.
Isolation of DNA fragments from agarose gels
Gel Extraction Kit from Qiagen was used for all gel extraction. DNA bands were 
excised from the agarose gel using a clean, sharp scalpel. Three volumes of buffer QX1 
was added to each gel slice in 1.5 ml Eppendorf tubes, 10 pi of resuspended QIAEX II 
was added and the samples were incubated at 50°C for 10 min with shaking. Samples 
were then centrifuged (14 000 rpm, 30 sec, RT), the pellets were washed once with 
QX1 and twice with PE, each time the pellet was resuspended by vortexing. After 
washing the pellets were air-dried for 10 to 15 min. To elute the DNA, 20 pi of ddH20  
was added to the pellets and incubated at room temperature for 5 min. The samples 
were centrifuged for 30 sec and the supernatant, containing the DNA, was pipetted into 
clean Eppendorf tubes.
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Phenol/chloroform extraction
Backbone vectors were extracted from restriction enzyme reactions by 
phenol/chloroform extraction. To the restriction enzyme reactions was added 0.5 
volumes phenol and 0.5 volumes chloroform. The samples were vortexed 3 times for 20 
sec with 2 min intervals. Samples were then centrifuged (14 000 rpm, 5 min, RT). After 
centrifugation, the top layer was transferred into a clean Eppendorf tube and 0.5 
volumes of chloroform was added to remove traces of phenol. Samples were 
centrifuged again and this time the bottom layer was transferred into a clean Eppendorf 
tube, to this was added 0.1 volumes 3M sodium acetate, 0.005 volumes glycogen 
(Gibco) and 2 volumes 100% ethanol, samples were mixed and incubated at -80°C for 
30 min. Samples were then centrifuged (14 000 rpm, 30 min, 4°C), the pellets were air- 
dried and resuspended in 20 pi ddH20  or TE.
Ligations
Vector 0.5 pi
Insert 5 - 7.5 pi
ATP (25 mM) 0.4 pi
10 x ligation buffer 1.0 pi
T4 ligase (Epicentre Technologies) 0.5 pi
dH20 made up to 10 pi
Ligation reactions were incubated at 14°C overnight or at room temperature for 1 to 3 
hours then transformed into E. coli competent cells.
Preparation of E.coli electro-competent cells
For the preparation o f electro-competent cells, cultures of DH5a E.coli cells were 
grown in LB medium at 37°C with shaking, to an OD600 of 0.5 to 1.0. Cells were 
harvested by centrifugation (5000 rpm, 15 min, 4°C) in sterile centrifuge tubes. The cell 
pellet was washed, in decreasing amounts, twice with cold, sterile water and once with 
cold 10% glycerol. The pellet was then resuspended in an approximately equal volume 
of 10% glycerol. Cells were divided into aliquots in pre-cooled Eppendorf tubes on dry 
ice and stored at -80°C.
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Transformation of E.coli electro-competent cells
One 50 (al aliquot of DH5a competent cells per transformation was thawed on ice and 3 
pi of the ligation reaction or yeast mini DNA was added. The cells were then 
transferred to a pre-chilled electroporation cuvette and electroporated using a BioRad 
Gene Pulser (400 Q, 1 kV, 25 pF). Immediately after electroporation 1 ml sterile SOC 
medium was added. Cells were resuspended and recovered at 37°C for 1 hour in 
Eppendorfs. After recovery, 200 pi was plated out directly onto selective LB plates. The 
remaining cells were pelleted (5000 rpm, 5 min, RT), most of the SOC medium was 
removed, leaving approximately 200 pi in which the cells were resuspended then plated 
out on selective LB plates. Transformation plates were incubated at 37°C overnight, 
then stored at 4°C for no longer than 2 weeks.
Preparation of E.coli rubidium chloride competent cells
Cultures of Sure, DH5a or BL21 E.coli cells were inoculated from an overnight pre­
culture and grown in PSi Broth at 37°C with shaking, to an OD550 of 0.48. Cultures were 
then chilled on ice for 15 min, then pelleted at 5000 rpm, 4°C for 5 min. All the 
following steps used ice cold buffers, tubes and pipettes. The pellet was resuspended in 
0.4 volumes (here volume = original culture volume) o f cold Tfbl. Cells were pelleted 
as before and the pellet was resuspended in 0.04 volumes of cold TfbIL Cells were 
divided into aliquots in pre-cooled Eppendorf tubes, snap-frozen in liquid nitrogen and 
stored at -80°C.
Transformation of E.coli rhubidium chloride competent cells
One 100 pi aliquot per transformation, of Sure, DH5a or BL21 E.coli competent cells 
was thawed on ice. The thawed cells were mixed with the 10 pi ligation reaction or 0.5 
pg plasmid DNA and left on ice for 30 min. The cells were then heat shocked at 42°C 
for 1 min (in a waterbath) and placed back on ice for 2 min, 1 ml of SOC medium was 
then added to the cells and they were recovered at 37°C for 1 hour. After recovery, 200 
pi was plated out directly onto selective LB plates. The remaining cells were pelleted 
(5000 rpm, 5 min, RT), most of the SOC medium was removed, leaving approximately 
200 pi in which the cells were resuspended then plated out on selective LB plates.
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Transformation plates were incubated at 37°C overnight, then stored at 4°C for no 
longer than 2 weeks.
Mini and Midi preps
Mini preps
LB containing the appropriate antibiotic was used to make 1.5 ml aliquots, which were 
inoculated with single E. coli colonies from transformation plates and incubated at 37°C 
overnight with shaking. The cells were harvested and resuspended in 300 pi PI. P2 was 
added, 300 pi per sample, and mixed by inverting 5 to 10 times. Then 300 pi P3 was 
added and mixed in the same way. Samples were centrifuged at 14 000 rpm for 5 min 
and the supernatants containing the DNA were transferred into fresh tubes. To each 
sample 500 p i isopropanol was added and the DNA was precipitated by centrifugation 
(14 000 rpm, 10 min). The DNA pellet was washed with cold 70% ethanol, air-dried 
and resuspended in 20 pi ddH20 . DNA was analysed by restriction enzyme digests and 
agarose gel electrophoresis. Strains containing the plasmid of interest were used to 
make glycerol stocks (1 ml E. coli culture mixed with 500 ml 50% glycerol). Glycerol 
stocks were stored at -80°C
Midi preps
The E.coli strain containing the plasmid of interest was used to inoculate 50 ml LB 
containing the appropriate antibiotic. Cultures were grown overnight at 37°C with 
shaking. The bacteria were harvested by centrifugation (5000 rpm, 15 min, 4°C) and the 
pellets were resuspended in 4 ml of PI. The cells were lysed by addition of 4 ml of P2, 
the samples were then mixed by inverting and incubated at room temperature for 5 min. 
4 ml of P3 was added, the samples were mixed by inverting and chilled on ice for 15 
min. During this time, one QIAGEN-tip 100 per sample was equilibrated by applying 4 
ml of QBT and allowing the columns to empty by gravity flow. The lysates were 
cleared by filtration using QIAfilter Midi Cartridges and the liquid was applied to the 
columns. Once the columns had emptied they were washed twice with 10 ml QC. 
Plasmid DNA was eluted from the columns with 5 ml QF, the eluate was collected in 
glass centrifuge tubes. The DNA was precipitated by adding 3.5 ml isopropanol, mixing
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and centrifuging at 11 000 rpm for 30 min at 4°C (glass tubes were placed in rubber 
adapters then centrifuged in a Sorvall SS-34 rotor). The DNA pellets were washed with 
2 ml 70% ethanol, air-dried, resuspended in 200 pi ddH20  and stored at -20°C.
Preparation of yeast competent cells
A single colony of the yeast strain of interest was used to inoculate a 10 ml YPD pre­
culture which was grown overnight at 30°C (or 23 °C for temperature sensitive strains) 
with shaking. The pre-culture was then used to inoculate 50 ml YPAD to an OD600 of 
0.15. This culture was grown to an OD600 of 0.5 to 0.6, then harvested by centrifugation 
in a 50 ml falcon tube (all centrifugation steps: 3200 rpm, 5 min, RT, using a Heraeus 
centrifuge). The cells were washed with 20 ml sterile water and then 20 ml LiSorb. 
After all the residual LiSorb was removed the cell pellet was resuspended in 300 pi 
LiSorb and 30 pi carrier DNA was added (Salmon Sperm DNA from Gibco was heated 
at 95°C for 5 min then cooled on ice before adding to cells as carrier DNA). Cells were 
divided into 50 pi aliquots and stored at -80°C.
Transformation of yeast competent cells
Yeast competent cells were thawed at room temperature (one 50 pi aliquot per 
transformation). DNA (0.5 to 1 pg) was added to the cells followed by 300 pi LiPEG 
and brief vortexing to mix. The cells were incubated at room temperature with shaking. 
After 20 min, 35 ml DMSO was added to each transformation and mixed immediately 
by vortexing. Cells were heat shocked at 42°C, in a waterbath, for 20 min (5 min for 
temperature sensitive strains). Cells were pelleted by centrifugation (1500 rpm, 2 min, 
RT), resuspended in 200 pi selective medium and plated out on selective plates. 
Transformation plates were incubated at 30°C (23°C for temperature sensitive strains), 
then stored at 4°C for no longer than 1 month.
For transformation of PCR fragments, one 50 pi aliquot of competent cells was used per 
transformation. For plasmid DNA, as little as 10 pi of competent cells could be used per 
transformation and all volumes were altered accordingly.
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For transformations that relied on kanamycin selection, a recovery time of at least 2 
hours (in 2 ml YPD, 30°C with shaking) was needed before plating out cells.
Glycerol stocks were made of the strains of interest. To do this blocks of cells were 
grown on selective plates, then scraped off and resuspended in 15% glycerol and frozen 
on dry ice. Glycerol stocks were stored at -80°C.
Preparation of yeast mini DNA
To isolate plasmid DNA from yeast cells 1 ml of the overnight cultures of the yeast 
strains of interest was pelleted by centrifugation. The cell pellets were resuspended in 
500 (al freshly prepared S buffer and incubated at 37°C for 30 min. 100 pi lysis solution 
was added to each, the samples were mixed by vortexing and incubated at 65°C for 30 
min. 166 pi 3 M potassium acetate was added and the samples were chilled on ice for 
10 min. The samples were centrifuged (14 000 rpm, 10 min, 4°C) and the DNA- 
containing supernatants were transferred into clean tubes. The DNA was precipitated by 
adding 800 pi cold 100% ethanol, chilling on ice for 10 min and centrifuging (as 
above). The DNA pellets were washed with 70% ethanol, air dried and resuspended in 
40 pi sterile water. Yeast mini DNA (1 to 5 pi) was then transformed into E.coli by 
electroporation.
Preparation of yeast chromosomal DNA
Wild type (YPH499) yeast cells were grown to early stationary phase (OD600 of 1 to 2) 
in 30 ml YPAD at 30°C with shaking. Cells were harvested by centrifugation (5000 
rpm, 5 min, 4°C, in a Sorvall SS-34 rotor, using polypropylene tubes with screw caps) 
and resuspended in 3 ml of 0.9 M sorbitol, 0.1 M EDTA, 50 mM DTT, pH 7.5. Cells 
were spheroplasted by adding 0.5 mg of zymolyase 50T (Seikagaku Corporation, 
Tokyo) and incubating at 37°C for 30 min with occasional shaking. Spheroplasting was 
followed using the light microscope. The spheroplasts were pelleted by centrifugation 
(5000 rpm, 5 min, 4°C), resuspended in 3 ml 50 mM Tris-HCl, 50 mM EDTA, pH 8.0 
then mixed with 300 pi of 10% SDS and incubated at 65°C for 30 min. Then 1 ml of 5 
M potassium acetate was added and the solution was chilled on ice for 1 hour. The 
sample was cleared by centrifugation (15 000 rpm, 30 min, 4°C) and the supernatant
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was transferred to a clean glass tube and 4 ml cold 100% ethanol was added to 
precipitate the DNA and RNA. The nucleic acids were pelleted by centrifugation (10 
000 rpm, 10 min, 4°C). Salt was removed from the pellet by a 5 min incubation with 4 
ml of 50% ethanol and vortexing to break up the pellet. The sample was centrifuged 
again (10 000 rpm, 10 min, 4°C), the supernatant was removed and the pellet was dried 
under reduced pressure. The DNA and RNA was then dissolved by incubating in 3 ml 
of 10 mM Tris, 1 mM EDTA, pH 7.5, for 1 hour. RNA was removed from the sample 
by addition of 150 pi of 1 mg/ml RNase (Boehringer Mannheim) and incubating for 30 
min at 37°C. The DNA was precipitated by adding 3 ml isopropanol and centrifugation 
(10 000 rpm, 10 min, 4°C). The DNA pellet was washed with 50% isopropanol and 
dried under reduced pressure. The DNA was then dissolved in 500 pi TE and stored at 
4°C or -80°C.
Construction of strains expressing tagged proteins
Plasmids containing the 3HA, 3Myc, protein A or GFP coding regions and the 
kanamycin marker were used as templates for PCR. The tags with the marker were 
amplified by PCR using primers designed to contain sequences homologous to the 3' 
region of the gene of interest. The PCR products were excised from an agarose gel, then 
transformed into the strain of interest. The kanamycin marker was used to select for 
cells that had successfully integrated the tag into the genome via homologous 
recombination. The strains were checked by immunofluorescence and by preparing cell 
extracts which were analysed by SDS-PAGE followed by Western blotting. Glycerol 
stocks were made of the strains of interest.
Construction of the SPC29 shuffle strain
Shuffle strains are yeast strains in which the chromosomal copy of the gene of interest 
has been replaced with a marker gene and a wild type copy of the gene of interest is 
present in the cell on a URA3-plasmid. First a diploid strain with one copy of SPC29 
replaced with a marker gene (Aspc29::HIS3) was constructed. This strain was then 
plated out on SPO plates, which induce sporulation due to lack of nutrients. Formation 
of spores was followed using the light microscope. When a cell sporulates it divides 
into four spores, these four spores are known as a tetrad. Tetrads (2 mm3) were scraped
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off the SPO plate and resuspended in 200 pi o f sterile water. 3 pi o f zymolyase (27 
mg/ml) was added and the cells were incubated at room temperature for 10 min. The 
tetrads were separated into 4 single spores on YPD plates with the dissecting 
microscope. Only two of the four spores grew on YPD plates, but these two spores 
could not grow on SC-His plates, therefore they did not contain the SPC29 disruption 
cassette. This shows that SPC29 is essential (see Results). Therefore to construct the 
shuffle strain, the diploid strain containing the SPC29 disruption cassette was 
transformed with SPC29 on a £//M3-plasmid (pRS316-5PC2P). This strain was 
subjected to spore analysis as above. Colonies that evolved from a single spore and 
carried the deletion marker (HIS3) as well as the URA3 marker were selected as these 
cells would be spc29::HIS3 pRS316-»S,PC29 (the SPC29 shuffle strain).
Construction of temperature sensitive SPC29 mutants
SPC29 was amplified using PCR under mutagenic conditions (in the presence of 
decreased dATP concentration and/or manganese chloride and Goldstar polymerase). 
The PCR products were cloned into pRS315 by homologous recombination. This was 
achieved by designing the primers (M 1 and M2) so that the sequence at the ends of the 
PCR product overlapped with the vector pRS315. The PCR product was then co­
transformed with pRS315 (restricted with Sac\/Xhol then purified) into the 
Aspc29::HIS3 pRS316-SPC29 shuffle strain. Transformants were selected for on SC- 
Leu plates at 23°C. The SPC29 shuffle strain contains a HIS3 disruption cassette in the 
native SPC29 locus, growth of the shuffle strain is dependent on the URA3-plasmid 
(pRS316) containing a wild type copy of SPC29 (see Results). Therefore, the 
transformation plates were replica plated onto 5-FOA plates at 23°C to select for cells 
that could grow without the wild type SPC29 (present on pRS316). The 5-FOA plates 
were replica plated onto SC-Leu, SC-Ura and SC-His plates at 23°C and YPD plates at 
23°C and 37°C. Plasmid DNA (pSR315-.spc2P) was isolated from cells that were LEJT 
URA", HIS+ (cells that still contained the HIS disruption cassette) and temperature 
sensitive for growth (grow at 23°C, but not 37°C). Plasmid DNA was amplified by 
transforming 3 pi of yeast mini DNA into DH5a E.coli cells by electroporation. Mini 
DNA was checked by restriction enzyme digests. Plasmids containing the potential 
temperature sensitive alleles of SPC29 were then transformed again into the 
Aspc29::HIS3 pRS316-SPC29 shuffle strain and subjected to the same selection process 
as described above. The spc29(ts) alleles were then integrated into the yeast genome at
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the native SPC29 locus. This was achieved by restricting the mini DNA of plasmids 
containing spc29(ts) alleles (pSR315-s;?c29) with the enzymes Kpnl and Xbal to 
liberate the spc29(ts) alleles which were then co-transformed with pRS414 (contains a 
TRP1 marker) into the Aspc29::HIS3 pRS316-SPC29 shuffle strain. Cells that had taken 
up DNA were selected for on SC-Trp plates. Cells were then replica plated onto 5-FOA 
(to select for cells that had lost the URA3 plasmid containing wild type SPC29). The 5- 
FOA plates were then replica plated onto YPD plates at 23°C and 37°C and SC-His 
plates at 23°C to detect cells that had lost the HIS3 cassette due to integration of 
spc29(ts) in the native SPC29 locus. H IS  temperature sensitive colonies were streaked 
out (cells taken from the YPD plate at 23°C) on YPD at 23°C and 37°C to double check 
the temperature sensitive phenotype. Finally, the YPD (23°C) plates were replica plated 
on to YPD plates and SC-Trp plates to identify colonies that had lost the plasmid 
pRS414. Glycerol stock cultures were made of cells that were URA', HIS, TRF  and 
temperature sensitive. Temperature sensitive alleles spc29-2, spc29-3 and spc29-9 were 
chosen for further analysis. The temperature sensitive phenotype of spc29-2, spc29-3 
and spc29-9 cells was rescued by pRS315-SPC29. The spc29(ts) alleles were 
sequenced, spc29-2 and spc29-3 were found to contain point mutations resulting in 
R161S and L158Q respectively and spc29-9 carries multiple mutations.
Synthetic lethality
To investigate the function of SPC29, spc29(ts) alleles were tested for synthetic 
lethality with temperature sensitive alleles of other SPB components. Temperature 
sensitive strains containing spc42-9, spcllO-2, cmdl-1, spc97-14 or spc98-l alleles 
were made into SPC29 shuffle strains. This was done by transforming the strains first 
with pRS3 \6-SPC29, then with the SPC29 disruption cassette (HIS3Mx6 or KanMx6 
marker). The strains were checked for the appropriate markers and for growth on 5- 
FOA (a correct SPC29 shuffle strain does not grow on 5-FOA). All work was done at 
23°C as all strains were temperature sensitive. These shuffle strains were then 
transformed with spc29-2 or spc29-3 on a LEU2-plasmid (pRS315) or control plasmids, 
then grown on 5-FOA to test for cells that could still grow in the presence of the two 
temperature sensitive alleles (see Results).
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The two hybrid system
SPC29, SPC42, SPC110 and BBP1 were amplified by PCR and inserted into the two 
hybrid vectors pEG202 and pACT2 or pMM5 and pMM6. pEG202 and pMM5 contain 
a sequence encoding the LexA DNA-binding protein and a HIS3 marker, pACT2 and 
pMM6 contain a sequence encoding the activation domain of GAL4 and the LEU2 
marker. The plasmids were designed in such a way that cloning via the BamHl and 
Xhol restriction sites produces gene fusions between LexA or GAL4 and the gene of 
interest. The two plasmids were then co-transformed into the yeast strain SGY37VII 
which contains the reporter construct lexA-operator-lacZ. Transformants were selected 
for on SC-His-Leu plates. Interactions were detected by streaking transformants on to 
X-Gal plates or SC-His-Leu plates then overlaying with X-Gal top agar.
Overexpression experiments
Yeast strains were constructed that contained combinations of SPC29, SPC42 and 
SPC110 under the control of the GAL1 promoter either on a plasmid (GAL1-SPC110- 
HIS3) or integrated into chromosomal markers (GAL1-SPC29-URA3, GAL1-SPC42- 
LEU2) using integration vectors. Cells were grown in selective media containing 2% 
raffmose instead of glucose. Overexpression via the GAL1 promoter was achieved by 
transferring the cells into selective media containing 2% raffmose and 2% galactose 
instead of glucose and incubating at 30°C for up to 3 hours with shaking.
Sequencing
Sequencing of DNA was provided as a service by The Beatson Institute for Cancer 
Research.
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Protein Techniques 
Preparation of yeast cell lysates
To prepare whole cell lysates 1 to 3 OD600 were harvested from overnight cultures of the 
yeast strains of interest. The cell pellets were resuspended in 1 ml cold, sterile water, 
150 pi of 1.85 M sodium hydroxide containing 7.5% P-mercaptoethanol (prepared 
immediately before use) was added per sample and mixed by vortexing. The samples 
were chilled on ice for 15 min, vortexed, and then 150 pi 55% TCA was added, the 
samples were again mixed by vortexing and chilled on ice for a further 10 min. The 
precipitated protein was pelleted by centrifugation (14 000 rpm, 10 min, 4°C). The 
supernatants were discarded, the samples were centrifuged briefly and the residual 
supernatant was removed. The protein pellets were resuspended in 300 pi HU buffer 
and analysed by SDS-PAGE followed by Western blotting.
SDS-PAGE
Protein samples were separated by SDS-PAGE and then analysed by Coomassie blue 
staining or Western blotting.
Mini gels
Separating gels Stacking gels
10% 12% 15% 4%
30% Acrylamide (Severn Biotech Ltd.) 3.35 ml 4.0 ml 5 ml 650 pi
ddH20 4.05 ml 3.4 ml 2.35 ml 3.1 ml
1.5 M Tris, pH 8.8 (separating buffer) 2.5 ml 2.5 ml 2.5 ml -
0.5 M Tris, pH 6.8 (stacking buffer) - - - 1.25 ml
10% SDS 100 pi 100 pi 100 pi 50 pi
10% APS 50 pi 50 pi 50 pi 25 pi
TEMED (SIGMA) 5 pi 5 pi 5 pi 5 pi
Volumes given are sufficient for two mini gels made using SDS-PAGE apparatus from 
BioRad. Protein samples were loaded into the wells of the mini gel and the protein was 
separated by running the gel at 25 mA, 200 V for approximately 1 hour in Laemmli 
running buffer. Gels were then either subjected to Western blotting or stained with 
Coomassie blue stain (30 min, RT with gentle rocking) followed by destaining until the
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background staining was reduced to an acceptable level (approximately three times 30 
min incubations in destain at RT with gentle rocking). The gels were then dried using a 
gel dryer.
Protein molecular weight markers were from BioRad. These markers consist of myosin 
(200,000 Da), p-galactosidase (116,250 Da), phosphorylase B (97,400 Da), serum 
albumin (66,200 Da), ovalbumin (45,000 Da), carbonic anhydrase (31,000 Da), trypsin 
inhibitor (21,500 Da), lysozyme (14,400 Da) and aprotinin (6,500 Da).
Gradient gels
Separating gel Stacking gel
8% 18% 4%
30% Acrylamide (Severn Biotech Ltd.) 8.1 ml 18 ml 1.95 ml
ddH20 14.1 ml 4.05 ml 9.3 ml
1.5 M Tris, pH 8.8 (separating buffer) 7.5 ml 7.5 ml -
0.5 M Tris, pH 6.8 (stacking buffer) - - 3.75 ml
87 % Glycerol (ALDRICH) - 1.7 ml -
10% SDS 300 pi 300 pi 150 pi
10% APS 150 pi 150 pi 75 pi
TEMED (SIGMA) 22.5 pi 15 pi 15 pi
The above volumes are sufficient for two gradient gels made using gradient gel 
equipment from Biometra. Gels were run at 25 mA, 200 V per gel for up to 6 hours in 
Laemmli running buffer. Gradient gels were stained using the Fairbanks staining 
method as it is more sensitive than the Coomassie blue stain.
Fairbanks solutions: A) 25% isopropanol, 10%acetic acid, 0.05% Serva Blue G250
B) 10% isopropanol, 10% acetic acid, 0.005% Serva Blue G250
C) 10% acetic acid, 0.002% Serva Blue G250
D) 10% acetic acid
E) 7% acetic acid, 50% methanol
Gels were incubated as follows: 15 min in E, 2 hours in A, 1 hour in B, 1 hour in C, 
then destained in D.
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Western blotting
For Western blot analysis polyacrylamide gels were blotted onto Protran nitrocellulose 
transfer membranes (Schleicher and Schuell) using blotting apparatus made at the Max- 
Planck Institute for Biochemistry, Martinsreid, Germany. After SDS-PAGE, the gels, 
membranes and 6 Whatman papers per gel were soaked in blotting buffer for 15 min 
prior to blotting. A blotting sandwich was then assembled using three pieces of 
Whatman paper followed by the membrane and the gel then another three pieces of 
Whatman paper. Gels were blotted for 1 to 1.5 hours at 100 mA, 5 V per gel. After 
blotting, membranes were stained with Ponceau S and the molecular weight markers 
were marked with a ball point pen.
After Western blotting, membranes were blocked with TBS/PBS, 10% powdered milk 
(Marvel). Membranes were then incubated with the appropriate primary antibody in 
TBS/PBS, 5% powdered milk. After extensive washing (5 times 5 min TBS or PBS) the 
membranes were incubated with the appropriate HRP-coupled secondary antibody 
(Dianova) in TBS/PBS, 5% powdered milk. Membranes were washed as before then 
antibody binding was visualised by enhanced chemiluminescence (ECL, Amersham 
Life Science) followed by exposure to FUJI medical X-ray film (SUPER RX). All 
incubations were carried out at room temperature for 1 to 2 hours with rocking or 
overnight at 4°C.
Immunofluorescence
For immunofluorescence, a pre-culture of the yeast strain of interest was used to 
inoculate 15 ml of YPAD (sterile filtered). Cells were grown to an OD600 of 0.3 to 0.6 
then prepared for immunofluorescence in one of the following ways:
Preparation for Methanol/Acetone fixation only
Once the yeast culture had reached an OD600 of 0.3 to 0.6, 10 ml was harvested in a 15 
ml falcon tube by centrifugation (3200 rpm, 3 min, RT using a Heraeus centrifuge). The 
cell pellet was resuspended in SP buffer and transferred to a 2 ml tube (Sorenson 
BioScience). The cells were spheroplasted by adding 80 pi glusulase (NEN), 22 pi 
zymolyase (Seikagaku Corporation, Tokyo) (25 mg/ml in ddH20 ) and 10 pi p-
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mercaptoethanol (SIGMA) per sample and incubating at 30°C for up to 90 min 
(spheroplasting was followed using the light microscope). Glusulase and zymolyase 
were always centrifuged before use (14 000 rpm, 5 min, 4°C). Spheroplasts were 
pelleted by centrifugation (2500 rpm, 3 min, RT) then resuspended in Wickerman's 
solution and incubated at room temperature on a rotating wheel for 30 to 60 min. 
Spheroplasts were washed three times with SP buffer and finally resuspended in about 
500 pi (depending on size o f pellet) SP buffer.
Formaldehyde fixation
Alternatively, cells could be fixed with formaldehyde. Once the yeast culture had 
reached an OD600 of 0.3 to 0.6, 10 ml was transferred to a 15 ml falcon tube. Cells were 
fixed by addition of 1 ml KPi and 1 ml 39% formaldehyde (SIGMA). Fixation was 
carried out for 10 to 60 min at room temperature on a roller or on the bench with 
occasional gentle mixing. Fixed cells were pelleted by centrifugation (2200 rpm, 3 min, 
RT, using a Heraeus centrifuge). The cells were resuspended in 1.5 ml 40 mM KPi and 
transferred to a 2 ml tube. Cells were washed twice with SP buffer (2200 rpm, 3 min, 
RT) and finally resuspended in 1 ml SP buffer. Cells were spheroplasted by adding 10 
pi zymolyase (25 mg/ml) and 3 pi p-mercaptoethanol per sample and incubating for 15 
to 30 min at room temperature. Spheroplasting was checked using the light microscope. 
Spheroplasts were washed three times with SP buffer and then resuspended in about 
500 pi (depending on size of pellet) SP buffer.
Fluorescence labelling
During incubations or fixation, the 12 well (7 mm) slides (Polyscience) were prepared, 
10 pi of 1% polylysine (SIGMA) was placed on each well and left at room temperature 
for 10 min, wells were then washed three times with ddH20 . 15 pi of the spheroblast 
suspension was placed on each well and left at room temperature for 10 min. Excess 
cells were then carefully removed by aspiration. Slides were gently immersed first in 
methanol (-20°C) for five minutes, then in acetone (-20°C), for 30 seconds and air-dried 
at room temperature. From this point the slides were kept in a moist chamber. The cells 
were blocked with PBS-B (20 pi per well) for 30 min at room temperature. During this 
time the appropriate primary antibodies were diluted in PBS-B. The cells were
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incubated with the primary antibodies (20 jal per well), after removal of the blocking 
buffer by aspiration, for 1 hour at room temperature or overnight at 4°C. Wells were 
washed 3 to 5 times with PBS-B (5 min incubations, 40 pi per well). The primary 
antibodies were detected by incubation for 1 to 2 hours with the appropriate 
fluorescently labelled secondary antibodies (Dianova) (diluted in PBS-B, 20 pi per 
well). Cells were washed twice with PBS-B and 3 to 5 times with PBS (5 min 
incubations, 40 pi per well). Slides were then air-dried and 4 pi DAPI-mounting 
solution was placed in the centre of each well. A clean coverslip (24 mm by 60 mm) 
was fitted on each slide and sealed with nail varnish.
Cells were viewed using the appropriate fluorescent filters and images were saved using 
the NIH Image programme.
Preparation of anti-Spc29p antibodies
Preparation o f antigen
GST-Spc29p was expressed in BL21 E.coli. The BL21 cells containing the pGEX-5X 
expression plasmid of interest was used to inoculate an over night pre-culture of LB 
medium containing ampicillin (0.1 mg/ml). The pre-culture was diluted 1:50 using 400 
ml LB medium containing ampicillin. The bacteria were grown for 4 hours at 30°C with 
shaking. Expression of fusion proteins was induced by the addition of IPTG to the 
cultures (final concentration of IPTG was 1 mM) and further incubation at 30°C for 3 
hours with shaking. The cells were harvested (6000 rpm, 5 min, 4°C), the cell pellet was 
resuspended in 20 ml PBS containing the protease inhibitors PMSF (1 mM) and 
benzamidine (5 mM) and chilled on ice.
The cells were lysed by ultra sonication (2 times 4 min, 50% output, sonicator from 
Bandelin electronic, Berlin). During lysis cells were kept on ice. Lysis was followed 
using the light microscope and sonication was repeated if necessary. Protease inhibitors 
were added as before. When lysis was complete, the lysate containing the GST-Spc29p 
fusion protein was adjusted to 1% Triton X-100 and incubated on ice for 30 min with 
occasional mixing. The lysate was centrifuged (12 000 rpm, 5 min, 4°C, Sorvall SS-34 
rotor) and the supernatant was incubated with 1 ml pre-washed (2 times PBS, 2000 rpm, 
3 min) glutathione sepharose for 2 hours at 4°C on a roller. The sepharose was then 
washed twice with PBS, 1% Triton X-100 and loaded onto a column (Mini columns
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from Pierce) The following steps were carried out at room temperature. The column 
was washed twice with PBS and the GST-Spc29p fusion protein was eluted with 10 
times 1 ml 50 mM Tris-HCl (pH 8.0), 10 mM glutathione. Each 1 ml was incubated in 
the column for 10 min before elution. Each fraction was tested for protein with 
Bradford Reagent (100 pi Bradford Reagent (SIGMA) was mixed with 10 pi of the 
fraction, blue colour indicates presence of protein). Fractions were also analysed by 
SDS-PAGE followed by Coomassie blue staining. Fractions containing GST-Spc29p 
were pooled and stored at -20°C.
Rabbit immunisation protocol
For the first immunisation, 1 ml of the pooled fractions was mixed with 1 ml Freud's 
complete adjuvant (SIGMA) and, after a pre-bleed, the mixture was injected 
subcutaneously into the rabbit. The rabbit was boosted 3 times at 4 week intervals with 
1 ml o f the pooled fractions mixed with 1 ml Freud's incomplete adjuvant. A test bleed 
was taken and tested between boosts 2 and 3, the final bleed was taken 10 days after the 
third boost.
The test bleed and final bleed were incubated at 37°C for 1 hour, then overnight at 4°C. 
The serum was separated by centrifugation (3000 rpm, 5 min, RT) and carefully 
pipetted into a clean falcon tube. Serum was stored at -20°C. The serum was tested for 
antibodies by using it to probe a Western blot containing cell extracts of wild type cells, 
cells expressing tagged SPC29 and cells overexpressing SPC29.
Affinity purification of anti-Spc29p antibodies
Anti-Spc29p antibodies were affinity purified from the serum of the final bleed. This 
was achieved by running the serum through a GST pre-column to remove anti-GST 
antibodies. The eluate from the pre-column runs directly into the main column 
containing GST-Spc29p, to which the anti-Spc29p antibodies bind. The anti-Spc29p 
antibodies were then eluted from the main column, dialysed against PBS and stored at - 
80°C.
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Preparation o f GST and GST-Spc29p protein
For the pre-column, a 200 ml culture of BL21 E.coli cells containing the plasmid 
pGEX-5X were induced (as above) to express GST. The cells were harvested (6000 
rpm, 5 min, 4°C) and the pellet was resuspended in 20 ml CB buffer. The cells were 
lysed by sonication (as above). For the main column GST-Spc29p was freshly purified 
as above. The GST-containing lysate and the pooled fractions of GST-Spc29p were 
transferred into dialysis tubing (SIGMA) which had been boiled in distilled water for 10 
min, and dialysed against CB buffer (3 times 1.5 litres at 4°C, one incubation can be 
carried out over night).
Preparation o f CNBr-sepharose
4 g of CNBr-sepharose freeze-dried powder (Pharmacia) was swelled with 500 ml 1 
mM HC1 then transferred to a glass filter funnel and the liquid was removed by 
applying the vacuum. The resin was washed in a further 500 ml 1 mM HC1 then 
removed from the filter (resin was removed by resuspending in 5 ml of 1 mM HC1 then 
transferring into a falcon tube, this was repeated twice to give a 15 ml sepharose 
suspension). The resin was divided into four (for 2 pre-columns and 2 main columns) 
15 ml falcons and centrifuged (3200 rpm, 2 min, 4°C), HC1 was removed and the resin 
was washed with 10 volumes CB buffer.
Coupling
The dialysed samples were added to the CNBr-sepharose immediately after the CB 
buffer was removed from the sepharose (sample volume:sepharose volume was 2:1). 
The coupling reactions were incubated at room temperature for 2 hours on a roller. 
Coupled samples were centrifuged (3200 rpm, 2 min, RT) and the supernatant was 
removed by aspiration. The samples were blocked by incubating with 0.2 M glycine, pH 
8.0, overnight at 4°C.
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Preparation o f affinity columns
Columns from Pierce were assembled (filled with PBS and fitted with a filter at the 
bottom then left to empty by gravity flow). The blocked sepharose was added to the 
columns (2 pre-columns and 2 main columns). The columns were washed with:
1) volumes 100 mM sodium acetate, pH 4.0, 0.5 M NaCl
2) 2 volumes PBS
3) 2 volumes PBS, 1% SDS, when the second volume had run into the column, 
the column was closed and incubated at 65°C for 40 min.
4) 1 volume PBS, 1% SDS
5) Main column: 2 volumes PBS, 1% Triton X-100. Pre-column: 4 volumes 
PBS, 1% Triton X-100.
6) Main column only: 2 volumes PBS, 1% Triton X-100, 1% BSA
Purification o f antibodies
The pre-column was placed over the main column (using a clamp stand). The 
centrifuged serum (5 ml, 14 000 rpm, 15 min, 4°C) was added to the pre-column and 
allowed to run through the pre-column and into the main column. Once all the serum 
had run into the pre-column, 2 volumes PBS were added and allowed to run through 
into the main column. The pre-column was then removed and the main column was 
washed with 3 volumes PBS, 1% Triton X-100, followed by 4 volumes PBS. Before all 
the PBS had run through, the column was closed and stored at 4°C for 30 min. The anti- 
Spc29p antibodies were eluted with 8 times 1 ml cold glycine buffer (0.2 M glycine, 1 
mM EGTA, pH 2.5). The eluate was collected in 1.5 ml Eppendorf tubes containing 300 
pi 1 M Tris-HCl, pH 8.0, to neutralise the glycine buffer. The eluate was mixed 
immediately by vortexing and stored on ice. Then 5 times 1 ml guanidium-HCl, pH 7.0, 
was added to the column and the eluates were collected in Eppendorf tubes and stored 
on ice. The Bradford spot test was used to test all the fractions for protein. The protein 
containing fractions were pooled (glycine fractions were kept separate from guanidiun 
fractions) and adjusted to 0.2% BSA. The pooled fractions were then dialysed twice 
against PBS at 4°C. The affinity purified antibodies were divided into aliquots and 
stored at -80°C.
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Coupling of antibodies to Protein A beads
For immunopurification experiments, the appropriate antibodies were first coupled to 
Protein A Sepharose Fast Flow (Amersham Pharmacia Biotech Inc.) or Protein A 
Dynabeads (DYNAL).
Coupling o f antibodies to Protein A Sepharose
This was achieved by incubating 2 ml o f the washed Protein A Sepharose beads (beads 
were washed twice with PBS) with affinity purified antibodies diluted in 5 ml PBS 
overnight at 4°C on a roller. The beads were then washed twice with 20 ml of 0.2 M 
sodium borate (pH 9.0) by centrifugation (2000 rpm, 5 min, RT, using a Heraeus 
centrifuge). The beads were resuspended in 20 ml of 0.2 M sodium borate and 20 mM 
of the crosslinker DMP (104 mg solid DMP) was added. The beads were incubated for 
30 min, at room temperature, on a roller. The reaction was stopped by washing the 
beads with 0.2 M ethanolamine (pH 8.0) and then incubating for 2 hours, at room 
temperature on a roller in 0.2 M ethanolamine. Finally the antibody-coupled beads were 
washed twice with PBS and stored in PBS, in the presence of sodium azide, at 4°C. 
Before use, beads were washed twice with PBS and once with IP buffer (low salt).
Coupling o f antibodies to Protein A Dynabeads
The magnetic Protein A Dynabeads were resuspended in the vial and 1 ml was 
transferred into an Eppendorf tube. The beads were washed twice with 1 ml NaPi 
buffer. Dynabeads in small volumes (<1.5 ml) were pelleted using the Dynal MPC 
(magnetic particle concentrator). Beads were then resuspended in 1 ml of affinity 
purified antibodies diluted in PBS. The beads were incubated with the antibodies for 1 
hour at room temperature on a roller. The beads were then washed twice with NaPi 
buffer and twice with Tris buffer (0.2 M Tris-HCl, pH 9.0). The beads were 
resuspended in 10 ml Tris buffer and transferred to a falcon tube. 20 mM of the 
crosslinker DMP (52 mg solid DMP) was added and the beads were incubated at room 
temperature, for 45 min on a roller. The beads were pelleted by centrifugation (2000 
rpm, 2 min, RT). The beads were then resuspended in 0.2 M ethanolamine, pH 9.0 and 
incubated for 2 hours at room temperature. Beads were again pelleted by centrifugation, 
resuspended in 1 ml PBS and transferred to an Eppendorf tube. Beads were then washed
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twice with PBS and stored in PBS in the presence o f sodium azide, at 4°C. Before use, 
beads were washed twice with PBS and once with IP buffer (low salt).
Immunopurification
A pre-culture of the yeast strain of interest was used to inoculate 200 ml of YPAD. The 
cells were grown to an OD600 of 0.5 to 1.0 and then harvested. The cell pellet was 
washed once with sterile water in a 50 ml falcon tube. From this point on all steps were 
carried out on ice and all buffers contained protease inhibitors. The cell pellet (-1 gram) 
was resuspended in 1 to 2 ml of IP buffer (low salt). Cells were lysed by adding glass 
beads (SIGMA) and vortexing. Glass beads were added until -3  mm of buffer was 
visible above the level of the beads, samples were vortexed 10 to 20 times for 30 
seconds with the cells chilling on ice for 30 to 60 seconds between vortexing. Lysis was 
followed using the light microscope. After lysis, the solution was altered to 0.2% Triton 
X-100 and the lysed cells were left on ice for 20 min. The lysed cells were then 
transferred into 1.5 ml Eppendorf tubes and centrifuged at 12 000 rpm for 20 min at 
4°C. The supernatant containing the soluble cellular fraction was removed, the pellets 
were resuspended in 500 pi of IP buffer (high salt), 1% Triton X-100 and incubated for 
40 min, at 4°C on a rotating wheel. After this time 1 ml o f IP buffer was added and the 
samples were centrifuged at 10 000 rpm for 15 min at 4°C. The supernatant was 
removed and incubated with -50  pi antibody-coupled sepharose beads or -15 pi 
antibody-coupled Dynabeads, for 2 to 4 hours at 4°C on a rotating wheel. The beads 
were then washed 5 times with IP buffer (low salt). The bound protein was eluted from 
the beads by adding 100 pi HU buffer, incubating at 65°C for 5 to 10 min, then 
centrifuging (14 000 rpm, 5 min, RT). Samples were analysed by SDS-PAGE, followed 
by Coomassie blue staining or Western blotting.
For purification of ProA-Spcl lOp, sepharose coupled to rabbit IgGs (Dianova) was 
used and the purification was carried out on a larger scale. This was done by growing 
large cultures of yeast cells in YPAD using Microferm fermentors (New Brunswick 
Scientific Co. Inc.) The cells were harvested using the continuous centrifuge then 
washed once with ddH20  (3200 rpm, 5 min, 4°C). The cell pellet was then resuspended 
in approximately 10 ml ddH20  to make a thick paste that was then dripped in to liquid 
nitrogen, the frozen cells were stored at -80°C. For the ProA-Spcl lOp purification 60 g 
of ProA-SPCl 10 cells and 60 g of wild type cells was used. All buffers contained
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protease inhibitors. The frozen cells were mixed with 70 ml of TBS and glass beads. 
The cells were lysed using a bead beater (Biospec Products) (10 times 1 min, on ice, 
lysis was followed by light microscopy). The lysed cells were adjusted to a volume of 
150 ml with TBS and Triton X-100 was added to a final concentration of 1%. The lysed 
cells were then left on ice for 20 min. The cell lysates were then transferred to 
centrifuge tubes and centrifuged at 12 000 rpm for 20 min at 4°C (Sorvall rotor and 
centrifuge). The supernatants were removed and the pellets were slowly solubilised in 
IP buffer (high salt), 1% Triton X-100, to a final volume of 130 ml, then stirred on ice 
for 40 min. To the solubilised pellet was added 260 ml IP buffer, 1% Triton X-100. The 
samples were then centrifuged (9000 rpm, 15 min, 4°C). During this time the columns 
(Pierce) were prepared, 1 ml of IgG-sepharose was added to each column. The columns 
were washed with 2 ml TST buffer, 2 ml 0.5 M acetic acid pH 3.4, then again with 2 ml 
TST buffer, then 2 ml 0.5 M acetic acid pH 3.4 and finally with 5 ml TST buffer. The 
following steps were carried out in the cold room. The supernatants from the last 
centrifugation step were added to the columns (one for wild type and one for ProA- 
SPC110) and allowed to run through. The columns were then washed with:
1) 20 ml IP buffer (low salt), 1% Triton X-100
2) 5 ml IP buffer (0.5 M KC1), 1% Triton X-100
3) 10 ml IP buffer (0.5 M NaCl), 1% Triton X-100
4) 20 ml TST buffer
5) 5 ml 5 mM ammonium acetate pH 6.5
6) 5 ml 5 mM ammonium acetate pH 5.5
7) 5 ml 5 mM ammonium acetate pH 5
The bound protein was eluted from the columns with 4.5 ml 0.5 M acetic acid pH 3.4. 
The eluate from each column was collected in a falcon tube, then divided into 800 pi 
aliquots in Eppendorf tubes. The samples were lyophilised using a speed vac 
(Bachhofer Vacuum Concentrator) then washed with distilled water. The samples were 
finally resuspended in 100 pi HU buffer and stored at -20°C. Samples were analysed 
using 8-18% SDS-PAGE gradient gels, followed by staining using the Fairbanks 
staining method or Western blotting.
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Preparation of yeast cells for electron microscopy
Preparation o f samples
Cells of the yeast strains of interest were grown to an OD600 of 0.2 to 0.6. 15 ml of these 
cultures were harvested and all residual medium was removed. The cells were gently 
resuspended in Phosphate-Mg buffer, 2% glutaraldehyde (TAAB) and incubated at 
room temperature for 30 min with occasional inverting. Cells were washed with 
Phosphate-citrate buffer and transferred into a 2 ml tube. Cells were washed with pre­
treatment buffer, followed by a 5 min incubation at room temperature in pre-treatment 
buffer. The cells were then washed twice with Phosphate-citrate buffer. Spheroplasting 
was achieved by resuspending the cells in 900 pi Phosphate-citrate buffer, 100 pi 
glusulase and incubating overnight at 30°C with shaking, if samples were prepared early 
in the day, an additional 50 pi glusulase was added in the evening, or the following 
morning (glusulase was always centrifuged before use, 14 000 rpm, 5 min, 4°C) 
Spheroplasting was followed using the light microscope. After spheroplasting, the cells 
were washed twice with 0.1 M sodium acetate, (pH 6.1). Cells were then incubated with 
osmium tetroxide (SIGMA) and then with uranyl acetate (Agar Scientific), both are 
toxic, therefore safety precautions were used and both were handled in the fume hood. 
4% osmium tetroxide was diluted 50:50 with 0.1 M sodium acetate and the cells were 
resuspended in 500 pi of the mix, then incubated for 15 min at room temperature, 
before washing twice with ddH20 . Cells were then incubated with 1 ml 1% aqueous 
uranyl acetate for 1 hour at room temperature in the dark then washed twice with 
ddH20 . Cells were dehydrated by incubating twice with 95% ethanol, followed by two 
incubations with 100% ethanol (5-15 min incubations). Spurr resin (Agar Scientific) 
was used to embed the cells, this was done by resuspending the dehydrated cells in 200 
pi Spurr resin and incubating for 1 hour at room temperature, incubation was then 
repeated with fresh Spurr resin. Cells were pelleted and resuspended again in fresh 
Spurr resin, then divided into two BEEM capsules (Polysciences, Inc.), before pelleting 
using a horizontal centrifuge (Beckman Microfuge 11) at 10 000 rpm for 15 min. The 
BEEM capsules were topped up with Spurr resin and an identification label was 
inserted into the top of the resin. The capsules were then incubated overnight at 65°C to 
harden.
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Sectioning o f samples
Samples were cut into serial sections (70 nm) using a diamond knife (TAAB) and 
mounted on formvar (TAAB) coated grids. This was provided as a service by the 
technical support team at The Beatson Institute of Cancer Research.
Contrasting o f samples
Samples were contrasted first by submerging the grids in uranyl acetate (2% uranyl 
acetate in 70% methanol) for 5 min in the dark. Grids were washed 10 times with 70% 
methanol using a dimpled porcelain dish, each dimple was filled with 70% methanol 
and the grids were transferred through all the dimples before being left to air-dry on 
Whatman paper. The grids were then floated, sample side down, on a drop of lead 
citrate stain in a sodium hydroxide atmosphere for 5 min. This was achieved by using a 
petri dish with a circle of parafilm in the middle, the parafilm was surrounded with 
sodium hydroxide pellets to scavenge carbon dioxide thereby preventing precipitation 
of lead salts. The inside of the lid of the petri dish was covered with a round piece of 
Whatman paper soaked in 5 M sodium hydroxide. Therefore, when the lead citrate 
drops were placed on the parafilm and the grids were floated on the drops, the lid was 
placed on the dish creating a chamber containing a sodium hydroxide atmosphere. The 
grids were then transferred onto a drop of ddH20  then washed individually by holding 
the grid in forceps over a beaker and allowing a fine stream of ddH20  to gently flow 
down the forceps and over the grid. The grids were then air-dried and stored in a grid 
holder.
Samples were visualised using the electron microscope (Zeiss 902) at Glasgow 
University.
FACS analysis
Cells were prepared for FACS analysis as follows. For FACS analysis cells were grown 
to an OD600 of 0.2 to 2.0 and 5 ml of the yeast culture was used for each sample. Cells 
were pelleted in 15 ml falcon tubes by centrifugation (3200 rpm, 5 min, RT using a 
Heraeus centrifuge) then resuspended in 70% ethanol and left on a rotating wheel 
overnight at room temperature. The cells were then washed twice with 1 ml Tris buffer
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(50 mM Tris-HCl, pH 7.8) and transferred to a 2 ml tube. To the cell pellet was added 
800 pi Tris buffer and 200 pi of 5 mg/ml RNaseA (SIGMA) followed by incubation at 
37°C overnight. Cells were pelleted and resuspended in 500 pi of freshly prepared 5 
mg/ml pepsin (Roche) in 55 mM HCI, then incubated in a 37°C water bath for 30 min. 
Cells were washed in TNM buffer (200 mM Tris-HCl pH 7.5, 211 mM NaCl, 78 mM 
MgCl2), resuspended in 500 pi TNM buffer and 55 pi of 500 pg/ml propidium iodide 
(SIGMA) in water was added. To read the samples on the FACS machine (FACScan 
from Becton and Dickinson) the samples were first sonicated for 30 sec in a water bath 
sonicator (Transsonic T420 from Elma), then 50 pi was transferred into a FACS tube 
(Falcon 2052) containing 2 ml Tris buffer. 20 000 events were read per sample. Files 
were processed using the Cell quest programme.
In vitro labelling of Spc29p with [35S]
In vitro labelling of Spc29p with [35S] was achieved using the TnT Coupled 
Reticulocyte Lysate System (Promega). The following components were added in the 
order given.
1. TnT buffer 2 pi
2. DEPC H20 16 pi
3. Amino acid mix (minus methionine), 1 mM 1 pi
4. RNasin Ribonuclease inhibitor, 40 U/pl 1 pi
5. TnT Rabbit Reticulocyte Lysate 25 pi
6. TnT T7 RNA Polymerase 1 pi
7. pET28c based DNA template (0.5 pg/pl) 2 pi
8. [35S]methionine (>1 000 Ci/mmol at 10 mCi/ml) 2 pi
Total 50 pi
The translation reaction was incubated in a waterbath at 30°C for 3 hours. 1 pi of each 
reaction was taken for analysis by SDS-PAGE. Control reactions, containing an empty 
plasmid, were carried out in parallel.
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In vitro binding assay
Expression o f GST and Histidine fusion proteins in E.coli
Fusion proteins were expressed in BL21 bacteria. The bacteria of interest were used to 
inoculate over night pre-cultures of LB medium containing the appropriate antibiotics. 
The pre-cultures were diluted 1:50 using 200 ml LB medium containing the appropriate 
antibiotics. The bacteria were grown for 4 hour at 30°C with shaking. Expression of 
fusion proteins was induced by addition of IPTG to the cultures (final concentration of 
IPTG was 1 mM) and further incubation at 30°C for 3 hours with shaking. The cells 
were harvested (6000 rpm, 5 min, 4°C) and the cell pellet was resuspended in 5 ml PBS 
and stored at -20°C.
Lysis
The bacterial cell pellets were thawed and a further 15 ml PBS was added along with 
the protease inhibitors PMSF (to a final concentration of 1 mM) and benzamidine (to a 
final concentration of 5 mM). The cells were lysed by ultra sonication (3 times 1 min, 
50% output, sonicator from Bandelin electronic, Berlin). During lysis cells were kept on 
ice, all further steps were also carried out on ice. Lysis was followed using the light 
microscope and sonication was repeated when necessary. Protease inhibitors were 
added as before. When lysis was complete, the lysate containing GST/GST-Bbplp 
protein was adjusted to 1% Triton X-100 and incubated on ice for 15 min with 
occasional mixing. The lysate containing the His-Mps2p fusion protein was adjusted to 
0.1% Triton X-100 and incubated on ice for 1 to 2 hours with occasional mixing.
Preparation o f glutathione sepharose
500 pi of glutathione sepharose (Amersham Pharmacia Biotech Inc.) per binding assay 
was washed with 5 volumes PBS followed by three times 5 volumes PBS, 1% Triton X- 
100 (2000 rpm, 3 min, 4°C).
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Binding assay
After 15 min on ice 1.5 ml (per binding assay) o f the GST containing lysates were 
transferred into Eppendorf tubes and centrifuged (14 000 rpm, 5 min, 4°C). 1 ml of the 
supernatant was mixed with an aliquot of washed glutathione sepharose. Then 2 mM 
Mg2+ (1 mM MgCl2, 1 mM M gS04) and 2 mM ATP was added and GST/GST-Bbplp 
was allowed to bind to the glutathione sepharose by incubating at 4°C for 45 min on a 
roller. The sepharose was washed once with PBS, 0.1% Triton X-100, followed by three 
times with PBS (2000 rpm, 3 min, 4°C). The lysate containing the His-Mps2p was 
prepared for the binding assay (1.5 ml, per binding assay, was transferred into 
Eppendorf tubes and centrifuged, 14 000 rpm, 5 min, 4°C). The supernatant (1 ml) was 
then mixed with washed glutathione sepharose (+/- GST/GST-Bbplp) and incubated for 
1 hour at 4°C on a roller (Mg2+ and ATP were added as before). The sepharose was 
washed (once with PBS, 0.1% Triton X-100, followed by three times with PBS) then 
incubated with in vitro translated [35S]~Spc29p for 1 hour at 4°C on a roller (Mg2+ and 
ATP were added as before). The sepharose was then washed twice with PBS, 0.1% 
Triton X-100 and transferred into spin columns (Bio 101). The sepharose was then 
washed a further two times with PBS, 0.1% Triton X-100 and three times with PBS (10 
000 rpm, 3 min, 4°C). Spin columns were transferred to clean Eppendorf tubes and the 
proteins were eluted from the sepharose by adding 100 pi HU buffer, heating at 65°C 
for 5 min, then centrifuging (14 000 rpm, 5 min, RT). The eluted proteins were analysed 
by SDS-PAGE and Western blotting or autoradiography.
Alkaline phosphatase treatment
The yeast cells of interest were lysed using glass beads. Spc29p was then purified from 
the soluble cellular fraction and the extracted pellet using ~60 pi Protein A sepharose 
coupled to anti-Spc29p antibodies. The purification was taken to the last wash, but the 
protein was not eluted, instead the sepharose was washed twice with AP buffer and 
divided into three tubes. The beads were then resuspended in an equal volume of AP 
buffer, 0.4% SDS (20 pi beads plus 20 pi buffer) and incubated at 65°C for 3 min. The 
tubes were cooled, and the following was added;
tube 1) 10 U alkaline phosphatase (Roche)
tube 2) 10 U alkaline phosphatase, 100 mM 3GP (SIGMA)
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tube 3) AP buffer only.
The tubes were incubated at 30°C for 30 min. The reaction was stopped by adding an 
equal volume of HU buffer (40 pi), and incubating at 65°C for 15 min. Samples were 
centrifuged (14 000 rpm, 5 min, RT) and analysed by SDS-PAGE and Western blotting.
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RESULTS
Identification of Spc29p
Purification of the ProA-Spc110p subcomplex
At the inner plaque of the SPB, the y-tubulin-complex binding protein is S pell Op. 
S pell Op is an important structural component of the SPB and therefore worth further 
investigation. In an attempt to find novel Spcl lOp-interacting proteins a protein A- 
tagged S pell Op (ProA-SpcllOp) was purified from salt extracted SPBs using an IgG- 
sepharose column to which protein A binds with high affinity (Figure 9). The purified 
proteins were then run on an SDS-PAGE gradient gel which was then stained using the 
Fairbanks method (Figure 9A). This allowed identification of seven bands specifically 
present in the ProA-Spcl lOp purification. Bands 1-4 were derived from ProA-Spcl 1 Op, 
whereas band 5 was identified as Spc42p by immunoblotting. Bands 6 and 7 were sent 
to A. Shevchenko at the EMBL in Heidelberg for identification by MALDI peptide 
mapping. Band 7 was identified as calmodulin, which is known to bind to the C- 
terminus of SpcllOp (Geiser et al., 1993; Spang et al., 1996b; Stirling et al., 1994). 
Band 6 was a previously uncharacterised protein that was then named Spc29p. There 
were no components o f the y-tubulin complex detected in the Spcl lOp-complex, this is 
probably due to the harsh conditions used in the purification.
To confirm the presence of Spc29p in the Spcl lOp-complex, a strain was constructed 
that expressed SPC29-3HA and ProA-SPCl 10. The ProA-SpcllOp purification was 
then repeated using the strain containing Spc29p-3HA (Figure 9B). The precipitate 
from this purification and the control purification (SPC110 SPC29-3HA) were probed 
for the presence of numerous SPB components. Positive results were seen for ProA- 
Spcl 1 Op, Cnm67p (a component of the outer plaque), Spc42p and Spc29p-3HA. Only 
small amounts of Cnm67p were detected in the SpcllOp-ProA purification, this was 
due to the interaction of Cnm67p with Spc42p as Cnm67p was later shown to be an 
outer plaque component that interacts with Spc42p (Elliott et al., 1999).
The results of these purifications show the identification of a salt stable SPB sub 
complex containing SpcllOp, calmodulin, Spc42p, low amounts of Cnm67p and the 
novel SPB component Spc29p.
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Figure 9 Spc29p is a component of the Spcl lhp subcomplex
A An Spcl lOp-containing SP13 s 1 r ' ex was purified from cells 
witli a protein A tagged SpcllOp, ProA-Spcl lOp (lane 2), using IgG 
sepharose. Wild type cells, containing SpcllOp without the ProA-tag 
(lane I ), were treated identically to identify proteins that bound non- 
specifically to the IgG resin. The protein bands present only in the 
ProA-Spcl lOp lane were identified by immunoblotting or matrix- 
assisted laser desorption ionisation (MALDI) peptide mapping. The 
major proteins in lane 2 were encoded by SPCllO  (band 1, ProA- 
Spcl 1 Op homodimer; band 2, ProA-Spcl l()p; bands 3 and 4, ProA- 
Spcl 10p degradation products), SPC42 (band 5), SPC29 (band 6) and 
CMD1 (band 7).
B Co-immunoprecipitation of Spc29p and Spcl lOp. High salt extracts 
from cells expressing SPCllO  SPC29-3HA (lane 1) or ProA-SPCl 10 
SPC29-3HA (lane 2) were incubated with IgG sepharose. The 
immunoblots were probed with the indicated antibodies.
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Spc29p is essential
When beginning work on a novel protein it is important to know if that protein is 
essential for viability. To determine whether Spc29p is essential, a wild type diploid 
strain was transformed with a HIS3Mx6 disruption cassette that was designed 
specifically to integrate into the native SPC29 locus. The HIS* colonies were sporulated 
and the resulting tetrads were dissected and grown on YPD plates (Figure 10A). Each 
tetrad contained two viable and two non-viable spores. The viable spores were unable to 
grow on SC-His plates, therefore they did not contain the HIS3Mx6 disruption cassette. 
This is a strong indication that SPC29 encodes an essential protein. However, this result 
does not discount the possibility that the defect is only in sporulation, therefore a shuffle 
strain was made. To make an SPC29 shuffle strain the diploid strain containing a HIS3 
cassette in one of the SPC29 loci was transformed with a URA3-based plasmid 
containing a wild type copy of SPC29. The resulting strain was sporulated and tested 
for growth on selection plates, all HIS* spores were also URA* again indicating that 
SPC29 is essential. One o f the HIS* URA+ spores was taken for use as a shuffle strain 
(Aspc29::HIS3Mx6 pRS316-6*PC2P). If SPC29 is essential, viability of the shuffle 
strain should depend on the presence of the plasmid. To test this the shuffle strain was 
grown on 5-FOA plates. 5-FOA is lethal to cells containing a URA3 marker, therefore 
only cells that can grow without the URA3-based plasmid will grow on 5-FOA plates. 
The SPC29 shuffle strain was unable to grow on 5-FOA, however when the shuffle 
strain was transformed with SPC29 on a LEU2-based plasmid, growth on 5-FOA was 
possible (Figure 10B). Therefore Spc29p is an essential SPB component.
Localisation of Spc29p
Co-purification of Spc29p with SpcllOp strongly suggests that Spc29p is an SPB 
component. To confirm this notion, the localisation of Spc29p was established. This 
was done by tagging the single chromosomal copy of SPC29 in wild type haploid cells 
with GFP and the 3Myc epitope. When observed by fluorescence microscopy Spc29p- 
GFP exhibited typical SPB behaviour throughout the cell cycle (Figure 11 A). In G1 
cells there is no bud and a single GFP signal in the form of a dot. As the cell moves 
through the cell cycle, the bud appears and begins to grow as the GFP signal becomes 
two dots positioned close to each other. As the bud grows the two GFP signals move 
apart and one GFP dot moves into the bud, therefore when cytokinesis occurs each cell
Sarah L. Elliott, 2001 93
3
4
B
5-FOA plate, 3()°C
Aspc29::HIS3 
shuffle strain
shuttle strain 
+ pRS315
shuttle strain + pR S 3 \5-SPC29
Figure 10 SPC29 is essential
A Spore analysis of four tetrads formed by sporulating a diploid strain 
containing a HI S3 cassette specific for disrupting the SPC29 gene. From 
each tetrad only two spores grow, indicating that SPC29 is essential 
(spores that grow are HIS ).
B Growth of the Aspc29::HIS3 shuttle strain on 5-FOA is dependent on 
the presence of SPC29 on pRS315, a LEU2-bused plasmid (shuttle 
strain + pRS315-SPC29), confirming that SPC29 is essential.
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Figure 11 Spc29p localises to the SPB
A Spc29p-GFP exhibits typical SPB behaviour throughout the cell 
cycle in live cells.
B Localisation of Spc29p by indirect immunofluorescence. Spc29p- 
3Myc was detected in fixed cells with mouse anti-Myc (9E10) 
antibodies. The Spc29p-3Myc signal co-localised with a known SPB 
component (Spc98p detected with rabbit anti-Spc29p antibodies). DNA 
was stained with DAPI.
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will contain one GFP signal. In addition, immunofluorescence using the strain 
expressing SPC29-3Myc showed that Spc29p-3Myc co-localised with a known SPB 
component in formaldehyde fixed cells (Figure 1 IB). Therefore, Spc29p is indeed a 
component o f the SPB that is localised at the SPB throughout the cell cycle.
Genetic interactions between SPC29, SPC42, SPC110 and 
CMD1
Synthetic lethality
An advantage to working with yeast is that genetics can be used as a tool to study 
functional interactions between gene products. Synthetic lethality is one such genetic 
approach, it occurs when two temperature sensitive mutants are lethal in combination at 
the permissive temperature o f the individual mutants. If a defined combination is lethal 
to the cell it suggests an interaction between the gene products. For example, if two 
proteins interact in an essential pathway, a mutation in one may be tolerated, however if 
both binding partners are mutated the interaction between them may be compromised 
causing a lethal phenotype. To gain an insight into the biological significance of 
Spc29p's presence in the ProA-Spcl lOp subcomplex, spc29(ts) mutants (see Figures 18, 
19 and 20 for phenotype of spc29(ts) mutants) were tested for synthetic lethality with 
mutants o f other SPB components. This investigation was carried out by making the 
SPB mutant strains into SPC29 shuffle strains then introducing a LEU2-based plasmid 
containing either spc29-2 or spc29-3. These strains were then grown on 5-FOA at 23°C 
to select for cells that could grow in the presence of the two mutant genes and the 
absence o f wild type SPC29. Strains that can not grow with the defined combination of 
mutations at the permissive temperature of the mutants (23°C) are said to be 
synthetically lethal.
Synthetic lethality was observed when spc29-2 or spc29-3 was combined with spc42-9, 
spcl 10-2 or cmdl-1 (Figure 12, compare sectors ts/spc29-2 with wt/spc29-2 and 
ts/spc29-3 with wt/spc29-3). However no synthetic lethality was observed when spc29- 
2 or spc29-3 was combined with mutants of the y-tubulin-complex components spc97- 
14 ox spc98-l, indicating that the synthetic lethality observed between the spc29(ts) 
mutants and mutants of the other SpcllOp subcomplex components is specific. This
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Figure 12 spc29(ts) mutants exhibit synthetic lethality with cmdl-1, spcl 10-2 and 
spc42-9, but not with spc97-14 or spc98-l
The chromosomal SPC29 of cm dl-1 , spcl 10-2, spc42-9, spc97-14 and spc98-l (sectors 
"ts") mutants or wild type cells (sector "wt") was deleted in the presence of a plasmid 
containing SPC29 (£/&43-based). Growth of mutant and SPC29 wild type cells with the 
control plasmid pRS315 (sector "pRS315"), or spc29-2 (sector "spc29-2"), spc29-3 
(sector "spc29-3"), or SPC29 (sector "SPC29") on pRS315 were tested for growth at 
23°C (the permissive temperature of the mutants) on plates containing 5-FOA, which 
selects against the URA3-based pRS316-57^29 plasmid. Lack of growth on 5-FOA in 
the presence of pRS315 (sector '7s/pRS315") shows that SPC29 is an essential gene. All 
cells grow with SPC29 on pRS315 (sectors "ts/SPC29" or "wt/SPC29”). The reduced 
growth of cm dl-1 , spcl 10-2 and spc42-9 cells with pRS31 5 -^ 2 9 -2  (ts/spc29-2) or 
pRS315-52?c29-3 (ts/spc29-3) indicates synthetic lethality. In contrast, spc97-14, spc98- 
1 and wild type (wt/spc29-2, wt/spc29-3) cells with spc29-2 or spc29-3 on pRS315 
grow on 5-FOA. As a control, the ts strains were complemented with CMD1, SPC llO , 
SPC42, SPC97 or SPC98 (sector "ts/TS") on pRS315, which allowed growth on SC-Leu 
plates at 37°C, however these cells did not grow on 5-FOA as SPC29 is essential for 
growth.
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Figure 12 spc29(ts) m utants exhibit synthetic lethality with cmdl-1 , 
spcl 10-2 and spc42-9, but not with spc97-14 or spc98-l
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confirmed that the gene products of SPC29, SPC42, SPC110 and CMD1 function 
together. Also, it was interesting to find that calmodulin (CMD1) and SPC29 mutants 
were synthetically lethal as the role of calmodulin at the SPB is poorly understood.
The two hybrid system
At this point it was clear that Spc29p was an SPB component and was part of a 
subcomplex with other well characterised SPB components. To further characterise the 
interaction of Spc29p with Spc42p and Spcl lOp, the two hybrid system was used. The 
two hybrid system identifies protein-protein interactions in vivo. This system is based 
on the construction of a transcription factor from the activation domain of the 
transcriptional activator Gal4p and the bacterial DNA-binding protein LexA. Interaction 
of the activation domain and the DNA binding protein can be obtained by fusing two 
proteins to the Gal4 and LexA proteins. If the two fusion proteins interact, the complex 
can activate the transcription of p-galactosidase in a specially constructed yeast strain 
bearing a lexA-operator-lacZ reporter construct. p-Galactosidase activity can be 
determined using plates containing X-Gal or by overlaying the yeast plate with top agar 
containing X-Gal. When an interaction occurs P-galactosidase hydrolyses X-Gal 
resulting in accumulation of an blue dye within the cells.
Two hybrid plasmids containing SPC29 were constructed and combined with two 
hybrid plasmids containing fragments of other SPB component genes. All two hybrid 
plasmids were also tested with the empty two hybrid vectors as controls. Spc29p 
interacts specifically with the N-terminus of Spc42p and the C-terminus o f Spcl lOp as 
shown by the blue colour of the colonies (Figure 13). These interactions are specific as 
all the controls are white. This result suggests that Spc29p is localised at the central 
plaque between the Spc42p layer and the C-terminal domain of Spcl lOp.
S pell Op has a calmodulin-binding site at its C-terminus between residues 900 and 914 
(Geiser et al., 1993; Stirling et al., 1994). Mutations within this region result in lethality 
or in a temperature sensitive phenotype (Geiser et al., 1993; Stirling et al., 1994; 
Sundberg et al., 1996). However, STOP codons introduced into SPC110, N-terminal to 
the calmodulin binding site, do not affect viability (Geiser et al., 1993; Stirling et al., 
1994) and can rescue the temperature sensitive phenotype resulting from a defect in 
calmodulin binding to SpcllOp (Geiser et al., 1993). This indicates that a region of
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Figure 13 Spc29p interacts with C-SpellO p and N-Spc42p in the 
two hybrid system
The indicated pACT2 and pEG2()2 derivatives were transformed into 
the indicator strain SGY37VII. (3-Galactosidase activity was determined 
by an X-Gal plate assay. Blue colour indicates interaction.
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Spell Op, N-terminal of the calmodulin-binding site, is responsible for the binding of 
Spcl lOp to the spindle pole body. As Spc29p and calmodulin both interact with the C- 
terminus of Spcl lOp, the two hybrid system was used to investigate whether the Spc29p 
and Cmdlp-binding sites of Spell Op are adjacent or overlapping. To test this Spc29p 
was combined with the C-terminal truncation of S p e ll Op that lacked the Cmdlp- 
binding site {spcl 10-120). An interaction was still seen between the truncated C- 
terminus of SpcllOp and Spc29p (Figure 14). This suggests that Spc29p interacts with 
S pell Op at a site adjacent to the calmodulin-binding site. There was also an indication 
that calmodulin affects Spc29p binding to Spcl 1 Op as Spcl lOp mutants with a defect in 
calmodulin binding {spcl 10-116, spcllO-118  and spcl 10-124) no longer showed an 
interaction with Spc29p (Figure 14). However, when the entire calmodulin-binding site 
of SpcllOp was removed {spcl 10-120), binding to Spc29p was restored. This result 
supports the theory that the C-terminus of SpcllOp has an inhibitory role that is 
relieved by calmodulin binding or truncation mutations deleting the calmodulin-binding 
site of Spcl lOp (Stirling et al., 1994).
Multicopy suppression
Suppression occurs when a growth defect, resulting from a mutation in a gene, is 
rescued either by a second mutation or by increased gene dosage of a second gene. 
Suppression indicates an interaction between the protein products of the genes involved. 
For example if a mutant protein has a defect resulting in reduced stability or a reduced 
affinity for a binding partner, this may be over come by increasing the concentration of 
the binding partner. Therefore, genetic interactions can be shown by the rescue of 
temperature sensitive mutants by the introduction of multiple copies of another gene. 
This is known as multicopy suppression. To further investigate the function of Spc29p 
numerous SPB components were tested for multicopy suppression of spc29(ts) mutants. 
In addition, multiple copies of SPC29 were introduced into spcllO(ts) and spc42(ts) 
mutants and growth was tested at permissive and non-permissive temperatures (Table 
9). Genetic interactions were seen by the allele specific multicopy suppression o f the 
temperature dependent growth defect of spc42-10 but not spc42-9 by SPC29. In 
contrast the presence of multicopy SPC42 or SPC110 increased the growth defect of 
some spc29(ts) alleles. In addition the presence of multiple copies of SPC29 increased 
the growth defect of spcllO-118  and spcll0-120  cells, whereas multiple copies of
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Figure 14 Spc29p interacts with SpcllO p at a site adjacent to the 
C nid lp  binding site.
Plasmid pEG2()2 containing SPC110Hl 1944 of wildtype SPC110 (top) or 
of spc] 10 mutants (spcl 10-116, spcl 10-1 IS, spcl 10-120 and spcl JO- 
124) carrying the indicated mutations in the Cmdlp-binding site were 
tested in the two hybrid system for interaction with SPC29 in pACT2 
using a plate assay. C m dlp  binding to the Spcl l()p mutants has been 
determined before using an in vitro binding assay (Stirling et al, 1994).
/ indicates truncated protein resulting from the introduction of a STOP 
codon. +++ indicates strong binding, + indicates weak binding, - 
indicates no binding.
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Table 9 Multicopy suppression analysis
102
Temperature
Mutant Multicopy gene 23°C 30°C 33°C 35°C 37°C
spc29-2 SPC29 +++ +++ +++ +++ + -H -
SPC42 +++ +++ +++ - -
SPC110 +++ +++ +++ - -
CDC31 +++ +++ +++ -H - + +++
pRS315 -KAR1 +++ +++ - - -
control +++ +++ +++ - -
spc29-3 SPC29 +++ +++ +++ +++ +++
SPC42 +++ +++ - - -
SPC110 +++ + - - -
CDC31 +++ +++ - - -
pRS3\5-KARl +++ - - - -
control -H -+ +++ - - -
spc29-9 SPC29 +++ +++ +++ +++ +++
SPC42 +++ + - - -
SPC110 +++ + - - -
CDC31 +++ +++ - - -
pRS315 -KAR1 +++ +++ - - -
control +++ +++ - - -
spc42-9 SPC42 +++ +++ +++ +++ +++
SPC29 +++ +++ -H -+ +++ -
SPCJ10 +++ +++ +++ +++ -
control +++ +++ +++ +++ -
spc42-10 SPC42 +++ +++ +++ +++ +++
SPC29 +++ +++ +++ +++ +++
SPC110 +++ +++ +++ - -
control +++ +++ +++ - -
spcl 10-118 SPC110 +++ +++ +++ +++ +++
SPC29 +++ +++ + - -
CMD1 +++ +++ +++ +++ +++
control +++ +++ +++ + -
spcl 10-124 SPC110 +++ +++ +++ +++ +++
SPC29 +++ +++ +++ - -
CMD1 +++ +++ +++ +++ +++
control +++ +++ +++ +++ -
The conditional lethal spc29-2, spc29-3, spc29-9, spc42-9, spc42-10, spcllO-118  and 
spcllO-124 mutants were transformed with either an empty 2p plasmid (control) or 
with a 2p plasmid carrying one of the indicated genes. Transformants were tested for 
growth at various temperatures. +++, good growth; +, reduced growth; no growth.
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CMD1 rescued the defect. These genetic interactions support the theory that Spc29p 
functions with Spc42p and Spcl lOp at the SPB.
Overexpression experiments
Overexpression has given valuable data about SPB components in the past (Bullitt et 
al., 1997; Donaldson and Kilmartin, 1996; Kilmartin and Goh, 1996). Overexpressing 
Spc42p (Figure 15) shows that Spc42p is a component of the central plaque and that 
Spc42p forms a polymer which extends out from the central plaque forming a dome like 
structure around the SPB. However, the dimensions of the outer and inner plaque 
remain as wild type. This shows that the expression levels of a single SPB component 
does not dictate the size of the entire SPB. Nevertheless, the size of the SPB must be 
tightly controlled as the SPBs in haploid yeast cells are relatively uniform in size (80- 
110 nm) and in diploid cells the SPBs are approximately twice the size of SPBs in 
haploid cells (-160 nm) (Byers and Goetsch, 1974).
SPC29, SPC42 and SPC110 were overexpressed in various combinations. Initially 
SPC29-GFP was expressed under the control of the GAL1 promoter. This caused 
accumulation of Spc29p-GFP in the nucleus and at the SPB (Figure 16A). However, 
looking at these cells using the electron microscope the structure of the SPB is not 
drastically changed (Figure 16B). The accumulation of overexpressed GFP-Spc29p in 
the nucleus suggests that Spc29p contains a nuclear localisation signal or is imported 
into the nucleus via interaction with another protein. If Spc29p is a nuclear protein then 
Spc29p would assemble at the SPB from the nuclear side of the SPB. During SPB 
duplication the spatial arrangement of the soluble SPB components may be important 
for the proper assembly of the SPB. SpcllOp is already known to be a nuclear protein 
(Adams and Kilmartin, 1999; Sundberg et al., 1996). To determine whether Spc42p is 
incorporated into the SPB from the nucleus or the cytoplasm, SPC42 was overexpressed 
in an MPS2 mutant strain. mps2-l cells arrest at the non-permissive temperature with an 
enlarged satellite that is unable to embed in the nuclear envelope (Winey et al., 1991b). 
When mps2-l GAL1-SPC42 cells were incubated at 37°C in the presence of galactose 
and were observed by electron microscopy, an Spc42p polymer could be seen extending 
from the satellite into the cytoplasm (Figure 17, compare A to B). This confirms that 
Spc42p is a cytoplasmic protein and is a component of the satellite. These results also 
suggest that Spc29p interacting with Spc42p brings the cytoplasmically organised SPB
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Figure 15 Overexpression of SPC42
Electron micrograph showing an SPB from a cell overexpressing 
SPC42. Arrow indicates the Spc42p polymer extending from the 
central plaque.
Reproduced from The Journal of Cell Biology, 19%, 132., p897. by
copyright permission of The Rockefeller University Press.
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Figure 16 Overexpression of SPC29
A Localisation of Spc29p-GFP after its overexpression from the Gall 
promoter for 3 hours at 30°C was determined by fluorescence 
microscopy. Cells were fixed in 4°/c para-formaldehyde for 10 min. 
DNA was stained with DAPI.
B Electron micrographs of SPBs from a wild type cell and from a cell 
overexpressing SPC29 from the Gall promoter. C, central plaque; Cy, 
cytoplasm; I, inner plaque; NE, nuclear envelope; Nu, nucleus. Bar = 
0.25 pm, both micrographs are the same magnification.
Sarah L. Elliott, 2001 106
*  r :  f :v  m
* •' P Jt t ‘V .' '
. . -V  !" .- v- j /* r ,•1'■* • * ■- 4: • • *3 y
■ - ^
Figure 17 Overexpression of SPC29, SPC42 and SPC110
A and B Electron micrographs of SPBs of mps2-l cells with (B) or 
without (A) overexpression of SPC42. Cells of mps2-l with or without 
Gal 1-SPC42 were shifted to 37°C for 30 min in 2% raffinose medium 
followed by induction of the Gall promoter by addition of 2% 
galactose. * in B indicates the Spc42p polymer.
C and D Electron micrographs of SPBs from cells with (D) or without 
(C) co-overexpression of SPC29, SPC42 and SPCIU).  C m d lp  is 
present in excess in the cell and was therefore not ove rex pressed. * in 
D indicates the Spc42p polymer.
C, central plaque; Cy, cytoplasm; HB, half-bridge; I, inner plaque; NE, 
nuclear envelope; Nu, nucleus; O, outer plaque; S, satellite. Bar = 0.25 
pm, A-D are all the same magnification.
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substructures and the nuclear SPB substructures together during SPB duplication. 
However, recent immunoelectron microscopy studies have localised Spc29p to the 
satellite as well as the central plaque (Adams and Kilmartin, 1999). Therefore, it may be 
that an interaction of Spc29p retained at the satellite with Spc29p in the nucleus forms 
this interface. This is a possibility as Spc29p interacts with itself in the two hybrid 
system (Figure 25 C). Alternatively, overexpression o f SPC29 may cause 
mislocalisation of Spc29p and the interface could be between Spc29p at the satellite 
interacting with Spcl lOp-Cmdlp in the nucleus.
In addition, triple co-overexpression of SPC29, SPC42 and SPC110 caused a dramatic 
increase in the size of the SPB (Figure 17, compare C to D). As mentioned above 
overexpression of SPC42 causes a polymer of Spc42p to extend from the central plaque, 
however the dimensions of the inner and outer plaques remain the same as those of wild 
type cells. Overexpression of SPC29 or SPC110 alone has little effect on the SPB 
proper, CMD1 was not overexpressed as Cmdlp is present in excess in the cell. 
However, triple co-overexpression of SPC29, SPC42 and SPC110 dramatically 
increases the diameter of the inner plaque as well as the central plaque. This indicates 
that expression levels of the components of the Spcl lOp-complex contribute to size 
regulation of the SPB.
Analysis of spc29(ts) mutants
SPC29 is an essential gene, therefore to study the function of Spc29p, conditional lethal 
mutants of SPC29 were made using mutagenic PCR. Alleles that conferred temperature 
sensitivity were selected for and sequenced. Three spc29(ts) alleles were chosen for 
further analysis and integrated into the wild type SPC29 locus. spc29-2 and spc29-3 
contain single point mutations, resulting in R161S and L158Q respectively, spc29-9 
contains multiple point mutations. To gain an insight into the function of Spc29p the 
phenotype of wild type, spc29-2 and spc29-3 cells was observed after incubation at the 
non-permissive temperature in order to identify any physical differences between 
spc29(ts) mutants and wild type cells. Cultures of wild type, spc29-2 and spc29-3 cells 
were synchronised at 23°C using the pheromone a-factor, the synchronised cultures 
were then washed to release the cell cycle block and shifted to the non-permissive 
temperature. Sample were taken at hourly intervals after the shift for analysis by FACS,
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Figure 18 Analysis of spc29(ts) mutants by FACS and immunofluorescence
Wild type cells (SPC29) and cells of spc29-2 and spc29-3 were incubated for 2.5 hours 
at 23°C with 0.01 mg/ml a-factor. a-factor was removed by washing with pre-warmed 
YPD medium (37°C) to release the cell cycle block. Cells were incubated for 3 hours 
(B) or for up to 4 hours (A) at 37°C.
A The DNA content of cells of SPC29, spc29-2 and spc29-3 was determined by FACS 
analysis before release (0 hours) and 1 , 2 , 3  and 4 hours after release of the cell cycle 
block.
B After 3 hours at the non-permissive temperature, SPC29 and spc29-2 cells were fixed 
with formaldehyde for 15 min then prepared for immunoflourecence. Microtubules 
were detected with the anti-tubulin antibody Wa3, the SPB was detected using anti- 
Spc72p antibodies and DNA was stained with DAPI. In wild type cells 100% of large 
budded cells had two Spc72p signals. Microtubule staining shows a bipolar spindle in 
wild type cells, connecting the two SPB signals. However, in spc29-2 cells only -30%  
of large budded cells contained two Spc72p signals (arrow indicates example of second 
Spc72p signal). In cells with one SPB signal, the SPB was localised near the bud neck, 
microtubule staining showed monopolar spindles and DAPI staining showed, that the 
chromosomes had not been equally segregated between the mother and bud.
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Figure 18 Analysis of spc29(ts) m utants by FACS and immunofluorescence
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immunofluorescence and electron microscopy. Wild type cells, when analysed by 
FACS (Figure 18A), could be seen to be synchronised in G1 at the time of a-factor 
release (0 hours) as seen by the large IN peak signifying that the cells had not moved 
into S phase. The wild type cells then moved into S phase, as seen by the increased 
number o f cells with 2N DNA (1 hour), followed by mitosis (2 hours) shown by the IN 
(new G1 cells) and 2N (cells in mitosis) peaks. At 3 hours the synchrony o f the cultures 
is lost as newly bom daughter cells in G1 are smaller than the mother cells in G l, 
therefore must grow for longer before they can enter into another cell cycle. Cells of 
spc29-2 and spc29-3 strains are viable at 23°C, but when an a-factor synchronised 
culture of either mutant was incubated at the non-permissive temperature (37°C) the 
cells arrested in G2 of the first cell cycle with a large bud and a 2N DNA content 
(Figure 18A). This arrest was only transitory as DNA contents larger than 2N were seen 
at later time points.
Wild type cells in late mitosis have a 2N DNA content and appear as large budded cells, 
mother and daughter cells have a single SPB each which are connected by the mitotic 
spindle and sister chromatids have been separated to the spindle poles. This can be seen 
by observing cells by immunofluorescence (Figure 18B, SPC29). When the spc29(ts) 
cells were observed by immunofluorescence after 3 hours at the non-permissive 
temperature, they showed chromosomal segregation defects (Figure 18B, spc29-2). This 
can be seen by looking at the DAPI staining o f the DNA (note the DAPI staining in the 
mutants is not separated equally into the mother and daughter cells, this indicates a 
defect in chromosomal segregation). Also, by using an antibody against the SPB 
component Spc72p (an outer plaque component), it was observed that the mutants have 
a defect in SPB duplication or separation as most mutant cells have only one SPB 
signal, whereas wild type large budded cells have two SPB signals separated by the 
mitotic spindle. In 30% of spc29(ts) cells there was a second, fainter SPB signal close to 
the first (Figure 18B, arrow).
To ensure that the localisation of Spc72p in the spc29(ts) mutants is a true 
representation of SPB localisation, the spc29(ts) strains were modified by fusing GFP to 
SPB components of the outer, central and inner plaques. These strains were then 
synchronised with a-factor and incubated at 37°C for up to 3 hours then observed by 
fluorescence microscopy. A similar result to the Spc72p immunofluorescence, 
regarding SPB number and intensity o f signal, was seen when the SPBs of spc29(ts) 
cells were marked using GFP fusions o f the outer plaque component Cnm67p or the
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Figure 19 Analysis of spc29(ts) mutants using GPF fusions of SPB components
a-factor synchronised spc29-2 cells containing Cnm67p-GFP, Spc42p-GFP or 
Spcl lOp-GFP were shifted to the non-permissive temperature (37°C) for up to 3 hours. 
Samples were taken after 15 mins, 30 mins, 1, 2 and 3 hours. Cells were fixed with 4% 
paraformaldehybe for 10 min and DNA was stained with DAPI. The GFP signal was 
then observed by fluorescence microscopy.
A A wild type budded cell showing typical SPB staining by Spc72p-GFP.
B Examples of spc29-2 cells at the non-permissive temperature expressing the 
indicated GFP fusion protein. In ~ 70% of spc29-2 CNM67-GFP and spc29-2 SPC42- 
GFP large budded cells only one SPB signal could be seen. In cells where a second 
SPB was observed, the two signals were close together and one was weaker than the 
other (arrow). When Spcl lOp-GFP was used as an SPB marker only one SPB signal 
was observed in -95%  of large budded spc29-2 cells.
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Figure 19 Analysis of spc29(ts) m utants using G FP fusions of SPB 
components
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central plaque component Spc42p (Figure 19B). However, when the inner plaque 
component SpcllOp was expressed as a GFP fusion protein in the spc29(ts) strains, 
95% of cells contained only one SPB signal (Figure 19B). These results confirm that 
there is an SPB duplication or separation defect in spc29(ts) cells incubated at the non- 
permissive temperature.
To understand the SPB defect in spc29(ts) cells, wild type and spc29(ts) cells were 
prepared for electron microscopy after 3 hours at the non-permissive temperature 
(Figure 20). Large budded wild type cells contain two SPBs, with a diameter of 
approximately 80 nm, one in the mother and one in the bud. Each SPB has an outer and 
inner plaque with associated microtubules and a central plaque with associated half­
bridge (Figure 20A). When serial sections of spc29(ts) cells were observed using 
electron microscopy (Figure 20B-F) only one SPB was found per cell, despite the 
appearance of two SPB signals in 30% of cells as seen by immunofluorescence. This 
difference may be due either to detachment of the outer plaque or disintegration of the 
newly formed SPB (a phenotype described for some SPC110 mutants). In addition, the 
morphology of the single SPB in spc29(ts) cells was not as wild type. For example the 
SPB shown in Figure 20B appears to have two inner plaques, whereas the SPB in 
Figure 20C is greatly enlarged. In Figure 20D the SPB has an associated half-bridge 
with, what appears to be a malformed satellite, whereas in Figure 20E SPB duplication 
appears to have taken place, but the two SPBs remain attached. It should also be noted 
that all o f the SPBs observed in spc29(ts) cells were associated with microtubules, 
therefore spc29(ts) mutants do not have a microtubule nucleation defect. Taken 
together, these results suggest that Spc29p is involved in SPB duplication.
In conclusion, analysis of spc29(ts) cells by FACS, immunofluorescence and electron 
microscopy showed that these cells are able to replicate their DNA, but arrest in G2 
with unsegregated chromosomes, probably due to a defect in SPB duplication which 
results in triggering of the spindle assembly checkpoint pathways.
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Figure 20 Analysis of spc29(ts) mutants by electron microscopy
Wild type cells and cells of spc29-2 and spc29-3 were incubated for 2.5 hours at 23°C 
with 0.01 mg/ml a-factor. a-factor was removed by washing with prewarmed YPD 
medium (37°C) to release the cell cycle block. Cells were incubated for 3 hours at 37°C 
then prepared for electron microscopy followed by serial sectioning.
A Wild type SPB. B and C SPBs from spc29-2 cells. D-F SPBs from spc29-3 cells.
C, central plaque; Cy, cytoplasm; HB, half-bridge; I, inner plaque; NE, nuclear 
envelope; Nu, nucleus; O, outer plaque. Bar = 0.25 pm, A-F are all the same 
magnification.
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Figure 20 Analysis of spc29(ts) mutants by electron microscopy
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Spc29p is present in a subcomplex containing Cdc31p and 
Karlp
Genetic interactions
Spc29p appears to have a role in SPB duplication, therefore other SPB components 
known to be involved in SPB duplication were tested for genetic interactions with 
spc29(ts) alleles. The half bridge components Cdc31p and K arlp are essential for SPB 
duplication (Byers, 1981a; Rose and Fink, 1987; Winey et al., 1991b). When CDC31 
was introduced into spc29(ts) strains on a multicopy plasmid, it rescued the temperature 
dependent growth defect of spc29-2, but not spc29-3 or spc29-9 cells. However, a 
single additional copy of KAR1 increased the temperature sensitivity of spc29-2 and 
spc29-3, but not spc29-9 cells (Table 9). These allele specific genetic interactions 
indicate a functional relationship between Cdc31p, Karlp and Spc29p.
There have been numerous genetic interactions reported between CDC31, KAR1, and 
DSK2 (Biggins et al., 1996), therefore DSK2 was tested for genetic interactions with 
spc29(ts) mutants. DSK2 was found to be a multicopy suppresser of spc29-2 and spc29- 
3 mutants (Figure 21). This again indicates a connection between Cdc31p, K arlp and 
Spc29p.
Localisation of Cdc31-16p
Cdc31p and Karlp are essential and are the only two known components of the half­
bridge. K arlp has a membrane anchor and it has been shown that localisation of 
Cdc31p at the half-bridge was dependent on its interaction with Karlp (Biggins and 
Rose, 1994; Spang et al., 1995). CDC31-16 contains a gain of function mutation that 
allows a strain carrying this allele to survive when KAR1 is deleted. CDC31-16 Akarl 
cells were observed by immunofluorescence to localise Cdc31-16p. In wild-type cells 
Cdc31p localises to the SPB and the nuclear envelope, K arlp localises to the SPB 
(Figure 22A). However, in CDC31-16 Akarl, where there is no Karlp, Cdc31-16p also 
localises to the SPB (Figure 22B). This indicates that Cdc31-16p interacts with at least 
one other SPB component.
As Cdc31p and Karlp are the only known components of the half-bridge, the 
morphology of the half-bridge of CDC31-16 Akarl cells was examined for defects or
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Figure 21 DSK2 is a multicopy suppressor of spc29(ts) mutants 
DSK2 present on the multicopy plasmid pRS425 allows g of
spc29-2 and spc29-3 at the non-permissive temperature (35"C).
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Figure 22 Localisation of Cdc31p
Wild type and CDC31-16 Akarl cells were fixed with methanol/acetone 
then prepared for immunofluorescence. DNA was stained with DAPI.
A Karlp and Cdc31p co-localise with Spc98p (anti-90kDa (Rout and 
Kilmartin, 1990)) in wild type cells.
B In CDC31-16 Akarl cells Cdc31-16p still localises to the SPB, even 
in the absence of Karlp.
antt-90kDa DAPI
anti-90kDa DAPI
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abnormalities using electron microscopy (Figure 23). Wild type and CDC31-16 Akarl 
cells were arrested with a-factor, to increase the number of cells containing single SPBs 
with associated half-bridges, then prepared for electron microscopy. CDC31-16 Akarl 
cells still contained a half-bridge, however the morphology was a little unusual. The 
half-bridge of CDC31-16 Akarl cells appeared thicker when compared to wild type, 
also the half-bridge only extended over the cytoplasmic side of the nuclear membrane 
whereas in wild type cells the half-bridge extends over both the nuclear and cytoplasmic 
sides o f the nuclear membrane. The important observation though is that CDC31-16 
Akarl cells do contain a half-bridge, therefore the half-bridge in these cells must either 
contain additional proteins or consist exclusively of Cdc31-16p. So how is Cdc31-16p 
connected to the central plaque and the satellite? Does Cdc31p bind directly to satellite 
and central plaque components or is the interaction via another protein?
Spc29p immunoprecipitation
Spc29p is a component of the central plaque, where it interacts with Spc42p and 
SpcllOp. Spc29p is also a component of the satellite (Adams and Kilmartin, 1999) 
where it may play its role in SPB duplication and interact with components of the half­
bridge. To further investigate the role of Spc29p, Spc29p was purified from wild type 
cells using anti-Spc29p antibodies coupled to Protein A Dynal magnetic beads in the 
presence o f 1M NaCl and 1% Triton. Cdc31p and K arlp specifically co-purified with 
Spc29p, as shown by immunoblotting (Figure 24, compare lane 1 to lane 3). However, 
when Spc29p was purified, under the same conditions, from CDC31-16 Akarl cells, 
K arlp did not co-purify, as expected, but neither did Cdc31-16p (Figure 24, compare 
lane 4 to lane 6). These results suggest that Spc29p, Cdc31p and K arlp interact in vivo. 
The interaction of Spc29p with Cdc31p may be via K arlp as in the absence o f Karlp 
Cdc31-16p does not co-purify with Spc29p. Alternatively, the interaction o f Spc29p 
with Cdc31-16p may be weaker than the interaction with Cdc31p and therefore was 
disrupted by the harsh conditions used in the purification or simply, the stability of the 
complex is reduced in the absence of Karlp.
Cdc31p was purified in the same experiment using anti-Cdc31p antibodies, again 
coupled to Protein A Dynal magnetic beads, in the presence of 1M NaCl and 1% Triton. 
K arlp specifically co-purified with Cdc31p, but Spc29p was not detected in the 
Cdc31p-purification (Figure 24, compare lanes 2 and 3). As expected, when Cdc31-16p
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Figure 23 Morphology of the SPB of CDC31-16 Akarl cells
A Wild type SPB 
B SPB of a CDC31-16 Akarl cell.
C, central plaque; Cy, cytoplasm; HB, half-bridge; I, inner plaque; MT, 
microtubules; NE, nuclear envelope; Nu, nucleus; O, outer plaque; S, 
satellite.
Bar = 0.25 pm, A and B are the same magnification.
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Figure 24 Co-ini mu noprecipitation of Cdc31p and K a rlp  with 
Spc29p in wild type cells
High salt extracts of wild type (lanes 1-3) or CDC31-16 Akarl (lanes 4- 
6) cells were incubated with control beads bound to non-specific IgGs 
(lanes 3 and 6) or anti-Spc29p (lanes 1 and 4) or anti-Cdc31p (lanes 2 
and 5) antibody-coupled magnetic beads. Immunoblots were probed 
with the indicated antibodies.
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was purified from CDC31-16 Akarl cells, there was no K arlp in the precipitate, but 
there was no Spc29p either (Figure 24, compare lanes 5 and 6).
Despite this, the finding that Cdc31p and K arlp co-purify with Spc29p indicates an 
interaction in vivo between half-bridge components and central plaque components. 
This interaction may be important during SPB duplication.
Additional interactors of Spc29p
Bbplp was identified as a novel SPB component when its presence was identified in a 
highly enriched spindle pole body preparation (Wigge et al., 1998). At this time the 
function of B bplp was not known, however BBP1 was found as a multicopy suppresser 
of spc29(ts) mutants (Figure 25A). To further investigate the relationship between 
Bbplp and Spc29p, Bbplp-ProA was immunoprecipitated using an IgG sepharose 
column. Spc29p was not detected in the precipitate, however a protein of 45 kDa was 
specifically present in precipitates from BBPl-ProA cells, but not in BBP1 cells 
(Schramm et al., 2000). This protein was identified as Mps2p by MALDI peptide 
mapping. Mps2p is a nuclear membrane protein that is involved in embedding the SPB 
in the nuclear envelope (Winey et al., 1991b). Immunoelectron microscopy studies have 
shown that both Bbplp and Mps2p are located at the periphery of the SPB, close to the 
central plaque (Schramm et al., 2000; Winey et al., 1991b). These results, along with 
numerous genetic interactions, indicate that Bbplp and Mps2p form a complex at the 
periphery of the central plaque where they have a function in embedding the central 
plaque in the nuclear membrane. In order to carry out this role it would be expected that 
the Bbplp/Mps2p complex would interact with the central plaque. Further attempts to 
co-precipitate Spc29p and Bbplp gave inconclusive results, therefore alternative 
methods were employed to investigate the possible physical interaction between Bbplp 
and Spc29p. Interactions were tested using an in vitro binding assay and the two hybrid 
system. SPC29 was translated and transcribed in vitro in the presence of [35S]-labelled 
methionine to give [35S]-Spc29p. GST, GST-Bbplp and His-Mps2p were expressed in 
E.coli. GST and GST-Bbplp were bound to glutathione sepharose beads. These GST 
and GST-Bbplp beads were then incubated with [35S]-Spc29p alone, to test for direct 
binding o f [35S]-Spc29p to GST-Bbplp (Figure 25B compare lanes 1 and 3). GST and 
GST-Bbplp beads were also incubated with His-Mps2p followed by incubation with 
[35S]-Spc29p to test whether [35S]-Spc29p binds to the Bbplp/Mps2p complex (Figure
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Figure 25 Spc29p interacts with Bbplp
A BBP1 is a multicopy suppresser of the temperature dependent growth defect of 
spc29(ts) cells. Cells of spc29-2 and spc29-3 with the indicated plasmids were 
incubated at 35°C for 3 days.
B Spc29p interacts with Bbplp in vitro. GST (lane 1 and 2) or GST-Bbplp (lane 3 and 
4) was bound to glutathione sepharose beads. These beads were incubated with (lanes 2 
and 4) or without (lanes 1 and 3) His-Mps2p. The beads were washed then incubated 
with [35S]-labelled Spc29p (lanes 1-4). The bound proteins were eluted from the beads 
with HU buffer and analysed by immunoblotting with anti-Bbplp and anti-Mps2p 
antibodies or by autoradiography ([35S]-Spc29p).
C Two-hybrid interactions between Spc29p and Bbplp. (3-Galactosidase activity was 
determined using an X-Gal overlay assay, blue colour indicates interaction. The control 
cells carry, for example, the pMM5 derived LexA-BBPl plasmid combined with pMM6 
without an insert.
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25B compare lanes 2 and 4). [35S]-Spc29p was found to interact with GST-Bbplp in the 
presence and absence of His-Mps2p, but neither [35S]-Spc29p nor His-Mps2p interacted 
with the GST beads. Therefore Spc29p interacts with B bplp and the Bbplp/Mps2p 
complex in vitro. Further support for an interaction between Spc29p and Bbplp came 
from the two hybrid system. Interactions were seen when B bplp was combined with 
Spc29p (Figure 25C), Mps2p or Karlp in the two hybrid system (Schramm et al, 2000) 
Taken together, these results are the first to give an insight into the proteins involved 
directly in embedding the SPB in the nuclear membrane and connecting the half-bridge 
to the central plaque.
Spc29p is a phosphoprotein
During the study of Spc29p it was noted that Spc29p appeared as a doublet when 
identified by immunoblotting. As a number of SPB components are phosphoproteins, it 
was predicted than the appearance of Spc29p as a doublet was due to phosphorylation. 
This was tested by purifying Spc29p from the soluble cellular fraction of lysed wild 
type cells and the salt extracted pellet containing the insoluble cellular material 
(including SPBs). Spc29p purified from these two cellular fractions was treated with 
alkaline phosphatase, which dephosphorylates proteins, then visualised by immuno­
blotting. The Spc29p purified from the soluble cellular fraction appeared as a single 
band, independent of alkaline phosphatase treatment, indicating that soluble Spc29p is 
not phosphorylated in vivo. Spc29p purified from the salt extracted pellet appeared as a 
doublet in the absence of alkaline phosphatase, however after treatment with alkaline 
phosphatase the upper band of the Spc29p doublet was greatly reduced. This was due to 
dephosphorylation by alkaline phosphatase as when the phosphatase inhibitor 3GP was 
added, at the same time as alkaline phosphatase, the appearance of the Spc29p doublet 
was the same as the buffer only control (Figure 26A). Therefore, Spc29p is a 
phosphoprotein.
In addition, Spc29p phosphorylation is cell cycle dependent. This was shown by taking 
samples from an a-factor synchronised culture at 15 minute intervals after release. 
Immunoblots of the cell extracts showed that Spc29p is phosphorylated at the same 
point o f the cell cycle as S pell Op (Figure 26B-D, note the upper band of the Spc29p 
and Spcl lOp doublets is stronger in intensity between 45 min and 75 min after release 
from a-factor arrest). Spell Op phosphorylation has previously been shown to occur at
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Figure 26 Spc29p is a phosphoprotein
A Wild type cells were lysed with glass beads, then separated into a soluble fraction 
and an insoluble pellet (containing SPBs) by centrifugation. The pellet was extracted 
with high salt, 1% Triton X-100. Spc29p was purified from the soluble fraction and the 
extracted pellet using anti-Spc29p antibodies coupled to protein A sepharose. Immuno- 
precipitated Spc29p was incubated with alkaline phosphatase (lanes 1, 2, 4 and 5), with 
(lanes 2 and 5) or without (lanes 1 and 4) the phosphatase inhibitor 3GP. Lanes 3 and 6 
contain buffer only as an additional control. Spc29p was detected by immunoblotting 
with anti-Spc29p antibodies.
B and C Phosphorylation of Spc29p changes during the cell cycle. Wild type cells 
were synchronised with a-factor, samples were taken at 15 minute intervals after 
release and analysed by immunoblotting with anti-Spc29p antibodies. B and C 
represent two independent experiments. The control lane (c) contains overexpressed 
Spc29p (B) or Spc29p-3HA (C).
D The samples used in B were loaded identically on a second gel and probed with anti- 
Tub2p antibodies as a loading control. SpcllOp was detected with anti-SpcllOp 
antibodies for comparison with Spc29p.
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the time of spindle assembly, the level of phosphorylated S pell Op then diminishes as 
the cells enter anaphase (Friedman et al., 1996). As well as being phosphorylated, the 
protein levels of Spc29p appear to increase and decrease during the cell cycle reaching 
a peak at 45-60 minutes after release from a-factor arrest (Figure 26B and C).
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Discussion
Spc29p is an essential component of the spindle pole body
Spc29p was first identified as a spindle pole body component by its presence in a salt 
stable SPB subcomplex containing ProA-Spc 11 Op, calmodulin, Spc42p and small 
amounts o f Cnm67p. Spc29p had previously been named Nip29p (Nuplp interacting 
protein with a molecular weight of 29 kDa) as it was found to interact with the nuclear 
pore component Nuplp in a two hybrid screen carried out by G. Schlenstedt. However 
this interaction was described as "of no biological significance", therefore Nip29p was 
renamed Spc29p (spindle pole component). SPC29 is an essential gene as its deletion is 
lethal. This was confirmed by Wigge et al (1998) when they identified Spc29p as an 
essential component of purified SPBs. The fact that SpcllOp, Cmdlp, Spc42p and 
Spc29p were present in the same complex indicates that at least some of these proteins 
directly interact with each other. The C-terminus of SpcllOp contains a calmodulin 
binding site, explaining the presence of Cm dlp in the complex. The C-terminus of 
Spc 11 Op is also known to be positioned at the central plaque, close to the IL2 Spc42p 
layer (Bullitt et al., 1997; Spang et al., 1996b; Sundberg et al., 1996) suggesting that 
SpcllOp and Spc42p interact either directly or via an additional protein. SpcllOp can 
be truncated at its C-terminus, by introducing a STOP codon just before the calmodulin 
binding site, without consequence (Geiser et al., 1993). Therefore, it is unlikely that the 
calmodulin binding site is involved in anchoring Spcl lOp to the Spc42p layer. By using 
the two hybrid system Spc29p was shown to interact with the C-terminus of Spcl 10p811' 
898 adjacent to the calmodulin binding site and the N-terminus of Spc42p. The 
interaction of Spc29p with SpcllOp and Spc42p has been supported by the results of 
genetic studies. spc29-2 and spc29-3 exhibit synthetic lethality with spc 110-2, spc42-9 
and cmdl-1. Also, multiple copies of SPC110 or SPC42 increase the growth defects of 
some spc29(ts) alleles. These data suggest that Spc29p interconnects SpcllOp with 
Spc42p at the central plaque (Figure 27). In support of this Spc29p has been localised to 
the central plaque of the SPB by immunoelectron microscopy (Adams and Kilmartin,
1999). No other proteins have been identified as integral components of the central 
plaque.
The observations that mutations in Spcl lOp that reduce calmodulin binding are lethal or 
conditional lethal to yeast cells and that the deletion of the entire calmodulin binding
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Figure 27 Schematic diagram  of the spindle pole body
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site is not lethal, but suppresses the cmdl-1 mutation led to the suggestion that the 
calmodulin binding site of SpcllOp has an inhibitory function that is relieved by its 
deletion or by calmodulin binding (Geiser et al., 1993; Stirling et al., 1994). The two 
hybrid interactions between SpcllOp mutants and Spc29p presented here are in 
agreement with this model and raise the possibility that Spc29p binding to SpcllOp is 
regulated by calmodulin. It is likely that calmodulin binds first to Spcl lOp reliving the 
inhibition caused by the very C-terminus of Spcl lOp, therefore allowing Spc29p to bind 
to SpcllOp (Figure 28). This ordered assembly of the Spcl 10p/calmodulin/Spc29p 
complex may be important before or during SPB duplication. It is also interesting to 
find that the region of SpcllOp that contains the Spc29p-binding site overlaps with 
Region II described by Sundberg and Davis (1997) as being important for binding of 
Spcl lOp to the central plaque.
Size regulation of the SPB is an area of regulation that is not really understood. It has 
been observed that diploid cells have SPBs that are twice the size of SPBs in haploid 
cells (Byers and Goetsch, 1975a) and that the size of the SPB correlates with the 
number of nuclear microtubules organised. Also, expression of the components of the 
Spcl lOp-containing SPB subcomplex fluctuates during the cell cycle, mRNA 
abundance of SPC 110, SPC42 and SPC29 increases in G1 at the time of SPB 
duplication (Cho et al., 1998; Zhu and Davis, 1998). However, do the expression levels 
of SPB components control the size of the SPB? Overexpression of SPC42 has been 
shown to drastically increase the size of the Spc42p polymer at the central plaque (IL2 
layer) (Donaldson and Kilmartin, 1996), but there is no effect on the inner or outer 
plaques. Overexpression of SPC110 causes aggregation of SpcllOp in the nucleus 
(Kilmartin and Goh, 1996; Sundberg et al., 1996) and overexpression of SPC29 causes 
accumulation of Spc29p in the nucleus. However, when all three are co-overexpressed 
in the same cell there is a dramatic increase in the size of both the central and inner 
plaques. This indicates that the expression levels of SPB components may contribute to 
the size regulation of the SPB. If this is so, there must also be additional controls in 
place to direct SPB components to the satellite and prevent SPB components from 
assembling at the mother SPB during duplication. These controls have not been 
identified, however in mutants that prevent formation of a satellite (for example 
cdc31(ts) and karl(ts)), the cells arrest with a single enlarged SPB (Byers, 1981a; Rose 
and Fink, 1987). Even more confusing is the recent suggestion that there is turnover of 
SPB components throughout the cell cycle and that the protein level of GFP-Spc29p 
peaks in mitosis (Davis and Yoder, Colorado meeting, 2000). In a way, this certainly
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Figure 28 A model for binding of C m dlp  and Spc29p to SpcllO p
Binding of C m dlp  to the C-terminus of SpcllOp relieves a self­
inhibition loop within Spcl lOp, allowing Spc29p to bind.
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makes sense, as during numerous divisions it is hard to imagine that an SPB can survive 
for generations without turnover of its core components, however why there would be 
an increase in the protein levels of SPB components in mitosis is yet to be investigated.
Spc29p is involved in SPB duplication
To investigate the role of Spc29p, temperature sensitive mutants were constructed. The 
mutations introduced into SPC29 allowed the cells to grow as wild type at the 
permissive temperature, but caused lethality at the non-permissive temperature. The 
cause of this lethality can be elucidated by analysing the mutant cells after short 
incubations at the non-permissive temperature. Synchronised spc29(ts) mutant cells 
were analysed by FACS and, after 3 hours at the non-permissive temperature, by 
immunofluorescence and electron microscopy. This line of investigation showed that 
Spc29p is involved in SPB duplication as most spc29(ts) mutants arrested in G2 as large 
budded cells with replicated, but not segregated chromosomes and monopolar spindles 
emanating from a single SPB signal. This single SPB was usually positioned in an 
invagination of the nuclear membrane close to the bud neck and showed abnormal 
morphology as seen by electron microscopy. A similar result was reported by Adams 
and Kilmartin (1999) who analysed spc29-20 cells after 2 or 4 hours at the non- 
permissive temperature. After two hours at the non-permissive temperature, a second 
smaller SPB could be observed close to, but not connected to the larger SPB. However, 
after 4 hours at the non-permissive temperature only one SPB could be detected by 
electron microscopy indicating that the smaller SPB was unstable and had most likely 
disintegrated. This SPB duplication defect indicates that Spc29p may not be solely a 
structural protein and due to the variety of different SPB morphologies, may be 
involved in more than one step in SPB duplication. These observations led to the 
investigation of a possible interaction between Spc29p and proteins known to be 
involved in SPB duplication.
Initial studies investigated a possible link between Spc29p and components o f the half­
bridge. The presence of multiple copies of CDC21 was found to suppress the defects of 
spc29-2 cells, but a single extra copy of KAR1 increased the temperature sensitivity of 
spc29-3 cells. These genetic interactions point to a possible functional relationship 
between Spc29p and Cdc31p/Karlp. This was further investigated by immuno- 
precipitation experiments. When Spc29p was purified, K arlp and Cdc31p both co­
Sarah L. Elliott, 2001 134
purified with Spc29p in wild type cells. Spc29p was also purified from CDC31-16 
Akarl cells, but Cdc31-16p did not co-purify with Spc29p. This result indicates that 
either Spc29p interacts with Cdc31p via Karlp or that the stability of the complex is 
compromised in the absence of Karlp. However, the CDC31-16 mutation is termed a 
"gain of function" mutation as it allows the deletion of the essential KAR1 gene. This 
led to the hypothesis that Cdc31-16p is able to interact with another SPB component 
independently of Karlp, this interaction may be weaker in wild type cells or may not 
occur at all. This hypothesis is supported by the finding that Cdc31-16p localises to the 
SPB in the absence of Karlp, whereas in wild type cells localisation of Cdc31p to the 
SPB has been reported to be dependent on Karlp (Biggins and Rose, 1994; Spang et al., 
1995). An interesting observation was that CDC31-16 Akarl cells contained SPBs with 
half-bridges that appeared thicker and longer than in wild type cells, but only extended 
over the cytoplasmic side of the nuclear membrane. Centrins in other organisms are 
present at the centrosome and basal bodies (Salisbury, 1995). The function of centrins at 
the centrosome is yet to be fully understood, however centrin present in the flagella 
apparatus of unicellular green algae forms contractile fibres that connect basal bodies to 
one another and to the nucleus (Salisbury et al., 1984). These fibres are involved in 
basal body localisation, orientation and segregation (McFadden et a l, 1987; Taillon et 
al., 1992; Wright et al., 1989; Wright et al., 1985). Centrins form fibres in vitro (Wiech 
et al., 1996) however, fibre formation is prevented by addition of Karlp peptides to the 
reaction. In the absence of Karlp, a membrane protein, there is no known connection 
between Cdc31p and the nuclear membrane, so how is the half-bridge formed in 
CDC31-16 Akarl cells? There is little evidence for formation of Cdc31p polymers in 
budding yeast, however in the absence of Karlp, which inhibits centrin filament 
formation in vitro, it is possible that the half-bridge seen in CDC31-16 Akarl cells is a 
filament of Cdc31-16p anchored at the central plaque and the satellite. If  this theory is 
true then Cdc31-16p must interact with at least one other SPB component, most likely is 
the formation of a complex that includes Spc29p due to its localisation at the central 
plaque and the satellite. In further support o f an interaction between Spc29p and 
Cdc31p, Spang et al (1995), reported that a protein of approximately 30 kDa binds to 
Cdc31p as demonstrated by crosslinking studies.
One protein that has been proposed to be involved in the gain of function interaction 
with Cdc31-16p is Dsk2p. Dsk2p was proposed due to numerous genetic interactions 
between CDC31, KAR1 and DSK2 alleles (Biggins et al., 1996). DSK2 was also found 
as a multicopy suppresser of spc29-2 and spc29-3 mutants, indicating that Dsk2p
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functions with Spc29p. Purification of Dsk2p-3Myc and Dsk2p-ProA gave inconclusive 
results, due to insufficient protein levels (Dsk2p-3Myc) or the presence of IgGs in the 
precipitate (in the Dsk2p-ProA purification). Although attempts to identify a Dsk2p- 
containing complex by immunopurification yielded no convincing results, further 
investigation may shed light on the function of Dsk2p and the involvement o f Dsk2p 
with Spc29p and the components of the half-bridge. Work by Khalfan et al (2000) 
identified genetic interactions of karlA17 , cdc31-2 and Adsk2Arad23 mutants with 
components of the PKC1 cell integrity, signal transduction pathway, though the 
significance of these interactions is unclear.
Spc29p interacts with Bbplp
BBPl is an essential SPB component (Wigge et al., 1998) that was identified as a 
multicopy suppresser of the temperature dependent growth defect of spc29-2 and spc29- 
3 cells. This interaction raised questions regarding the function of Bbplp. Bbplp was 
then found to interact with Spc29p in the two hybrid system. Purification of Bbplp 
failed to identify a complex containing Spc29p, however a complex consisting of 
Bbplp and Mps2p was identified (Schramm et al., 2000). Mps2p and Bbplp both 
localise to the periphery of the SPB (Munoz-Centeno et al., 1999; Schramm et al.,
2000) where they are involved in inserting the newly formed SPB into the nuclear 
membrane during SPB duplication. This can be seen in the bbpl-1 and mps2-l mutants 
which arrest at the non-permissive temperature with a duplication plaque that is unable 
to insert into the nuclear membrane (Schramm et al., 2000; Winey et al., 1991b). It is 
the central plaque that is embedded in the nuclear membrane, therefore it is probable 
that Mps2p in the membrane interacts with a central plaque component via Bbplp. 
Therefore Spc29p was tested for direct binding to Bbplp. In vitro translated Spc29p 
interacted with recombinant GST-Bbplp and the Bbplp-Mps2p complex. It is possible 
then to suggest that the Mps2p-Bbplp-Spc29p complex forms the hook-like structures 
seen connecting the SPB to the nuclear membrane by high voltage electron tomography 
(O'Toole et al., 1999).
BBPl interacts with KAR1 genetically, as with spc29(ts) mutants, a single additional 
copy of KAR1 increased the temperature dependent phenotype of bbpl-1 cells 
(Schramm et al., 2000). Bbplp also interacted with K arlp in the two hybrid system, this 
is not necessarily a direct interaction as the two hybrid system identifies interactions in
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vivo, therefore any interaction seen may be via other proteins present in the yeast cells. 
However, it is possible that the Bbplp/Mps2p complex interacts with the half-bridge 
where it meets the central plaque (Figure 29). Two hybrid interactions were also seen 
when Spc29p was combined with Cdc31p or Karlp, however these results were not 
consistent. Despite this there are now indications, for the first time, of a link between 
core SPB components and half-bridge components.
Conclusions
Spc29p appears to interact with a number of different proteins (Figure 30) This has 
been shown using numerous genetic and biochemical methods. During these studies it 
appeared that some interactions were more obvious and more easily explained than 
others. For example it is easy to state that Spc29p is a structural component of the 
central plaque where it interacts with Spc42p and Spcl lOp. However this simple model 
does not explain the interactions with Cdc31p, K arlp and Bbplp, how do these 
interactions fit into the model? It may be that multiple proteins interact with Spc29p at 
the periphery of the Spc29p layer within the central plaque. These interactions would be 
important during SPB duplication and/or insertion of the newly formed SPB into the 
nuclear membrane. In this model the strongest interactions would be Spc29p with 
Spcl lOp and Spc42p at the central plaque, Bbplp with Mps2p in the membrane at the 
periphery of the SPB and Cdc31p with Karlp at the half-bridge. The weaker 
interactions would involve Spc29p, around the rim of the central plaque or at the 
satellite, interacting with Bbplp/Mps2p and Cdc31p/Karlp. These weaker interactions 
may explain why Spc29p was not present in precipitates from B bplp and Cdc31p 
purifications. Also, the Spc29p immunoprecipitate was probed for the presence of 
Bbplp, Mps2p, Spc42p and SpcllOp, unfortunately the only antibodies available for 
these proteins were rabbit antibodies, the secondary antibody therefore detected 
contamination by rabbit IgGs washed from the beads. These signals were strong and 
present on the gel in the areas where Bbplp, Mps2p and Spc42p would be found, 
identification of SpcllOp was inconclusive. However, Cdc31p and K arlp could be 
detected specifically in the Spc29p purification using goat antibodies.
The observation that Spc29p is phosphorylated allows the formation of a hypothesis in 
which phosphorylation of Spc29p may regulate interactions of Spc29p with different 
proteins at different cell cycle stages.
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Figure 29 Model describing the interactions between Spc29p, the 
Bbplp/M ps2p complex and the C dc31p/K arlp  complex
A Cross section through an SPB showing Bbplp-Mps2p binding Spc29p at 
the central plaque.
B Horizontal cross section through Spc29p layer at the central plaque 
showing that the Bbplp-Mps2p complex forms a ring around the periphery 
of the central plaque. Dotted line shows position of cross section in A
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Figure 30 Summ ary of Spc29p interactions
Sarah L. Elliott, 2001 139
This research into the structure of the budding yeast spindle pole body and the control 
of its duplication have significance in other fields and to other organisms. Since the 
discovery o f Tub4p (y-tubulin) the budding yeast spindle pole body has become one of 
the most studies microtubule organising centres. Despite its structural difference to the 
centrosome, the SPB and centrosome share homology in their component proteins. 
Understanding the centrosome and how its duplication is controlled is an integral part of 
cancer research. Fidelity o f centrosome duplication is important to ensure that the 
replicated genome is correctly separated during mitosis and that mother and daughter 
cells each receive a full set of chromosomes. It has been shown that centrosomes are 
abnormal in number, form and function in a wide variety of human malignant tumours 
(Lingle et al., 1998; Pihan et al., 1998). It is easy to see how a defect in centrosome 
duplication could lead to aneuploidy and genetic instability, resulting in overexpression 
of oncogenes or loss of tumour suppresser genes and therefore contribute to the 
progression of cancer (Doxsey, 1998). The identification o f pathways and proteins that 
regulate centrosome function and duplication would provide an opportunity to 
determine the origins of cancer and develop novel treatments. Recently a protein related 
to SpcllOp has been implicated in the development of cancer (Doxsey et al, ASCB 
meeting, San Francisco, 2000). As yet no Spc29p homologues have been identified, 
however Spc29p interacts with two proteins (SpcllOp and Cdcl3p) that are known to 
have homologues in higher eukaryotes, therefore it is more than likely that as more 
discoveries are made and more genomes are sequenced, that homologues will be 
identified.
The Future
Were this project to continue, it would focus on elucidating the functions of the Spc29p 
interactions with Cdc31p/Karlp, Dsk2p and Bbplp/Mps2p, with the hope of gaining a 
greater understanding of spindle pole body duplication and of microtubule organising 
centres in general.
Further to this aim, a search for homologues of Spc29p would be carried out. This could 
be done by screening for suppression of spc29(ts) mutants using human, Xenopus or S. 
pombe cDNA libraries.
Sarah L. Elliott, 2001
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